weighted_completeness_percent,completeness_percent,weighted_error_percent,weighted_quality_score,publisher,title,id,quality_rating,weighted_quality_rating,schema_version,error_percent,pid,quality_score
4.76,4.76,46.03,29.36,,KPIC,0056a5c8-4f98-4e9e-b74a-bd498be71c0d,Not Rated,Not Rated,1.1.7,46.51,11dee486-22d2-4cf4-a955-512249e61645,29.12
33.33,19.05,50.79,41.27,,Mental Health Inpatient and Day Case - Scottish Morbidity Record (SMR04),00e1b694-3072-4d25-ab2d-a1de59629ae3,Not Rated,Not Rated,1.1.7,51.16,24de9d1a-1f48-4c10-b8fc-a3bd7449e191,33.95
46.03,50.0,26.98,59.52,ALLIANCE > HQIP,National Paediatric Diabetes Audit - Parent and Patient Recorded Experience measures,00ffee70-43d6-4a81-8568-32b0b6d9e39c,Not Rated,Not Rated,1.1.7,27.91,b0979e07-3331-408f-853b-5eeba80ce8f9,61.05
60.32,69.05,17.46,71.43,ALLIANCE > TISSUE DIRECTORY,PTCL Biobank,0121c132-5be6-414e-853b-885ff301854f,Bronze,Bronze,1.1.7,18.6,19fa25a7-c15d-441c-b635-ad49043e7a96,75.22
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,Human Developmental Biology Resource (HDBR),01470238-7a17-47a5-a131-17178ba26a0a,Silver,Bronze,1.1.7,16.28,399a6d67-7577-4476-a3b6-4bbceb5a8ff7,76.38
33.33,19.05,60.32,36.5,,BathTAP Switching Cohort 2,01a5c44c-c2fd-4c1e-856e-9875ee1beafa,Not Rated,Not Rated,1.1.7,55.81,ea1aca1f-6ddb-44a0-b530-0645a26b2bee,31.62
33.33,19.05,50.79,41.27,,Careers Wales Dataset (CARW),025706a9-538b-4773-aa8d-4004b1351c1a,Not Rated,Not Rated,1.1.7,51.16,e4004e0e-6adb-4b11-82c2-af0caf61d751,33.95
23.81,28.57,33.33,45.24,ALLIANCE > HQIP,National Diabetes Audit - Core Clinical Audit Dataset,02a6e7b7-ccf8-4446-b899-74065c8b3dd9,Not Rated,Not Rated,1.1.7,32.56,f4c8900b-5db5-4426-95e9-2f1617c92a76,48.0
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,Cam-UroOnc Biorepository,0315886c-f34a-4f1d-8f76-2dfa80a6e949,Silver,Bronze,1.1.7,16.28,21044030-1cd5-46b1-b072-c9959fd330b4,76.38
23.81,28.57,33.33,45.24,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,The Leicester City and County Chronic Kidney Disease Cohort,039c0b29-63f6-4ce9-8d89-87012a52e44f,Not Rated,Not Rated,1.1.7,32.56,4dfec37d-dd24-465f-85ea-30209aff3a26,48.0
53.97,61.9,20.63,66.67,HUB > BREATHE,"4 Country ChrOnic: estimating respiratory disease burden in adults, South India",03abf37c-41b2-4ff3-9c09-2cfea438526a,Bronze,Bronze,1.1.7,20.93,2f1244b8-7cbf-4fa3-8534-433efd769d48,70.48
33.33,19.05,55.56,38.88,,NIHR BioResource: Consent records,03cdf92e-b6ea-4e1d-a861-e9da4372ed36,Not Rated,Not Rated,1.1.7,53.49,1fb479b1-98d4-4d7b-91a2-8368ce3dc77c,32.78
68.25,59.52,36.51,65.87,OTHER > UNIVERSITY COLLEGE LONDON,COVIDsortium,03fb3b18-4419-44f7-a035-9ddfecfcadfc,Not Rated,Not Rated,1.1.7,30.23,529f126b-660c-4c31-aeb2-765dac1d9df0,64.64
14.29,16.67,36.51,38.89,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,SOLUS,0477b06f-cbed-4949-982e-ce248a47ed1a,Not Rated,Not Rated,1.1.7,37.21,e653b264-3e44-4ed1-a376-86df45db7f72,39.73
96.83,92.86,22.22,87.31,HUB > DISCOVER NOW,North West London COVID-19 Patient Level Situation Report (NWL COVID19 SITREP),04f22c93-53df-440a-a71a-50d6827450bc,Gold,Gold,1.1.7,18.6,ed08c844-343e-44fa-a02d-3ad5ecf25184,87.13
33.33,19.05,55.56,38.88,,NIHR IBD BioResource: Sample holding,04f28919-aa6c-4beb-b186-0ad0043c1c6c,Not Rated,Not Rated,1.1.7,53.49,f2af20f9-af84-40ce-8a07-7d095948653e,32.78
22.22,26.19,36.51,42.86,ALLIANCE > HQIP,National Asthma and COPD Audit Programme (NACAP):COPD and adult asthma secondary care organisational dataset,04fb4aac-415b-4493-986b-65bbef5214d3,Not Rated,Not Rated,1.1.7,37.21,1982d9ef-890a-41ff-a86a-de61d65aaa09,44.49
100.0,95.24,15.87,92.06,ALLIANCE > SAIL,Bowel Screening Wales,05716e41-9842-4c07-8ddd-af9f9231e056,Gold,Gold,1.1.7,13.95,9f29d47e-4e9a-41b8-b7bc-5ef3570294ef,90.64
100.0,95.24,20.63,89.69,ALLIANCE > SAIL,COVID-19 Shielded People list,05a0baf4-72ea-4e02-b4fb-64c37bb1eb0e,Gold,Gold,1.1.7,16.28,dc22db56-8791-4e96-9ce6-6b6a58b1241f,89.48
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,INCA Trial,0664f988-276e-4268-af43-1986a3101f38,Silver,Bronze,1.1.7,16.28,edd55990-a616-4a9c-a4a2-38af136a349b,76.38
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,HCV Research UK,069c213c-eb04-463e-a300-7614c03cf623,Silver,Bronze,1.1.7,16.28,01492322-9b33-41cc-9f51-484024e45878,76.38
98.41,92.86,19.05,89.68,HUB > PIONEER,"OMOP dataset: Hospital COVID patients: severity, acuity, therapies, outcomes",06dee089-8c10-4a8b-aa94-7cb699dc3c80,Gold,Gold,1.1.7,18.6,0eb789bb-0047-46ac-83ff-631f31e98da0,87.13
14.29,16.67,36.51,38.89,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,Millennium Clinical Events,0711cc7e-80d5-4781-a1ab-2637ea176ceb,Not Rated,Not Rated,1.1.7,37.21,5f45bcd1-970b-44ba-8ae2-0fb49b85ffa9,39.73
71.43,80.95,12.7,79.37,HUB > BREATHE,Prospective Observation of Fibrosis in the Lung Clinical Endpoints,0715a950-3999-46d8-a646-6496866638a1,Silver,Silver,1.1.7,11.63,bb8de9d2-cc38-4c40-b104-ffd167f64f76,84.66
33.33,19.05,55.56,38.88,,COVID-19 Shielded People List (CVSP),074e00d5-05c1-48c6-a6c3-d5228fa515bb,Not Rated,Not Rated,1.1.7,53.49,dc22db56-8791-4e96-9ce6-6b6a58b1241f,32.78
33.33,19.05,50.79,41.27,,COVID-19 Sequence Data,077a21b9-5c5a-4c68-a9f0-b4fa3384aead,Not Rated,Not Rated,1.1.7,51.16,602cbc9b-0113-4712-8c4a-0efe8d86b77c,33.95
31.75,33.33,26.98,52.38,UK Biobank,Exome sequencing,07b82dd5-adc3-42c5-8a60-914042b5bc40,Not Rated,Not Rated,1.1.7,27.91,2ddf0659-f05a-4f1c-b558-63a96e5b49f7,52.71
84.13,76.19,25.4,79.36,HUB > PIONEER,The impact of COVID on hospitalised patients with COPD; a dataset in OMOP,07e3ac82-a38d-45f3-9933-07439f6a761d,Bronze,Silver,1.1.7,25.58,323dc330-aad9-472a-b579-ab66f5f75906,75.31
33.33,19.05,50.79,41.27,,Breast Test Wales (SBTW),084ab1d8-78f6-4c04-b829-6891c6463ca9,Not Rated,Not Rated,1.1.7,51.16,8b9efd45-f56d-4aa3-b2b8-c66ff3813a2b,33.95
88.89,80.95,22.22,83.34,ALLIANCE > SAIL,Careers Wales dataset,08846261-45f0-4bcf-9801-fe785dcef1c9,Silver,Silver,1.1.7,20.93,e4004e0e-6adb-4b11-82c2-af0caf61d751,80.01
4.76,4.76,46.03,29.36,,Klang Asthma Cohort,089a0dd5-b2bd-4152-8033-d53552fe2c80,Not Rated,Not Rated,1.1.7,46.51,a2eddb27-c8bd-42ae-94f8-2a3026220da3,29.12
33.33,19.05,55.56,38.88,,Tayside Pathology,08d1a4f5-92b0-4142-a38d-8bac734086e8,Not Rated,Not Rated,1.1.7,53.49,419e5a82-2d82-48a7-a8f3-a83e64a54e92,32.78
33.33,19.05,55.56,38.88,,NHS Tayside and Fife Accident & Emergency Dataset (ISD/National),0910383a-44d6-4652-98da-550df7204416,Not Rated,Not Rated,1.1.7,53.49,750063ea-6bfd-4492-9748-2a18080cf6ea,32.78
82.54,73.81,25.4,78.57,HUB > PIONEER,The acute presentation of pregnant women to non-maternity Emergency departments,0942304f-8b91-4258-af9c-3a1801c7e79f,Bronze,Silver,1.1.7,25.58,86632207-1e57-4272-b178-ea069a13cae1,74.12
4.76,4.76,46.03,29.36,,National Cardiac Audit Programme - National Heart Failure Audit,0969dc51-1ab9-469a-8b35-3ec63f30fa89,Not Rated,Not Rated,1.1.7,46.51,834618f3-0c6d-4ed2-abae-39208c6b3080,29.12
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,ICON9 Trial,097cc6bd-ce98-47ec-a73d-5d2c250f2697,Silver,Bronze,1.1.7,16.28,1fdf266c-d5d8-418d-a423-81265da540a2,76.38
4.76,4.76,46.03,29.36,,Development of ELISA and Rapid Testing Kits for COVID-19,09f04291-670d-4db0-a3e4-7e0d84555231,Not Rated,Not Rated,1.1.7,46.51,6b2aca2c-b03a-44ba-80a1-883b744421b6,29.12
4.76,4.76,46.03,29.36,,Lothian Birth Cohort 1921 (LBC1921),0a137eec-4288-400b-8c47-0275319c9f09,Not Rated,Not Rated,1.1.7,46.51,df288318-6663-417d-9870-666e75920bed,29.12
100.0,95.24,20.63,89.69,ALLIANCE > SAIL,Pathology Data from WRRS,0abfceb7-5a56-4559-b0d4-88326e0331a3,Gold,Gold,1.1.7,16.28,48ef8f54-9606-4e6f-9256-3cc07ffd10b8,89.48
33.33,19.05,55.56,38.88,,Pathology Data from WRRS (PATH) - Legacy,0ac16d3d-5ca8-4e25-ad46-ce8e03a04e17,Not Rated,Not Rated,1.1.7,53.49,48ef8f54-9606-4e6f-9256-3cc07ffd10b8,32.78
85.71,78.57,28.57,78.57,NCS > OFFICE FOR NATIONAL STATISTICS,Census 2011 E&W - Household structure for COVID-19 models,0ac9438e-da8d-4488-bdc6-8285d1401b1d,Silver,Silver,1.1.7,25.58,2f66bcf9-e626-4e8d-bc6e-2d3958e709d8,76.5
4.76,4.76,46.03,29.36,,National Paediatric Diabetes Audit - survey of diabetes-related technologies,0afd2b0a-fee2-4002-b95a-36effe65a454,Not Rated,Not Rated,1.1.7,46.51,eecbdd8d-92a0-4dfd-a216-1cf7f1f8c98f,29.12
4.76,4.76,46.03,29.36,,Determinants of Adolescent Social Wellbeing & Health (DASH),0b06a5c0-f015-4ce6-bf53-cab304334ae0,Not Rated,Not Rated,1.1.7,46.51,9d242d12-2d2e-4941-93e4-9ec40d239dd1,29.12
60.32,69.05,19.05,70.64,ALLIANCE > TISSUE DIRECTORY,HPB Biobank,0b7ea326-fc05-4aca-a962-3f93128b91d1,Bronze,Bronze,1.1.7,18.6,ebe6c9dd-fb95-4301-a929-c21b8077753a,75.22
57.14,66.67,19.05,69.05,HUB > BREATHE,Teleconsultation in remote rural India: management of COPD and Asthma,0c219a61-a1d6-4c5b-bec2-3537454e4137,Bronze,Bronze,1.1.7,18.6,de496590-26b3-4e74-bc5e-1ff5c83f5b43,74.03
60.32,69.05,19.05,70.64,ALLIANCE > TISSUE DIRECTORY,Tissue Access for Patient Benefit (TAPb),0c50801d-1079-4879-b608-5e8f112b313f,Bronze,Bronze,1.1.7,18.6,35985f8e-f01a-41cc-a9e2-30299d3d6eed,75.22
58.73,71.43,19.05,69.84,HUB > BREATHE,Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II),0c78d1cf-4ba6-44f4-adcf-16c15142d8fb,Silver,Bronze,1.1.7,16.28,25bc9862-5b6c-4dda-80b2-46642d9e518a,77.58
33.33,19.05,55.56,38.88,,Substance Misuse Dataset (SMDS),0c8fcf41-177b-4ca8-a01f-d86ca8bd5a03,Not Rated,Not Rated,1.1.7,53.49,291c0dd4-0988-42d2-8e0b-878a892add57,32.78
46.03,47.62,30.16,57.94,ALLIANCE > NHS DIGITAL,Mental Health Services Data Set - Community,0c98200b-48b5-418a-b8d0-a7708abc1f39,Not Rated,Not Rated,1.1.7,32.56,f3bb6a68-2c32-40a7-9a79-61a718068893,57.53
4.76,4.76,46.03,29.36,,NIHR IBD BioResource: NHS Trust data,0d65fabc-6cb0-4a77-a01d-cb341b0b053c,Not Rated,Not Rated,1.1.7,46.51,ae1898da-7fe5-4fe0-b10d-9f06cdec1735,29.12
63.49,71.43,15.87,73.81,ALLIANCE > TISSUE DIRECTORY,The Cleft Collective,0d6ab9af-c43b-490d-b39c-2d72de46a661,Silver,Bronze,1.1.7,16.28,12288034-00a4-47a8-a779-1cf7a55270e4,77.58
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,MRC Brain Banks Network,0d70b5c8-da5d-49c5-8ff5-0bdc7b5f6306,Silver,Bronze,1.1.7,16.28,6f1b9a4e-2367-47f1-a985-3ed9bf3a7211,76.38
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,Leeds NIHR Biomarker Research Tissue Bank,0d79e0d8-9b3d-4450-9c34-0539673dc9a5,Silver,Bronze,1.1.7,16.28,8648d251-6186-4383-82fc-c036a87c3842,76.38
33.33,19.05,55.56,38.88,,Renal Register – PHS National Dataset,0ddb1d67-e0b9-4b08-898c-9957a09d7e69,Not Rated,Not Rated,1.1.7,53.49,32edd77d-533c-423f-b045-937507f8505d,32.78
79.37,73.81,33.33,73.02,HUB > DATA-CAN,Real Time Data Network (RTDN),0ddcb454-2372-4180-9ba0-a7e1896d4fe2,Bronze,Bronze,1.1.7,32.56,616c4488-65a5-4608-a187-0c6bc78b359a,70.62
79.37,71.43,30.16,74.61,ALLIANCE > NHS DIGITAL,Cancer Registration Data,0e07413c-892c-4f06-bd22-2a917eb5c905,Bronze,Bronze,1.1.7,27.91,2ed7bbbc-80db-46c2-a45b-632dda40794b,71.76
77.78,64.29,49.21,64.28,ALLIANCE > NHS DIGITAL,Mental Health Minimum Dataset v4 (Sensitive) Episodes,0e6e6ed5-ab81-4d7f-b06a-768bf33357ca,Not Rated,Not Rated,1.1.7,44.19,29c61f09-c4a1-425f-9bbc-888c23d99516,60.05
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,Cardamon Clinical Trial Samples,0ecedaa2-e8f5-4eb2-ad3f-fc2ce433fc36,Silver,Bronze,1.1.7,16.28,c0dcceca-c8cf-4269-a0e0-0c18b6ba2de1,76.38
33.33,19.05,50.79,41.27,,Better Rx BRIT2 Patient GP Dataset,0efcd6ce-4e7a-4f8e-8903-1a987ec76b1c,Not Rated,Not Rated,1.1.7,51.16,656b2c22-9e57-4f15-9b3c-1969da6495ca,33.95
4.76,4.76,46.03,29.36,,National Cardiac Audit Programme -  Congenital Heart Disease Audit (NCHDA),0f1a2789-e8b3-4e36-9622-65d76cebff26,Not Rated,Not Rated,1.1.7,46.51,2b640175-725a-465f-9aec-6794e6d27791,29.12
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,UKALL14 Trial,0faa4c3e-edf5-4ae8-9b26-c59c98e26b57,Silver,Bronze,1.1.7,16.28,b5533cb5-0c59-495b-9b11-3c401daeb958,76.38
77.78,64.29,49.21,64.28,ALLIANCE > NHS DIGITAL,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Events,0fc61ace-397d-4489-9e62-77f88082e775,Not Rated,Not Rated,1.1.7,44.19,9c8bd383-b117-4167-a25c-9e15fa5ec1c6,60.05
4.76,4.76,46.03,29.36,,"National Audit of Dementia - spotlight audit on  psychotropic medication, 2019",1045ca85-0c8f-453b-9da3-778144cf3744,Not Rated,Not Rated,1.1.7,46.51,949d9d7a-a3f1-480a-8563-3fb024300561,29.12
15.87,19.05,39.68,38.09,ALLIANCE > BARTS HEALTH,CDE Clinical Events,1092c90a-d3d5-4904-97ba-1861cfaddb65,Not Rated,Not Rated,1.1.7,41.86,e3b36044-e1fb-418b-946a-b83626bf2e3f,38.59
17.46,21.43,36.51,40.48,ALLIANCE > BARTS HEALTH,CDE Patient Demographics,10b10bc5-ce28-4cc0-b006-2a0e6d03a72d,Not Rated,Not Rated,1.1.7,37.21,209d7fae-0521-4d07-8a4d-e0843a46a107,42.11
4.76,4.76,46.03,29.36,,Bangladesh Asthma Hajj Study,112db000-f69f-47a4-8dd7-db7b6d839e68,Not Rated,Not Rated,1.1.7,46.51,27e1ffc7-5804-40e2-83e2-93f570906127,29.12
33.33,19.05,55.56,38.88,,UK SARS-CoV-2 viral sequencing data (COG-UK) - Lineage/Variant Data - NI,115109e7-9a35-420f-831e-0707bc96375c,Not Rated,Not Rated,1.1.7,53.49,3d2d9c5e-6111-4583-a6db-07affd628f1e,32.78
23.81,28.57,33.33,45.24,ALLIANCE > HQIP,National Maternity and Perinatal Audit Organisational Survey 2019,1199f5b5-99f0-4aae-9769-ab754f05dcdb,Not Rated,Not Rated,1.1.7,32.56,01ad25ed-8cde-43d7-bc77-d8cc3d165df4,48.0
33.33,19.05,50.79,41.27,,2019 UK Parkinson's Audit - Occupational therapy,125202ff-1d00-4f8e-96e1-1d5a310ab326,Not Rated,Not Rated,1.1.7,51.16,9890eee9-44d4-49f7-8674-16c05a5f82e0,33.95
4.76,4.76,46.03,29.36,,NIHR IBD BioResource: SNP imputation data,12d62b02-2167-407d-acdb-6ddb9d251d36,Not Rated,Not Rated,1.1.7,46.51,7dee2bd6-733a-4b2e-a942-7f9eaf8ebbc2,29.12
60.32,69.05,17.46,71.43,ALLIANCE > TISSUE DIRECTORY,UK primary Sjogren's syndrome Registry,12dba445-dfa9-46af-abc0-5bd3701061a7,Bronze,Bronze,1.1.7,18.6,38fe1a10-ebf9-4dc1-8c35-2e7b33b1f6b5,75.22
33.33,19.05,55.56,38.88,,Tayside Radiology,135f2650-ea0c-4cad-80ac-c86449a176a8,Not Rated,Not Rated,1.1.7,53.49,af10ec29-1866-4726-b33f-3948afe182f2,32.78
60.32,69.05,17.46,71.43,ALLIANCE > TISSUE DIRECTORY,Manchester Eye Tissue Repository,1406c52a-e5d6-4c57-883d-62e405eb604a,Bronze,Bronze,1.1.7,18.6,47fc8f03-eba1-4efa-ae3e-148a76b56517,75.22
33.33,19.05,55.56,38.88,,Referral to Treatment Times (RTTD),140ce7b6-8a58-4d0f-a24b-81b0f4289a68,Not Rated,Not Rated,1.1.7,53.49,0bf54842-c1db-4bdb-9f55-c5be490bf758,32.78
50.79,61.9,22.22,64.28,HUB > BREATHE,COPDMAP Consortium,1450ff1a-4526-4a6e-b9e9-25969878449d,Bronze,Not Rated,1.1.7,20.93,bcbc41cb-99f7-482e-ba3d-561164abbd4e,70.48
46.03,54.76,17.46,64.28,HUB > BREATHE,Optimum Patient Care Research Database,145916c8-d3ca-4465-a719-93dd0770a6e4,Bronze,Not Rated,1.1.7,16.28,e3ca35c1-b2e2-4479-adf1-6a78b1c8c088,69.24
33.33,19.05,55.56,38.88,,National Asthma and COPD Audit  (NACAP): secondary care  – CYP asthma (org),147576e2-b445-4d36-aecc-d604302bd34e,Not Rated,Not Rated,1.1.7,53.49,3efd9b30-1f84-48c0-a3e0-402ecb5c7724,32.78
100.0,95.24,30.16,84.92,ALLIANCE > CYSTIC FIBROSIS TRUST,Cystic Fibrosis Patient Sweat Tests,148ebbaa-28f4-42e0-a27f-8587e516c3bf,Gold,Silver,1.1.7,20.93,34f0c2bd-d42e-4441-a89b-e0e384f12afa,87.16
100.0,95.24,20.63,89.69,ALLIANCE > SAIL,Active Adult Survey,15805559-2115-4822-b91f-635de36fb289,Gold,Gold,1.1.7,16.28,1eb67fd5-33f6-49dd-a43d-854fff9f25f5,89.48
88.89,80.95,28.57,80.16,HUB > PIONEER,UHB 2020 Winter Society of Acute Medicine Benchmarking Audit,1584af1e-9683-4727-8c9b-9bea8beaa68d,Silver,Silver,1.1.7,25.58,5bf9bf39-3cd7-4a54-994b-9914405f945e,77.69
4.76,4.76,46.03,29.36,,Health and Employment After Fifty (HEAF),15aebc30-1e52-4a36-8b17-f9801f35f649,Not Rated,Not Rated,1.1.7,46.51,ea2d54a2-a6d4-4e82-b2e4-95184f00bbdc,29.12
100.0,95.24,19.05,90.47,GENOMICS ENGLAND,GENOMICS ENGLAND 100K QUICK VIEW,15efea36-d022-495c-a5b6-90f51631a643,Gold,Gold,1.1.7,18.6,4cc5ed33-3190-4f80-953b-cabd5a2b1c7c,88.32
88.89,83.33,26.98,80.95,ALLIANCE > ISARIC 4C,COVID-19 Clinical Information Network (CO-CIN),1638cce2-12f5-410b-9624-86d2f407c502,Silver,Silver,1.1.7,20.93,84336be3-23bd-466e-b29b-df48db897665,81.2
63.49,71.43,15.87,73.81,ALLIANCE > TISSUE DIRECTORY,MFT Biobank,16445ebd-bd45-4ded-a7ae-05f33f676598,Silver,Bronze,1.1.7,16.28,d17efe5d-325f-4fcf-b25e-87d1f6269bea,77.58
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,Cambridge Blood and Stem Cell Biobank,167cc04b-23b8-4a9e-9ff9-6c8e07d6a561,Silver,Bronze,1.1.7,16.28,c51ab59a-33ce-4145-a642-7f3f96bca545,76.38
33.33,19.05,50.79,41.27,,2019 UK Parkinson's Audit - Physiotherapy,16d40748-66f1-4fc3-bdb3-7c8103cadeb7,Not Rated,Not Rated,1.1.7,51.16,27690c58-a5da-4359-909a-8e19ff6ca463,33.95
33.33,19.05,60.32,36.5,,Suspected Cancer Pathway Daily (SPCD),16f11980-e2e7-4f79-8e33-39ba4dc3547f,Not Rated,Not Rated,1.1.7,55.81,9ea2f685-d6c2-49fe-a0e2-735910584d67,31.62
14.29,16.67,36.51,38.89,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,ARIA Medonc,172242ce-a1c5-4915-9c71-686f6e7d5789,Not Rated,Not Rated,1.1.7,37.21,88eb839c-bc51-45f0-b15e-ea89bba9ffca,39.73
4.76,4.76,46.03,29.36,,National Asthma and COPD Audit (NACAP): COPD secondary care clinical dataset,17256ce7-dc04-497d-ac27-d0d60de22b00,Not Rated,Not Rated,1.1.7,46.51,85b4dc84-88f4-4740-80fa-fa1eb04a0ae6,29.12
88.89,80.95,28.57,80.16,HUB > PIONEER,UHB 2019 Summer Society of Acute Medicine Benchmarking Audit,1785cc1a-ace0-4980-8352-5977b2b72969,Silver,Silver,1.1.7,25.58,5acfadf9-21a7-4517-a1b2-620d20469611,77.69
60.32,69.05,17.46,71.43,ALLIANCE > TISSUE DIRECTORY,IoN Trial,17cd75a2-e2b5-440c-89b1-22c9f3b03a03,Bronze,Bronze,1.1.7,18.6,e10a660d-b84c-475f-abd4-024dd1af7a5d,75.22
100.0,95.24,20.63,89.69,ALLIANCE > GENOMICS ENGLAND,GENOMICS ENGLAND 100K BIOINFORMATICS DATA,1900af1a-bd21-4157-ac48-203eec682073,Gold,Gold,1.1.7,16.28,98999c67-0133-4f11-be95-b84ee5727c84,89.48
4.76,4.76,46.03,29.36,,UK Biobank - Online Questionnaires,19231ac4-4256-46e5-958b-b98d12e036f8,Not Rated,Not Rated,1.1.7,46.51,70dc8c5d-2dfa-429d-bfd3-695f5904c244,29.12
33.33,19.05,55.56,38.88,,Improving Access to Psychological Therapies Data Set,19525c5f-92ee-41b6-bb79-673624b27bdd,Not Rated,Not Rated,1.1.7,53.49,bcf6e5ce-986d-4b84-9c9c-69de966e8bbd,32.78
33.33,19.05,50.79,41.27,,Patient Episode Dataset for Wales (PEDW),196dc924-9289-4f31-900d-d9310dc34361,Not Rated,Not Rated,1.1.7,51.16,4c33a5d2-164c-41d7-9797-dc2b008cc852,33.95
33.33,19.05,55.56,38.88,,COVID-19 Consolidated Deaths (CDDS),199b8c9f-baf2-4eb8-a8fe-783f58eceb2e,Not Rated,Not Rated,1.1.7,53.49,70e37f44-5c3e-4c83-a42a-89b3476d1d45,32.78
63.49,71.43,15.87,73.81,ALLIANCE > TISSUE DIRECTORY,UK real-world lymphoid tissue bank,1a412ff0-6275-4cab-a485-bb76befc7afe,Silver,Bronze,1.1.7,16.28,c9f82f86-79e1-4067-932f-5e6dc939006d,77.58
100.0,95.24,30.16,84.92,ALLIANCE > CYSTIC FIBROSIS TRUST,Cystic Fibrosis Patient CFQ-R,1a4b65e9-5241-4081-9cbb-43a8c8c6ea3b,Gold,Silver,1.1.7,20.93,9cf5dbd3-a109-4e8d-b1bb-7e4126bd887f,87.16
23.81,28.57,33.33,45.24,ALLIANCE > HQIP,National Joint Registry - Revision Knee Replacement dataset,1b85497d-af3c-4a4d-8240-ff680411a0a4,Not Rated,Not Rated,1.1.7,32.56,6664317b-39b9-4133-b6c7-ec4bddf78c76,48.0
33.33,19.05,50.79,41.27,,"Diabetic Eye Screening: the Birmingham, Solihull and Black Country Data Set",1bafa55c-5616-47db-8ac8-798038146254,Not Rated,Not Rated,1.1.7,51.16,36886b21-12ff-45e7-82bc-fb5308c12450,33.95
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,National Audit of Psychosis - Audit on Early Intervention in Psychosis services - contextual data,1bbcb128-dd3e-4f56-81d5-17df2dab3c52,Not Rated,Not Rated,1.1.7,34.88,4559a14f-563d-4fd2-93ae-27c6c0fd891e,46.84
90.48,80.95,31.75,79.37,ALLIANCE > CPRD,Mother-Baby Link for CPRD GOLD,1bc9ccd6-44d0-43db-843a-f9fa293c4090,Bronze,Silver,1.1.7,30.23,b734a1b5-37d3-4859-85d4-bf011df2a951,75.36
85.71,78.57,23.81,80.95,ALLIANCE > NIHR BIORESOURCE,NIHR BioResource: Health and Lifestyle Questionnaire,1c3f55ec-d6fc-477e-a1b7-4b8dd43323c6,Silver,Silver,1.1.7,23.26,321e3ad6-96b9-4f19-bbc4-d06dfe2a59d5,77.66
33.33,19.05,55.56,38.88,,Deaths General Registrar Office – National Records Scotland,1c524f7c-ee22-4bdc-877b-8dddc03e3aa2,Not Rated,Not Rated,1.1.7,53.49,5362cfea-d554-43ba-916a-4460da39cc0c,32.78
92.06,85.71,31.75,80.16,ALLIANCE > CPRD,HES Admitted Patient Care data for CPRD Aurum,1c942123-845d-4c31-9f04-8e044be00e58,Silver,Silver,1.1.7,30.23,ed2de8fe-a204-4a4e-bcfa-9e3ad85e2fee,77.74
4.76,4.76,46.03,29.36,,Sero-surveillance to monitor the trend of SARS-CoV-2 infection in rural India,1ca52b96-27d9-491a-b5f0-5787852d39d2,Not Rated,Not Rated,1.1.7,46.51,185e9c5c-e686-4174-bcba-5e2f584b5cbb,29.12
46.03,54.76,23.81,61.11,HUB > BREATHE,Asthma self-management behaviour in Bangladesh and Pakistan,1cb397d5-a86d-4354-b1f7-565b7ef5054b,Not Rated,Not Rated,1.1.7,23.26,3b378225-48e1-45fa-b62d-fc4ed4b39bec,65.75
33.33,19.05,55.56,38.88,,Tayside Microbiology: Tests,1d2acc70-0e2d-4601-bbbb-569a49bfaa5b,Not Rated,Not Rated,1.1.7,53.49,826be5be-9977-49f9-b6d1-83ed9de08ebe,32.78
100.0,95.24,20.63,89.69,ALLIANCE > SAIL,Critical Care Dataset,1d46f920-e253-4e7d-a72a-843d068d3c69,Gold,Gold,1.1.7,16.28,1789286a-deaf-49df-88cd-660e92934af6,89.48
46.03,47.62,30.16,57.94,ALLIANCE > NHS DIGITAL,Mental Health Services Data Set - Service Users,1d5e3b05-8ce3-4f80-ae3a-f6031ad8cf69,Not Rated,Not Rated,1.1.7,32.56,f48ad0a1-f90c-4a81-8c04-b23f2d8baf7a,57.53
17.46,21.43,36.51,40.48,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,Patient SIMD Postcode,1db7ce43-0dc3-4fa9-8bc8-14db16aba508,Not Rated,Not Rated,1.1.7,37.21,798567eb-d790-466e-880b-75a1e94ffdf2,42.11
15.87,19.05,38.1,38.88,ALLIANCE > BARTS HEALTH,Somerset Cancer Registry,1e465797-5e54-4667-9120-d373e75be64f,Not Rated,Not Rated,1.1.7,39.53,3ec5f1c4-95c0-4b1d-899b-399cec32ad49,39.76
33.33,19.05,55.56,38.88,,UK Renal Registry - CKD and AKI on Dialysis Dataset,1e875c15-4a99-4c3e-9621-e4ebf594469f,Not Rated,Not Rated,1.1.7,53.49,b7152f21-0f2c-4ed9-a013-51e725242f94,32.78
33.33,19.05,55.56,38.88,,Emergency Care Data Set (ECDS),1f6118ce-4051-4ba6-b13e-63dca0032d8d,Not Rated,Not Rated,1.1.7,53.49,7749d90e-dd7a-4697-8a9c-666491c64a0c,32.78
23.81,28.57,33.33,45.24,ALLIANCE > HQIP,Sentinel Stroke National Audit Programme Clinical Dataset,203cc8b4-7711-4d1f-9213-af982d6cff28,Not Rated,Not Rated,1.1.7,32.56,059a6495-a7d5-435b-8e2b-806c6ccccf2e,48.0
33.33,19.05,55.56,38.88,,Annual District Death Extract (ADDE),207c4fd9-9ef9-492e-bf64-4c268289824b,Not Rated,Not Rated,1.1.7,53.49,15cf4241-abad-4dcc-95b0-8cd7c02be999,32.78
96.83,92.86,23.81,86.51,HUB > INSIGHT,Moorfields Eye Image Dataset Release 001,208f79dc-2294-4370-8f16-0d0f7bec9d10,Silver,Gold,1.1.7,20.93,6bfe44ef-9532-4986-b8a2-9c2cda4a89cc,85.97
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,National Clinical Audit of Anxiety and Depression - spotlight audit on psychological therapies (clinical),21676706-0165-4469-bffe-fbe5c6cb0f18,Not Rated,Not Rated,1.1.7,34.88,6c81b082-bdc5-4dcc-838a-e6e52e1be1cb,46.84
71.43,80.95,31.75,69.84,ALLIANCE > SLaM,South London and Maudsley NHS Foundation Trust (SLaM) Clinical Record Interactive Search (CRIS) platform,21cd4b8e-f4f5-44a6-83eb-b7799e98ba55,Bronze,Bronze,1.1.7,32.56,a25a9892-9141-4e78-8415-945ba73da11e,74.19
4.76,4.76,46.03,29.36,,NIHR BioResource: Returned datasets,21d1277b-baf8-4fb8-826e-3f4910d18098,Not Rated,Not Rated,1.1.7,46.51,261bcf76-8621-4f0d-b2e6-310993d73daa,29.12
23.81,28.57,33.33,45.24,ALLIANCE > HQIP,National Joint Registry - Revision Hip Replacement dataset,21d2acc3-f943-4469-98a4-1d9a5045bed6,Not Rated,Not Rated,1.1.7,32.56,4b8286e2-c4e4-4db4-8fd9-5f1c8b4e56de,48.0
85.71,78.57,30.16,77.78,ALLIANCE > SAIL,NHS 111 Dataset,22173802-db99-475e-b95e-d69798734077,Silver,Silver,1.1.7,25.58,3d6b69dc-cb3c-4b9a-bdea-a798e7d5b5cf,76.5
33.33,19.05,55.56,38.88,,Death Registration Data - Provisional Monthly Extracts,224f725d-9180-496a-8bae-3dab0099688f,Not Rated,Not Rated,1.1.7,53.49,487222b7-5c13-4a92-8b41-044796048720,32.78
63.49,71.43,15.87,73.81,ALLIANCE > TISSUE DIRECTORY,QTL Programme at MRC HGU,22739526-317f-4b0e-a23b-ece0c859958f,Silver,Bronze,1.1.7,16.28,351cc017-caff-4303-8a48-1aa1b90fce2b,77.58
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,Children's Cancer and Leukaemia Group (CCLG) Tissue Bank,227fe0ea-d76e-4c14-a33e-ca255380937d,Silver,Bronze,1.1.7,16.28,c232fa07-5d28-4bdc-b540-1ad8d933c5f9,76.38
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,University of Liverpool - GCP Laboratory Facility,22974866-44c7-4176-9c51-6b57a1dda39d,Silver,Bronze,1.1.7,16.28,029b7f0f-911e-46ce-837f-031959f067da,76.38
19.05,21.43,38.1,40.48,ALLIANCE > BARTS HEALTH,CDE Encounters,22aecb42-9ea3-4d60-b392-d3cdd0a806f8,Not Rated,Not Rated,1.1.7,39.53,3598723f-62fb-4377-9a8b-b264ced1aabd,40.95
100.0,95.24,28.57,85.72,GENOMICS ENGLAND,GENOMICS ENGLAND 100K RARE DISEASE & COMMON,239e8253-a997-4676-8940-16b74a004365,Silver,Silver,1.1.7,23.26,3f2b37f1-e8f7-42e5-83c4-fc9e1c58725d,85.99
33.33,19.05,55.56,38.88,,NHS Tayside and Fife Accident & Emergency Dataset (PHS/National),23d790f2-de80-4c7a-b57a-03c8467c54e9,Not Rated,Not Rated,1.1.7,53.49,750063ea-6bfd-4492-9748-2a18080cf6ea,32.78
33.33,19.05,55.56,38.88,,Emergency Department Dataset Daily (EDDD),24562202-5f76-4ada-9495-2260e3e7c42f,Not Rated,Not Rated,1.1.7,53.49,fa257aa8-51fc-4eb7-a448-e473fa54686d,32.78
60.32,69.05,17.46,71.43,ALLIANCE > TISSUE DIRECTORY,SWIFT-RTB,24f2374a-e804-434e-a805-e29b332b0693,Bronze,Bronze,1.1.7,18.6,d387ed7c-14fa-49e2-8ced-df0f9372eb88,75.22
90.48,83.33,26.98,81.75,ALLIANCE > SAIL,Intensive Care National Audit and Research Centre - Covid19,2550f814-0849-4d19-b83e-edef46b157fb,Silver,Silver,1.1.7,23.26,add6226b-0f21-439a-84a6-51dc26cdc425,80.03
33.33,19.05,55.56,38.88,,DOLORISK,260f4fb2-b40a-4e20-888d-1e3c9c2ddd8e,Not Rated,Not Rated,1.1.7,53.49,0a467180-a898-44d8-a586-ca4762de362e,32.78
87.3,78.57,26.98,80.16,ALLIANCE > CPRD,Patient postcode linked deprivation measures for CPRD Aurum,262c28eb-151e-4ab2-a813-81841f5292eb,Bronze,Silver,1.1.7,27.91,bd85a09c-fe4a-41b8-81d2-77feadcd1a0a,75.33
77.78,64.29,49.21,64.28,ALLIANCE > NHS DIGITAL,Mental Health Minimum Dataset v4 (Non-Sensitive) Episodes,263ad0a8-ae90-4c1d-85d6-c3d2470eb2b7,Not Rated,Not Rated,1.1.7,44.19,2964d1b0-2630-468a-82c1-00f5ac901b3d,60.05
77.78,64.29,49.21,64.28,ALLIANCE > NHS DIGITAL,Mental Health Minimum Dataset v2.6 (Sensitive),263f28a4-9835-4856-b1c3-0a0d4085f207,Not Rated,Not Rated,1.1.7,44.19,dc37fcd6-1e68-46e5-b73d-4896e069746a,60.05
65.08,73.81,15.87,74.6,ALLIANCE > TISSUE DIRECTORY,Arden Tissue Bank,263f4ce3-7ccf-45c3-9d41-c1f5ed14cc81,Silver,Bronze,1.1.7,16.28,62fdfd1c-f195-49cc-b3a1-7d9fd2cc8e1b,78.77
33.33,19.05,50.79,41.27,,Child Health Systems Programme - 27-30Months Review,26ac9d75-df76-49e5-ba41-d4c0e83a8765,Not Rated,Not Rated,1.1.7,51.16,d2d57b7f-95d8-425f-b2fd-cc9aff05e659,33.95
66.67,76.19,17.46,74.6,ALLIANCE > TISSUE DIRECTORY,Scottish Human Papillomavirus Archive,270b55a8-a9ee-44ee-8db6-eb214e721eea,Silver,Bronze,1.1.7,18.6,4883530f-1c8d-49aa-886e-ea3b958772ea,78.8
85.71,78.57,25.4,80.16,HUB > PIONEER,"Deeply phenotyped sepsis patients within hospital: onset, treatments & outcomes",273e091c-d0b3-4529-9cd2-4bc1a1b6195a,Silver,Silver,1.1.7,25.58,38ff49e2-dffa-4103-87a8-386f9f424d22,76.5
30.16,35.71,28.57,50.8,HUB > BREATHE,Unified Cohorts Research Network,274238a8-ec06-4ee4-83ae-a419a925d43b,Not Rated,Not Rated,1.1.7,27.91,cffcf30d-cedb-421b-a5dc-6726633cb99a,53.9
33.33,19.05,60.32,36.5,,NIHR IBD BioResource: SNP chip data,27a97f1b-e7ac-4723-87db-0a4d9e3ed4b6,Not Rated,Not Rated,1.1.7,55.81,3c749cfc-4008-4916-b64f-969d6a754c0f,31.62
33.33,19.05,50.79,41.27,,Looked After Children Wales (LACW),28486729-6a76-4a03-8c28-3ea971071583,Not Rated,Not Rated,1.1.7,51.16,cfdafacb-48f0-4ad8-9f20-193a5eec2da4,33.95
79.37,71.43,28.57,75.4,NCS > OFFICE FOR NATIONAL STATISTICS,Labour Force Survey (Longitudinal),28bb6308-013f-47d3-8c4b-74720ad3901d,Bronze,Bronze,1.1.7,25.58,4ac15572-fe9a-46d3-860d-a46b616181f7,72.93
88.89,80.95,28.57,80.16,ALLIANCE > CPRD,National Radiotherapy Dataset (RTDS) for CPRD GOLD,2918676c-74b0-4a4e-8814-697e9aa6a81c,Bronze,Silver,1.1.7,30.23,56a66de8-3470-4a36-ac71-4d5471e72654,75.36
15.87,19.05,39.68,38.09,ALLIANCE > BARTS HEALTH,DENDRITE Dataset,29de7178-dcf3-4859-bd96-ca6d944db5f8,Not Rated,Not Rated,1.1.7,41.86,31920b14-d114-410f-8255-522e6451c44e,38.59
33.33,19.05,50.79,41.27,,COVID-19 Symptom Tracker Dataset (CVST),29e5de14-f1d8-49fc-8766-21c2fc488d47,Not Rated,Not Rated,1.1.7,51.16,594cfe55-96e3-45ff-874c-2c0006eeb881,33.95
4.76,4.76,46.03,29.36,,Treatment of Bangladeshi children with severe pneumonia,2a17a802-a2da-4bfc-8571-b2015350eed4,Not Rated,Not Rated,1.1.7,46.51,2f4c56b3-ca6a-4b30-a7f0-d83e68192c5b,29.12
23.81,28.57,33.33,45.24,ALLIANCE > HQIP,National Diabetes Audit - National Diabetes Foot Care Audit clinical dataset,2a4d55ba-3ea7-495e-9ffe-ab1b919c149d,Not Rated,Not Rated,1.1.7,32.56,dabf34b3-7368-4097-94c5-5b4f4be68fc6,48.0
77.78,64.29,49.21,64.28,ALLIANCE > NHS DIGITAL,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Records,2a725f9d-c4a9-4c89-aa37-b3c25cc83389,Not Rated,Not Rated,1.1.7,44.19,7c2b435c-5442-4a05-9b8d-08024ec57c30,60.05
98.41,92.86,22.22,88.09,ALLIANCE > SAIL,Millennium Cohort Study,2b09ea87-5b22-4049-b7dd-de0889699115,Gold,Gold,1.1.7,18.6,a380bd6b-009f-4b78-b638-ba9ee62be2eb,87.13
85.71,78.57,26.98,79.36,HUB > DATA-CAN,Leeds-IQVIA Collaboration,2b40a784-79ea-4403-a4bd-0950a7a36a6c,Bronze,Silver,1.1.7,27.91,00b897c7-d50d-486a-af1b-bd94821b58f7,75.33
33.33,19.05,50.79,41.27,,Maternity Inpatient and Day Case - Scottish Morbidity Record (SMR02),2b77663f-c71d-4138-8fad-f45a1f8b1222,Not Rated,Not Rated,1.1.7,51.16,d47c809f-3da8-4f8a-b1ee-258d21aad530,33.95
63.49,71.43,20.63,71.43,ALLIANCE > TISSUE DIRECTORY,UCL Infection DNA Bank,2bd45ffb-b22f-4f02-968b-f5ab8f9d6342,Bronze,Bronze,1.1.7,20.93,3e5fb54a-84ec-4888-9a72-4093c6e90dbc,75.25
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,MDSBio,2c3e75c3-141a-4d29-b7f0-0dbe14fb18fd,Silver,Bronze,1.1.7,16.28,13c71637-144e-4742-8aea-aefb778a360e,76.38
33.33,19.05,55.56,38.88,,Millennium Cohort Study Dataset (MCSD),2ca2a23d-64c3-4691-9289-197436dddfa3,Not Rated,Not Rated,1.1.7,53.49,a380bd6b-009f-4b78-b638-ba9ee62be2eb,32.78
33.33,19.05,55.56,38.88,,Higher Education Statistics Agency (HESA) Student Data,2cb07157-1c99-48dc-9926-0ad968a09166,Not Rated,Not Rated,1.1.7,53.49,68b04d3b-17b4-4a04-a8a3-e2a93ed231df,32.78
88.89,80.95,36.51,76.19,ALLIANCE > CPRD,Mental Health Dataset (MHDS) for CPRD GOLD,2d25b733-d95a-485b-9499-907a48b51919,Bronze,Silver,1.1.7,32.56,d5c0cc93-3347-46f0-b8dd-f44e82718e38,74.19
100.0,95.24,23.81,88.09,GENOMICS ENGLAND,GENOMICS ENGLAND 100K NHSD LINKED DATA,2d4b933d-1c8b-4fde-860e-c324454d28f9,Gold,Gold,1.1.7,20.93,14c31b39-f189-4417-bd38-635268495593,87.16
33.33,19.05,60.32,36.5,,COVID-19 Vaccination Adverse Reaction,2d4d0d89-edfb-448a-b95b-a3c0401ebe75,Not Rated,Not Rated,1.1.7,55.81,080a90e4-4bc6-4153-a4c6-c120eef5ba94,31.62
47.62,57.14,22.22,62.7,HUB > GUT REACTION,IBD NIHR BioResource: NHS Trust data,2d6e8e68-2fc9-4b9c-a517-c5c5677af225,Bronze,Not Rated,1.1.7,20.93,ae1898da-7fe5-4fe0-b10d-9f06cdec1735,68.1
33.33,19.05,50.79,41.27,,Welsh Cancer Intelligence and Surveillance Unit (WCISU),2d7a047c-a90f-48e4-82ee-9a8a082a696e,Not Rated,Not Rated,1.1.7,51.16,368ad790-3ad8-4f93-9a7c-0bfb64dc6015,33.95
33.33,19.05,55.56,38.88,,NHS Tayside - A&E drugs given during an A&E visit,2d9240b4-6f54-4d00-9c2e-d19220c33211,Not Rated,Not Rated,1.1.7,53.49,acfbef89-344c-49a5-8079-7344f4316e0f,32.78
33.33,19.05,55.56,38.88,,Emergency Department Dataset (EDDS),2e51fba7-c119-4892-9e4e-89748bcb96eb,Not Rated,Not Rated,1.1.7,53.49,75c4dcb8-33bf-43f4-b2bb-db51b6621b2c,32.78
33.33,19.05,55.56,38.88,,SARS-CoV-2 viral sequencing data (COG-UK data) - Lineage/Variant Data - NI,2e98ae87-b10d-4aa0-acec-773a2b028af1,Not Rated,Not Rated,1.1.7,53.49,3d2d9c5e-6111-4583-a6db-07affd628f1e,32.78
100.0,95.24,17.46,91.27,ALLIANCE > SAIL,Patient Episode Dataset for Wales,2ef8bfd7-3edb-49e0-a1eb-edc181c03e1d,Gold,Gold,1.1.7,16.28,4c33a5d2-164c-41d7-9797-dc2b008cc852,89.48
4.76,4.76,46.03,29.36,,Community perception on public health measures for COVID-19 prevention/control,2f9c0340-2116-41f5-bdbd-921561476061,Not Rated,Not Rated,1.1.7,46.51,6464fb4f-2838-495b-9963-4001204ed166,29.12
33.33,19.05,55.56,38.88,,Deaths – National Records Scotland,2fcd3d4f-773b-4adc-a8cf-c80841c92d51,Not Rated,Not Rated,1.1.7,53.49,5362cfea-d554-43ba-916a-4460da39cc0c,32.78
60.32,66.67,20.63,69.84,ALLIANCE > CPRD,Cancer Patient Experience Survey (CPES) for CPRD Aurum,2fee4aae-94c4-40b2-9e35-4f9558a5b223,Bronze,Bronze,1.1.7,20.93,fded6e24-8fef-47a4-a65e-9455bed043d3,72.87
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,Watch and Wait Trial,30a0ee0e-d9f9-4341-b00c-2fab8f122b5f,Silver,Bronze,1.1.7,16.28,e46dccbf-484d-45d2-a42a-4d308b87c113,76.38
33.33,19.05,55.56,38.88,,Diagnostic and Therapy Services Waiting Times (DATW),30ca0f33-0644-4c92-afc3-357aad57b6ec,Not Rated,Not Rated,1.1.7,53.49,97896866-ab5e-408a-ac5a-072802db9faf,32.78
33.33,19.05,50.79,41.27,,COVID-19 Sequence Data (CVSD),30e1343e-0628-47aa-b4f6-756cdb6e54c6,Not Rated,Not Rated,1.1.7,51.16,602cbc9b-0113-4712-8c4a-0efe8d86b77c,33.95
33.33,19.05,50.79,41.27,,General Acute Inpatient and Day Case - Scottish Morbidity Record (SMR01),31503f67-c546-4223-aec6-9255263e8b66,Not Rated,Not Rated,1.1.7,51.16,98cda353-0011-45b2-80ca-4ed24cd084bf,33.95
33.33,19.05,50.79,41.27,,Daily Situation Report Data (DSRD),31c026ce-fd30-4825-b6b9-e530a4dff9fc,Not Rated,Not Rated,1.1.7,51.16,c74a9b9e-1fea-4aac-99fd-54e30668e085,33.95
4.76,4.76,46.03,29.36,,Webex Cohort,320d4c1e-df08-4eaa-ab9f-bd342d1799a0,Not Rated,Not Rated,1.1.7,46.51,9254f941-db57-4a97-922e-880b84855a21,29.12
85.71,76.19,28.57,78.57,ALLIANCE > CPRD,Practice postcode linked deprivation measures for CPRD Aurum,32bff357-1c24-43d5-8741-261f5a764802,Bronze,Silver,1.1.7,30.23,9f689ef4-26c6-4f85-80ff-5116974f315a,72.98
33.33,19.05,55.56,38.88,,Falls and Fragility Fracture Audit  National Hip Fracture clinical dataset,32f2d582-3b99-44a8-ac30-0a0819fc2523,Not Rated,Not Rated,1.1.7,53.49,e06b951b-e9d8-4a2c-a51f-1d819f669205,32.78
100.0,95.24,22.22,88.89,HUB > BREATHE,Wales Asthma Observatory,333d92ca-3a32-41bd-8b16-96aee2dc85b1,Gold,Gold,1.1.7,18.6,8604bcdc-235a-4c70-b29b-1617396815e6,88.32
4.76,4.76,46.03,29.36,,National Bowel Cancer Audit -  Organisational Survey dataset,3373aa9c-219e-4036-91a5-78bb98e8a7f5,Not Rated,Not Rated,1.1.7,46.51,4e232aa8-ad56-4d82-adcc-cd06715a5c45,29.12
60.32,69.05,17.46,71.43,ALLIANCE > TISSUE DIRECTORY,TRICON8B,33e4b8c6-23cc-4c5f-a7a5-8380035b6601,Bronze,Bronze,1.1.7,18.6,ff875c08-58e6-4e33-8ffe-6f51c8364333,75.22
33.33,19.05,55.56,38.88,,National Neonatal Research Database,34396fa9-0691-42a6-9477-e49e3ae854e6,Not Rated,Not Rated,1.1.7,53.49,67020745-9def-4c6e-b5ac-bb273bd0a20e,32.78
33.33,19.05,55.56,38.88,,Emergency Department (eEMS),349f5326-67b5-4ff8-a9b8-8e6c4e42a9f2,Not Rated,Not Rated,1.1.7,53.49,2ba72371-1527-4d8d-94e2-f795e45b9f77,32.78
85.71,78.57,28.57,78.57,ALLIANCE > NHS DIGITAL,Hospital Episode Statistics Critical Care,34d2310f-c5f2-42c4-be1a-31c1ad579013,Bronze,Silver,1.1.7,27.91,80564a6b-1458-41de-a131-772eb93c0509,75.33
85.71,78.57,26.98,79.36,HUB > DATA-CAN,National Cancer TRE,34f9be53-2445-439b-8ca4-f151359d7e46,Bronze,Silver,1.1.7,27.91,b5439bc5-8141-4a13-a024-a6db2003b40e,75.33
63.49,71.43,15.87,73.81,ALLIANCE > TISSUE DIRECTORY,BRAIN UK,359006d7-1c6c-43c2-8905-09b016398ae1,Silver,Bronze,1.1.7,16.28,1c455ad3-af51-4b93-aff4-c5d3dacfa9f4,77.58
4.76,4.76,46.03,29.36,,National Audit of Dementia Round 4 - organisational checklist,3591992f-cfae-4e26-96e7-da80997e81e7,Not Rated,Not Rated,1.1.7,46.51,0a305b29-cf23-4261-9299-5251e41ee9f0,29.12
33.33,19.05,50.79,41.27,,NIHR BioResource: Full Blood Counts,35919e8c-5cea-4d79-bf3f-e28efec1b686,Not Rated,Not Rated,1.1.7,51.16,321e3ad6-96b9-4f19-bbc4-d06dfe2a59d5,33.95
33.33,19.05,55.56,38.88,,NHS Tayside and Fife Virology,35cc06b0-3de1-45b0-8d40-9a8da9b77866,Not Rated,Not Rated,1.1.7,53.49,855a84b2-9d58-4b2b-a450-b6c6d534e403,32.78
4.76,4.76,46.03,29.36,,The Malaysian Asthma Hajj Study,35fde6f6-ff7d-44f0-92fc-1d28b488cbc1,Not Rated,Not Rated,1.1.7,46.51,8187f77f-65e3-435e-ad7e-d7f22e2fcf80,29.12
77.78,64.29,49.21,64.28,ALLIANCE > NHS DIGITAL,Mental Health Minimum Dataset v3_3.5 (Sensitive),36047c5f-7d57-4d25-a114-2bcc6c11708f,Not Rated,Not Rated,1.1.7,44.19,c123f74c-0731-428e-b31b-eee2723df54d,60.05
85.71,76.19,28.57,78.57,ALLIANCE > CPRD,Practice postcode linked deprivation measures for CPRD GOLD,36d3480e-38ae-470c-ab6f-b704ee2645ec,Bronze,Silver,1.1.7,30.23,3326d554-ca11-4dc6-aff0-c5b314442d27,72.98
47.62,54.76,20.63,63.5,HUB > BREATHE,Exploring the provision of supportive care for patients with COPD in Malaysia,36e6b617-ecd5-4ae2-87d6-4a00bb2c653a,Bronze,Not Rated,1.1.7,20.93,af8cdc87-789e-4bea-9d8b-927aa689d211,66.91
88.89,80.95,28.57,80.16,ALLIANCE > CPRD,National Radiotherapy Dataset (RTDS) for CPRD Aurum,372083bc-3243-4fce-989d-914e677a12cd,Bronze,Silver,1.1.7,30.23,9c535c8d-ebac-4212-b602-fc2489df2c92,75.36
33.33,19.05,50.79,41.27,,Glaucoma dataset at University Hospitals Birmingham,375dae92-2015-478b-b1bc-5de90b6d53a9,Not Rated,Not Rated,1.1.7,51.16,48c44534-0184-471e-93b8-1385f92c6631,33.95
63.49,71.43,15.87,73.81,ALLIANCE > TISSUE DIRECTORY,Bristol Dental School Saliva Bank,37687806-bab2-4de8-87a7-844a0061e7f8,Silver,Bronze,1.1.7,16.28,8d77f0ad-f376-4d61-a97d-5e996c2bbe72,77.58
63.49,71.43,15.87,73.81,ALLIANCE > TISSUE DIRECTORY,UK MND Collections,381413fe-8808-47f8-b8df-e65baa543ae4,Silver,Bronze,1.1.7,16.28,89e2d798-c488-4eaf-a50f-a93616093304,77.58
96.83,92.86,26.98,84.92,HUB > DISCOVER NOW,North West London Pathology (NWL PATH),38194ca7-57f5-40ff-b463-900e306cd40f,Silver,Silver,1.1.7,20.93,2c5f3ef6-53f8-42e6-a077-8718261df026,85.97
60.32,69.05,19.05,70.64,ALLIANCE > TISSUE DIRECTORY,NIHR Nottingham Digestive Diseases Collection,38254214-35f1-4564-b7bb-aab331732dab,Bronze,Bronze,1.1.7,18.6,f20bf814-ee80-4e67-ab00-afff884ddbb4,75.22
100.0,95.24,15.87,92.06,ALLIANCE > SAIL,Congenital Anomaly Register and Information Service,38468759-3351-4722-9eeb-4c6dc9fa44ce,Gold,Gold,1.1.7,13.95,6fe7e004-eb51-4c7b-9905-1ec9a4827dca,90.64
85.71,78.57,25.4,80.16,HUB > PIONEER,Clinical response thresholds (acuity) in acutely unwell patients: onset-outcome,391ab58c-3412-4fa0-96f6-fdd5ae380b86,Silver,Silver,1.1.7,25.58,a9018475-452b-4864-bbc3-80eda2067820,76.5
77.78,64.29,42.86,67.46,ALLIANCE > NHS DIGITAL,Bridge file: Hospital Episode Statistics to Diagnostic Imaging Dataset,3935e2fd-0c30-4f56-8388-45a02e0499b4,Not Rated,Bronze,1.1.7,39.53,2f73575d-23c8-4bb8-87db-115cde076127,62.38
4.76,4.76,46.03,29.36,,Optimising the treatment of Bangladeshi adults with severe pneumonia or ARDS,39445f3f-c05c-4967-81a9-77a34529ad8e,Not Rated,Not Rated,1.1.7,46.51,224b1065-340b-4c01-842f-d422911d9334,29.12
4.76,4.76,46.03,29.36,,Neuropathic Pain Profiling in Retroviral Infection Study (NIPPR),396e55fb-9a71-4b8c-9e33-2e7179a87d1f,Not Rated,Not Rated,1.1.7,46.51,41f5c96c-a27a-4015-be50-af967b6c4bac,29.12
4.76,4.76,46.03,29.36,,"BRIAN App - Patient data; treatments, PROMs, multi-modal data and demographics",3a0a0acd-c549-41f4-8188-14235decf473,Not Rated,Not Rated,1.1.7,46.51,37c82bb7-eaae-4f16-97b6-045373b7ba18,29.12
38.1,42.86,23.81,57.14,UK Biobank,Death register,3a56c317-bf1b-448d-89ab-3421eae3aa18,Not Rated,Not Rated,1.1.7,25.58,722056a5-5fc6-4ad2-8efe-62a80dd6389b,58.64
33.33,19.05,60.32,36.5,,SICSAG Daily (Scottish Intensive Care Audit Group),3a880d1a-bd02-4d23-bca0-4b6ac45b09f1,Not Rated,Not Rated,1.1.7,55.81,811a54fb-8b79-442f-8e28-a725a0561a15,31.62
100.0,95.24,20.63,89.69,ALLIANCE > SAIL,Annual District Birth Extract,3ab70331-aa54-4f0d-aa95-ea2b95bed9d5,Gold,Gold,1.1.7,16.28,12a77014-4a77-4eb1-8b26-f49689352d1b,89.48
100.0,95.24,20.63,89.69,ALLIANCE > SAIL,Emergency Department Data Set,3abe6b38-e479-4eb3-87d6-ef4803ff88f9,Gold,Gold,1.1.7,16.28,75c4dcb8-33bf-43f4-b2bb-db51b6621b2c,89.48
33.33,19.05,55.56,38.88,,NHS 111 Dataset (NHSO),3ad98a4d-9018-4af0-9b7f-e9edcf9ac329,Not Rated,Not Rated,1.1.7,53.49,3d6b69dc-cb3c-4b9a-bdea-a798e7d5b5cf,32.78
92.06,88.1,22.22,84.92,HUB > GUT REACTION,IBD NIHR BioResource: Consent records,3b0a3b33-dbd5-4cb0-b863-0e1fd80c9a1e,Silver,Silver,1.1.7,18.6,44ca2cf8-679e-447c-a9eb-55b32159679a,84.75
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,National Audit of Psychosis - Audit on Early Intervention in Psychosis services - case note audit,3b6d2dbe-0241-4c38-9038-2d6ce1e280de,Not Rated,Not Rated,1.1.7,34.88,24b88d1a-4363-4619-870e-9ba9fc5d09e1,46.84
15.87,19.05,38.1,38.88,ALLIANCE > BARTS HEALTH,CDE Surginet Documentation,3b752633-8274-4418-b15b-4502bab03935,Not Rated,Not Rated,1.1.7,39.53,4c4bc482-16f5-462f-8daf-51ec6492074d,39.76
33.33,19.05,55.56,38.88,,IBD NIHR BioResource: Demographic,3b8357ac-bf06-44c4-9a43-8e772bec709c,Not Rated,Not Rated,1.1.7,53.49,b4121feb-f91b-4e20-a19b-fa49c7a5c1c1,32.78
57.14,64.29,19.05,69.05,HUB > GUT REACTION,IBD NIHR BioResource: SNP imputation data,3bb25cba-b4dc-47f1-ab5e-b63f89500612,Bronze,Bronze,1.1.7,18.6,7dee2bd6-733a-4b2e-a942-7f9eaf8ebbc2,72.84
33.33,19.05,55.56,38.88,,Active Adult Survey Dataset (AASD),3c14d319-4ff5-42ff-b440-400f099f9b13,Not Rated,Not Rated,1.1.7,53.49,1eb67fd5-33f6-49dd-a43d-854fff9f25f5,32.78
61.9,71.43,17.46,72.22,ALLIANCE > TISSUE DIRECTORY,Tissue Solutions Ltd,3c23941a-42a7-4940-b32f-aea743c0dc2a,Silver,Bronze,1.1.7,18.6,bbcdc352-e0f7-4672-93a7-134bcf5001b1,76.42
33.33,19.05,55.56,38.88,,Cancer Network Information System (CNIS / CANISC),3c54d5c1-fbf0-4f1e-979f-3b2251f9a26a,Not Rated,Not Rated,1.1.7,53.49,da91f0eb-1761-485b-8b7f-9121b6a1d004,32.78
33.33,19.05,55.56,38.88,,Intensive Care National Audit and Research Centre (ICCD),3c87fdb6-c58a-4827-93c1-d50cfb708761,Not Rated,Not Rated,1.1.7,53.49,fa8bf269-4769-491b-b398-fa63137d14ab,32.78
33.33,19.05,55.56,38.88,,COG-UK Viral Genome Sequences,3cefb3f4-a463-4762-909b-3e4f3cef8e93,Not Rated,Not Rated,1.1.7,53.49,1fe02b65-7b77-43bf-93c8-4f0743fee672,32.78
96.83,92.86,22.22,87.31,HUB > DISCOVER NOW,North West London Outpatient Care Data (NWL OP),3d51dc99-c44f-44ff-bdab-da205c5e394e,Gold,Gold,1.1.7,18.6,9f1df859-f1d0-4f1e-959e-affd05138a25,87.13
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,Ethical Tissue - University of Bradford,3db58c78-fc8b-49b2-a847-b43fd0184500,Silver,Bronze,1.1.7,16.28,fdf9ac68-fc89-4adf-9a73-3a94a9974aef,76.38
23.81,28.57,33.33,45.24,ALLIANCE > HQIP,National Joint Registry - Primary Ankle Replacement dataset,3de5a3fe-a1bf-4075-883f-f076a460ae26,Not Rated,Not Rated,1.1.7,32.56,b8d009d0-0163-4aaf-8bd6-ad363c859862,48.0
23.81,28.57,33.33,45.24,ALLIANCE > HQIP,National Joint Registry - Primary Elbow Replacement dataset,3e203d75-2b38-4e2f-bfca-793c710fbbd2,Not Rated,Not Rated,1.1.7,32.56,b06415af-9151-4ccc-83a1-ab859943fb2b,48.0
33.33,19.05,60.32,36.5,,Diagnostic Imaging Dataset,3e4d27e2-baa8-4bb5-a711-d0b36f1f278c,Not Rated,Not Rated,1.1.7,55.81,86f46be3-bc29-4820-8363-de6530a94c6f,31.62
4.76,4.76,46.03,29.36,,Higher Education Statistics Agency (HESA),3ed8d3fe-92a3-43bc-9fba-274fb34847af,Not Rated,Not Rated,1.1.7,46.51,36f54a48-6f0a-4827-a86b-fd677a22a88f,29.12
4.76,4.76,46.03,29.36,,mHealth for pneumonia prevention,3ee4c2af-ff04-4dcf-830e-420e0a21a6d2,Not Rated,Not Rated,1.1.7,46.51,fc66381e-cc46-4bca-85fc-fc2ee09cc5dd,29.12
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,Multiple Sclerosis and Parkinson's Tissue Bank,3f00330d-1f45-4cab-86c2-e91b7c1a59e9,Silver,Bronze,1.1.7,16.28,4684d391-a6a7-44f7-bf4b-62b6b693f9fa,76.38
85.71,78.57,26.98,79.36,ALLIANCE > BARTS HEALTH,Barts Health NHS Trust COVID-19 EHR Extracted Dataset,3fbef1ac-fa6d-4c72-836d-3a8d8a0f7b08,Bronze,Silver,1.1.7,27.91,d6e8163f-2ab8-4880-bbb6-a174b4a95632,75.33
85.71,78.57,30.16,77.78,HUB > PIONEER,The impact of ethnicity and multi-morbidity on C19 hospitalised outcomes,3fc555e1-3e36-46dc-bef1-2d94d560bcb2,Bronze,Silver,1.1.7,27.91,cfa1ef13-8ae0-4827-8a0f-9d2df5244725,75.33
100.0,95.24,15.87,92.06,ALLIANCE > SAIL,Cafcass Wales,3fceb952-0b21-40f4-bd69-fa5cd7ad7df9,Gold,Gold,1.1.7,13.95,29a714e1-5289-4362-be24-2848c954344e,90.64
4.76,4.76,46.03,29.36,,Estimating Chronic Respiratory Disease burden in adults in Asian LMICs,3fd2760d-ab12-48ee-8b32-b229aead60a4,Not Rated,Not Rated,1.1.7,46.51,56130df6-1880-4600-a7a4-afa9a4bcc895,29.12
14.29,16.67,36.51,38.89,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,Endobase,40573895-497b-4d47-90e1-6aafe70b93f6,Not Rated,Not Rated,1.1.7,37.21,e830b2a5-14d6-4643-a206-619bf5372dc8,39.73
77.78,71.43,26.98,75.4,ALLIANCE > SAIL,Domiciliary Social Care Worker [DSCW],41a667eb-1c84-4665-b0d4-d26405d277c5,Bronze,Bronze,1.1.7,25.58,0e38bbf4-c788-4a1a-9af8-a24821250154,72.93
55.56,64.29,17.46,69.05,HUB > BREATHE,Care-seeking practices for childhood pneumonia in non/tribal areas of Pune India,41ac5dfd-7b23-4f1b-a91e-03e8186e4ab8,Bronze,Bronze,1.1.7,16.28,4346676d-6108-47de-b579-6cef74c6acef,74.0
88.89,80.95,30.16,79.37,ALLIANCE > CPRD,Quality of Life of Colorectal Cancer Survivors: Patient Reported Outcomes (Aurum,41ce265a-c252-45c4-9b80-d764b0737f38,Silver,Silver,1.1.7,27.91,bfb90d2b-746d-44a6-a896-4979d73d9276,76.52
33.33,19.05,50.79,41.27,,Welsh Dispensing Dataset (WDDS),4232439b-610b-48ec-abe3-f8c8fe818817,Not Rated,Not Rated,1.1.7,51.16,50ef6443-ed4b-40f9-97fb-1cfd53be6579,33.95
33.33,19.05,55.56,38.88,,National Asthma and COPD Audit (NACAP): secondary care  – CYP asthma (clinical),425e39b4-cc2b-4a15-851a-a0093ef1e1f8,Not Rated,Not Rated,1.1.7,53.49,33b36393-3760-40d8-bb98-61806fea5398,32.78
74.6,61.9,39.68,67.46,ALLIANCE > NHS DIGITAL,Mental Health and Learning Disabilities Data Set,4262e057-6978-4e4c-a05d-c4f328422090,Not Rated,Bronze,1.1.7,39.53,e9b43936-e700-40c9-8b32-57ed44583f3d,61.19
100.0,95.24,30.16,84.92,ALLIANCE > CYSTIC FIBROSIS TRUST,Cystic Fibrosis Patient Microbiology Cultures,42ac7c27-a37b-4081-8a33-51ac077e6a4e,Gold,Silver,1.1.7,20.93,9c1727f6-2032-413f-bf60-470769b2616e,87.16
33.33,19.05,55.56,38.88,,Pathology - PATH,42e4299f-1e06-4e24-ab40-b71949f5cba3,Not Rated,Not Rated,1.1.7,53.49,48ef8f54-9606-4e6f-9256-3cc07ffd10b8,32.78
33.33,19.05,55.56,38.88,,Covid-19 Infection Survey linked with VOA and EPC data,4330b6ee-f333-4cd8-90b9-0f43f7cb0b67,Not Rated,Not Rated,1.1.7,53.49,2193ad56-6671-4ecc-9ecf-6da84e23e9fd,32.78
90.48,83.33,33.33,78.58,ALLIANCE > CPRD,Systemic Anti-Cancer Treatment (SACT) data for CPRD Aurum,4353b5fa-b3aa-4786-9e7f-4fb2273f5d3e,Bronze,Silver,1.1.7,32.56,f8af632e-442d-4931-a370-b7fa2fa4b896,75.38
98.41,92.86,15.87,91.27,ALLIANCE > SAIL,Welsh Ambulance Services NHS Trust,45499ef9-daca-4a88-8493-c3c1a92960d0,Gold,Gold,1.1.7,13.95,d415a5c5-8432-4a81-937f-12135ade6de7,89.45
58.73,69.05,17.46,70.63,HUB > BREATHE,Asthma and COPD: practices and perceptions of GPs in rural India,458d7f2d-9ba8-4593-862c-14160692d494,Silver,Bronze,1.1.7,16.28,c15bc3ad-c053-496b-863f-1d54075d5bd4,76.38
77.78,64.29,49.21,64.28,ALLIANCE > NHS DIGITAL,Mental Health Minimum Dataset v4 (Sensitive) Events,46493a09-b3bb-4c0e-b944-82665ee21508,Not Rated,Not Rated,1.1.7,44.19,9c31a2bd-ff3a-4379-a4b8-0b90527a4c38,60.05
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,National Paediatric Diabetes Audit - Spotlight survey of workforce in Paediatric Diabetes Units,46762bdc-42f9-4c92-92fe-9c757083ad33,Not Rated,Not Rated,1.1.7,34.88,fe8f8e2c-2f77-464d-9d45-a601cb2f8bf9,46.84
100.0,95.24,15.87,92.06,ALLIANCE > SAIL,Maternity Indicators Dataset,46e30817-b19e-40f2-9b06-9611b2985148,Gold,Gold,1.1.7,13.95,a0c27454-8cbe-418f-bdae-a85d5e92e9d4,90.64
4.76,4.76,46.03,29.36,,Developing and Evaluating Interventions to Improve Asthma Care,46f6e0d3-412e-4799-8683-1ca649b99eec,Not Rated,Not Rated,1.1.7,46.51,d57d7956-d13e-49c4-bb31-889b8e560596,29.12
23.81,28.57,33.33,45.24,ALLIANCE > HQIP,Sentinel Stroke National Audit Programme Acute Organisational survey dataset,4710222c-9830-4ae4-8be6-b25c723812e1,Not Rated,Not Rated,1.1.7,32.56,fe6a4c83-f46f-4f61-8460-e120fdf8d864,48.0
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,Tayside Biorepository,47d22aea-cbe9-47d4-8f65-45861d9c5f6f,Silver,Bronze,1.1.7,16.28,6ac9b356-00f1-49da-825a-6eb04d18e49d,76.38
33.33,19.05,55.56,38.88,,NIHR IBD BioResource: Consent records,47e26b2b-8be1-4595-a327-a9f00e0d4712,Not Rated,Not Rated,1.1.7,53.49,44ca2cf8-679e-447c-a9eb-55b32159679a,32.78
63.49,71.43,19.05,72.22,ALLIANCE > TISSUE DIRECTORY,"St Thomas' Hospitals Plasma, serum & DNA Bio bank from patients with antiphospholipid antibodies",47f57de8-aa71-4df1-af4a-a81e37d4ae8c,Bronze,Bronze,1.1.7,20.93,425f4534-51c4-4f75-8ca0-d7c731dbd903,75.25
34.92,38.1,25.4,54.76,UK Biobank,Genotype,480ccd8a-309e-417a-ac23-5b2d9cd281b1,Not Rated,Not Rated,1.1.7,25.58,93a7352f-fce4-42c9-9a8c-efc7fe23eda0,56.26
96.83,92.86,22.22,87.31,HUB > DISCOVER NOW,North West London Primary Care Prescriptions Data (NWL PCP),48182af6-2ccd-44b2-92d5-69cc140e7d67,Gold,Gold,1.1.7,18.6,0fb33df6-ab36-4170-9fad-1eaf35a3a812,87.13
33.33,19.05,55.56,38.88,,National Vascular Registry - Organisational Audit dataset,483f49ea-07b3-4efb-8bad-0d9af5ed5f0f,Not Rated,Not Rated,1.1.7,53.49,3c661240-e4d2-456c-a809-133c23f9c469,32.78
90.48,83.33,33.33,78.58,ALLIANCE > CPRD,Cancer registration data for CPRD Aurum,484bff65-c47e-47ce-9eb5-5d381f961160,Bronze,Silver,1.1.7,32.56,3f3df3be-05a8-42b2-89d9-f731deb7ea66,75.38
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,Falls and Fragility Fracture Audit Programme National Audit of Inpatient Falls clinical dataset,489cb34a-f20d-4fe0-849a-db85f00141f5,Not Rated,Not Rated,1.1.7,34.88,3c19e2c9-96d5-45f3-9c55-fc3cec762cd7,46.84
33.33,19.05,55.56,38.88,,NIHR BioResource: Sample holding,48deb24e-7a15-48d7-ba2c-c477ae61b55d,Not Rated,Not Rated,1.1.7,53.49,56993820-96e4-4a1f-9de1-bad53108c201,32.78
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,"National Audit of Dementia - spotlight audit on the prescription of psychotropic medication, 2019",491cc634-05e8-48fe-9018-ffb9e7eed84e,Not Rated,Not Rated,1.1.7,34.88,949d9d7a-a3f1-480a-8563-3fb024300561,46.84
33.33,19.05,50.79,41.27,,Health & Attainment of Pupils in a Primary Education Network (HAPN),4a860548-406b-4a05-991e-0bc840e67974,Not Rated,Not Rated,1.1.7,51.16,464d8653-4e69-406b-93fd-d68c29d5dfdc,33.95
33.33,19.05,55.56,38.88,,Tayside & Fife Radiology,4abe1436-3a14-4779-aa03-28929e817411,Not Rated,Not Rated,1.1.7,53.49,af10ec29-1866-4726-b33f-3948afe182f2,32.78
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,Epilepsy 12 - National organisational audit (service descriptor questionnaire) and Trust profile,4b2fbd88-71c7-4572-99ea-5987a72a0c1a,Not Rated,Not Rated,1.1.7,34.88,2c737d63-69f4-4a02-8df9-54c1e65e845f,46.84
4.76,4.76,46.03,29.36,,South East London Community Health Study (SELCoH),4b3d70f4-ce62-478b-9ada-0419850d17af,Not Rated,Not Rated,1.1.7,46.51,cda770e3-0d4d-466f-8102-c56beff04848,29.12
33.33,19.05,50.79,41.27,,Systemic Anti-Cancer Therapy Dataset (SACT),4b59ff6f-2830-4f2b-b35a-623ef4520eb8,Not Rated,Not Rated,1.1.7,51.16,6c4ed998-0f05-415c-a3e4-42430bb62d24,33.95
98.41,92.86,15.87,91.27,ALLIANCE > SAIL,Daily Situation Report Data,4b6d3344-e73a-4f46-8e9d-fabb85827772,Gold,Gold,1.1.7,13.95,c74a9b9e-1fea-4aac-99fd-54e30668e085,89.45
33.33,19.05,55.56,38.88,,National Early Inflammatory Arthritis Audit - organisational survey dataset,4b79bce2-6d1c-448b-969e-56b424f3d57a,Not Rated,Not Rated,1.1.7,53.49,a9ac99fe-32be-40ef-9509-03e6b2713ddf,32.78
4.76,4.76,46.03,29.36,,Assessment of ASHA’s workload and its determinants,4c171540-5caa-42f7-868d-1d4d7b969f11,Not Rated,Not Rated,1.1.7,46.51,1a02bc11-a378-4f9e-82f9-c52674b388bd,29.12
55.56,64.29,19.05,68.25,HUB > BREATHE,"Prevention, detection, treatment: adult lung disease/cancer in rural Tamil Nadu",4cb9082f-619d-4be2-8d09-641f2c573d38,Bronze,Bronze,1.1.7,18.6,2581994d-5be2-4465-bb62-60c4c97e8e2b,72.84
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,Obesity Research Biobank Syndicate (ORBiS),4cde083a-bf5a-4f57-97c6-38632e10050d,Silver,Bronze,1.1.7,16.28,264a1987-a8cb-4a83-81e0-70b4c3893b7d,76.38
23.81,28.57,33.33,45.24,ALLIANCE > HQIP,National Oesophago-Gastric Cancer Audit - clinical dataset,4d0c3779-9251-4a4a-9eff-41a47869157f,Not Rated,Not Rated,1.1.7,32.56,306274ee-a098-43cc-b113-2df8116a8703,48.0
23.81,28.57,33.33,45.24,ALLIANCE > HQIP,Paediatric Intensive Care Audit Network - core dataset (admission),4d1271dd-b256-454b-9b13-be38bef73f15,Not Rated,Not Rated,1.1.7,32.56,4ca76471-6970-4ad4-87c7-fae77a98cbf5,48.0
33.33,19.05,60.32,36.5,,NIHR BioResource: SNP chip data,4d560a49-6ab2-460c-980f-94d76d1527f2,Not Rated,Not Rated,1.1.7,55.81,c388676c-a5e5-419c-967c-239c1f0c3c5c,31.62
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,POUT-T,4dd3f23c-44be-4126-aac5-ba655d07855c,Silver,Bronze,1.1.7,16.28,c6e0e70e-7f23-4a44-a2cf-1d7d87be7808,76.38
33.33,19.05,55.56,38.88,,Annual District Death Daily (ADDD),4ddf1fe9-537e-4342-848d-8ec273979cba,Not Rated,Not Rated,1.1.7,53.49,584bf8c8-d58f-44c6-9b65-e1611144fd54,32.78
33.33,19.05,60.32,36.5,,Hospital Episode Statistics Outpatients,4ee43bb7-54a1-40a9-9a2a-4f07cd5b1920,Not Rated,Not Rated,1.1.7,55.81,d4362d41-0838-4f41-bba3-c3268312c444,31.62
4.76,4.76,46.03,29.36,,National Audit of Dementia Round 4 - carer experience survey,4f3fff58-7c32-4879-8ac2-f3c7641fbb85,Not Rated,Not Rated,1.1.7,46.51,3b5907da-256d-49a3-b24b-00893afe8bdd,29.12
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,"Maternal, Newborn and Infant Clinical Outcome Review Programme - perinatal surveillance dataset",501b0226-1cbf-4717-8dee-adf189dd0088,Not Rated,Not Rated,1.1.7,34.88,11deee42-5876-4ebe-acca-e996702e1343,46.84
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,National Cardiac Audit Programme - Myocardial Ischaemia National Audit Project (MINAP),50609a73-30a0-46ca-847d-4a9c1bfec5fc,Not Rated,Not Rated,1.1.7,34.88,3558f8a1-6d52-4b59-b513-51c068095bc2,46.84
88.89,83.33,31.75,78.57,ALLIANCE > CPRD,HES Outpatient data for CPRD Aurum,50925199-a35d-4327-87cd-7761d713a72b,Silver,Silver,1.1.7,30.23,8d3f3e58-be79-4450-b2e3-f5ab8a25fb0e,76.55
4.76,4.76,46.03,29.36,,National Audit of Dementia Round 4 - staff questionnaire,51221591-a4d4-4b9f-a220-b72d860d99fd,Not Rated,Not Rated,1.1.7,46.51,ef6e68d6-dcba-410c-943c-26ca21376a3a,29.12
33.33,19.05,50.79,41.27,,SAIL Dementia e-Cohort (SDEC),5255d52f-b094-4f23-a2d0-7de30e3f81fa,Not Rated,Not Rated,1.1.7,51.16,f48b7c05-6a44-480c-84c6-4f7a684f29f8,33.95
15.87,19.05,38.1,38.88,ALLIANCE > BARTS HEALTH,ARIA Dataset,5271131b-ba5b-452d-b230-077094a031c2,Not Rated,Not Rated,1.1.7,39.53,621dd611-adcf-4434-b538-eecdbe5f72cf,39.76
33.33,19.05,55.56,38.88,,Covid-19 UK Non-hospital Antigen Testing Results,52a9c00b-b66c-48c6-84bb-3558faad7618,Not Rated,Not Rated,1.1.7,53.49,f06ec631-77d0-4b12-a21f-f11e7af49ba5,32.78
88.89,80.95,36.51,76.19,ALLIANCE > CPRD,Mental Health Dataset (MHDS) for CPRD Aurum,52c784f6-99c6-4407-b660-abaa1682c955,Bronze,Silver,1.1.7,32.56,48627b2d-f247-4921-9ee1-6c37adfff10d,74.19
96.83,92.86,26.98,84.92,HUB > DISCOVER NOW,North West London Adult Social Care Data (NWL ASC),535a0983-6618-4211-a939-ae2edfe26f9a,Silver,Silver,1.1.7,20.93,de9cf0f5-b26a-4363-9df8-3628a4aa6b6e,85.97
33.33,19.05,65.08,34.12,,National Records of Scotland (NRS) - Deaths Data,53846ac7-61b7-4403-8556-c319d04b546d,Not Rated,Not Rated,1.1.7,58.14,e600dae2-a83c-4b7a-8d23-af4ac31ca374,30.45
82.54,73.81,25.4,78.57,HUB > PIONEER,Ventilatory strategies and outcomes for patients with COVID: a dataset in OMOP,53b7c446-667b-409e-920e-67cb516de3ae,Bronze,Silver,1.1.7,25.58,cacba424-6c2c-4b57-8f5b-64e92a78370a,74.12
33.33,19.05,55.56,38.88,,Scottish Medical Imaging (SMI) Research Dataset,53dbbca0-b57d-4f93-8f05-37f626f9a7bc,Not Rated,Not Rated,1.1.7,53.49,1c49a822-6432-468b-8ba5-6aab534654b9,32.78
33.33,19.05,50.79,41.27,,Cervical Screening Wales (SCSW),542bf16f-baea-4fca-be51-fcef9732494a,Not Rated,Not Rated,1.1.7,51.16,b32325d7-7f00-4d20-9935-dd02e1bc6932,33.95
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,Epilepsy Society Brain and Tissue Bank,54a7dd45-d6c7-4b4d-801d-2becd2b694f1,Silver,Bronze,1.1.7,16.28,f13258c3-f85a-4772-b42e-da8a84c5064a,76.38
4.76,4.76,46.03,29.36,,IBD Registry COVID-19,55b311a8-7162-410c-8cf7-eef1ac9ff544,Not Rated,Not Rated,1.1.7,46.51,ffdf167b-f3a3-4d78-a228-2865aea90509,29.12
33.33,19.05,50.79,41.27,,Welsh Ambulance Services NHS Trust (WASD),561ce879-88cc-415d-822e-10aaab966981,Not Rated,Not Rated,1.1.7,51.16,d415a5c5-8432-4a81-937f-12135ade6de7,33.95
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,LBIH Biobank,567b23fe-abf2-4e2e-88f7-505dfeaa3cde,Silver,Bronze,1.1.7,16.28,c0318a31-a32c-4d3a-9591-dfe9352bf2b9,76.38
4.76,4.76,46.03,29.36,,Assessing the feasibility and effectiveness of introducing pulse oximetry,567b5d24-07df-4430-8466-4444ecbe86c8,Not Rated,Not Rated,1.1.7,46.51,2f36b7b3-e50f-459f-a691-f62dde65e2bd,29.12
60.32,69.05,17.46,71.43,ALLIANCE > TISSUE DIRECTORY,TNT: Triple Negative breast cancer Trial,56f3e791-a204-4f67-a4d0-52803148d71a,Bronze,Bronze,1.1.7,18.6,5f4c825d-d6c3-453e-9667-8cdf2329b6e1,75.22
4.76,4.76,46.03,29.36,,Wellcome Sanger Institute: Whole Exome Sequencing,5727d014-0c5c-4dcb-89c9-ff33e1b680bb,Not Rated,Not Rated,1.1.7,46.51,cd20517c-2f75-40e9-9ee8-563d32624b55,29.12
33.33,19.05,55.56,38.88,,NIHR IBD BioResource: Health and Lifestyle Questionnaire,57458394-945e-4e6a-abc7-91df0f44cb60,Not Rated,Not Rated,1.1.7,53.49,18bfe765-5733-41f3-8114-0a1ec2524b5b,32.78
84.13,78.57,31.75,76.19,NCS > OFFICE FOR NATIONAL STATISTICS,Coronavirus and the social impacts on Great Britain,575514e3-6e8f-4218-bd75-ff32742abc52,Silver,Silver,1.1.7,25.58,e253257c-48c2-491b-b3b9-205161a16a7e,76.5
100.0,95.24,17.46,91.27,ALLIANCE > SAIL,COVID-19 Test results,57726e95-afe2-4d62-ab1e-81d90eb0ec1d,Gold,Gold,1.1.7,16.28,f5f6d882-163d-4ef1-a53e-000fba409480,89.48
4.76,4.76,46.03,29.36,,National Paediatric Diabetes Audit - core clinical dataset,58e16c60-966a-4199-ae60-211d69fa6b48,Not Rated,Not Rated,1.1.7,46.51,e355c9b9-44f0-4ba3-a872-645aa88f4f2b,29.12
4.76,4.76,46.03,29.36,,Exploration of Pneumonia Related Policy Formation and Implementation in Pakistan,590e7bb7-a6e3-4f87-af2f-e46943f98ce9,Not Rated,Not Rated,1.1.7,46.51,e0d00cb7-62e1-4a38-8df6-cf537b59228d,29.12
4.76,4.76,46.03,29.36,,Computational Framework to Interpret Chest X-rays and Diagnose Pneumonia,598ab9d9-04a3-4628-be64-d8f026d266ac,Not Rated,Not Rated,1.1.7,46.51,cf9bc775-1db7-44e4-9a16-317d5bb063a2,29.12
4.76,4.76,46.03,29.36,,National Cardiac Audit Programme - Percutaneous Coronary Interventions (PCI),59f5b724-234f-401d-a8f5-df35ea9ecdc9,Not Rated,Not Rated,1.1.7,46.51,ac7016ce-f7a9-4c71-bebb-6af6efa27844,29.12
4.76,4.76,46.03,29.36,,National Cardiac Audit Programme - National Adult Cardiac Surgery Audit (NACSA),5a6009f8-c74a-4e72-b2a1-83be100f7841,Not Rated,Not Rated,1.1.7,46.51,5f37e3c2-b5ac-43eb-8eba-ac94dbbff103,29.12
96.83,92.86,26.98,84.92,HUB > DISCOVER NOW,North West London Accident and Emergency Data (NWL A&E),5b9b7964-615b-438a-b151-d2f884a24aee,Silver,Silver,1.1.7,20.93,721db252-8069-433d-bb6d-4b44b243d364,85.97
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,VinCaP,5bb40472-fc5d-4b16-a0a6-d1d42fd1d3e8,Silver,Bronze,1.1.7,16.28,e57dd7a2-3c5c-4285-8001-8e2589c395e9,76.38
42.86,52.38,31.75,55.55,HUB > BREATHE,International Severe Asthma Registry,5c7ae78d-53e6-427d-a3a9-52538f8342dc,Not Rated,Not Rated,1.1.7,30.23,9711e6cc-426c-4cef-afb3-64382f8d7ed4,61.08
33.33,19.05,55.56,38.88,,National Waiting List Diagnostics,5ce6905a-8b54-4d6c-9da6-e2d57ce45419,Not Rated,Not Rated,1.1.7,53.49,e508951d-e118-4217-84a4-722e50fdd400,32.78
33.33,19.05,55.56,38.88,,Renal Register – ISD National dataset,5cf49b5c-bb8d-4ab2-90ce-74d801f7c090,Not Rated,Not Rated,1.1.7,53.49,32edd77d-533c-423f-b045-937507f8505d,32.78
33.33,19.05,50.79,41.27,,Moorfields Ophthalmic Prescription 004,5d577e70-2b9b-4286-81f3-824978dc3069,Not Rated,Not Rated,1.1.7,51.16,2ec8d8e3-35bc-4304-83e8-3afed4438cd5,33.95
33.33,19.05,60.32,36.5,,Public Health Research Database (PHRD),5de4bedb-32a9-4a66-9c92-5987453794f1,Not Rated,Not Rated,1.1.7,55.81,a325f33e-bac8-49af-896f-1e025941dae8,31.62
33.33,19.05,60.32,36.5,,NIHR BioResource: Case report form,5de9d313-fb9f-4dbf-a959-1329062eb1ef,Not Rated,Not Rated,1.1.7,55.81,4b8675d3-dd87-4cca-804c-aaf0e4ff8140,31.62
14.29,16.67,36.51,38.89,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,ARIA Radonc,5e022f8f-4d07-44bb-a87c-43e31200fe1e,Not Rated,Not Rated,1.1.7,37.21,59d72237-6969-4f59-9e87-48138978abe8,39.73
96.83,92.86,25.4,85.72,HUB > DISCOVER NOW,North West London Mental Health Data (NWL MH),5e19a471-64e3-4aa4-ac56-6901d5e39e28,Gold,Silver,1.1.7,18.6,2d3ec99a-a087-4355-8539-5a22cef58910,87.13
100.0,95.24,20.63,89.69,ALLIANCE > SAIL,Emergency Department Dataset Daily,5e2a7277-dc64-499a-b16d-51850d9ad00b,Gold,Gold,1.1.7,16.28,fa257aa8-51fc-4eb7-a448-e473fa54686d,89.48
33.33,19.05,55.56,38.88,,NHS Tayside and Fife Biochemistry (Lab Data Restructured),5e442584-9acd-4e8d-9448-5f8f2b937d56,Not Rated,Not Rated,1.1.7,53.49,10ffac16-d0c2-4d53-ab6a-69a38e283223,32.78
33.33,19.05,50.79,41.27,,Moorfields AMD Dataset Release 002,5e9d4a4b-544c-4739-b079-62f353086fde,Not Rated,Not Rated,1.1.7,51.16,bf392537-82b4-4d71-ace0-e7bea3b167fb,33.95
87.3,80.95,30.16,78.57,ALLIANCE > CPRD,HES Diagnostic Imaging Dataset for CPRD Aurum,5e9d9633-c4f4-47cc-96d9-350191e18539,Silver,Silver,1.1.7,27.91,617f9f54-3fb6-40c3-b391-fe51d1fc7c49,76.52
33.33,19.05,50.79,41.27,,National Community Child Health Database (NCCHD),5e9fba37-017b-4481-bc69-75ef1e005c2f,Not Rated,Not Rated,1.1.7,51.16,20fe153c-a5e5-4991-900e-8fa9988e771a,33.95
33.33,19.05,55.56,38.88,,National Cancer Registration and Analysis Service,5ef3573a-274a-41e1-8f64-9330109d59d1,Not Rated,Not Rated,1.1.7,53.49,0a852454-ee67-443b-a091-d13499a71b41,32.78
100.0,95.24,26.98,86.51,HUB > DISCOVER NOW,North West London population data (NWL POP),601f1504-2706-405b-94cb-8cd14231f434,Gold,Gold,1.1.7,20.93,1032850f-7631-4d9e-a760-b0532bffd21a,87.16
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,STAMPEDE,60b148f7-b48c-49c4-9286-b83691cfc7b2,Silver,Bronze,1.1.7,16.28,71eb0192-1124-4b27-86e4-1139e0047a02,76.38
33.33,19.05,50.79,41.27,,Healthcare Workers Risk Assessment (HWRA),62b7e273-1ec1-4eb1-b651-daebdb73cce3,Not Rated,Not Rated,1.1.7,51.16,ed131fee-0635-4613-a453-a383d5dd7cec,33.95
100.0,95.24,23.81,88.09,GENOMICS ENGLAND,GENOMICS ENGLAND 100K PHE LINKED DATA,62c01293-83a5-4d4d-9d36-9d7aa2bf120f,Gold,Gold,1.1.7,20.93,ea748742-568a-46e2-b603-2fada49024e1,87.16
30.16,35.71,28.57,50.8,HUB > BREATHE,Vitamin D supplementation meta-analyses,62fef8d2-c397-43c3-b14a-69cf89423887,Not Rated,Not Rated,1.1.7,27.91,2454a964-be58-4d1f-8f9a-ffae9db9129c,53.9
33.33,19.05,55.56,38.88,,Tayside Microbiology Lab,6421830a-148d-4f86-8cd3-cefb5177610c,Not Rated,Not Rated,1.1.7,53.49,826be5be-9977-49f9-b6d1-83ed9de08ebe,32.78
33.33,19.05,60.32,36.5,,Suspected Cancer Pathway Monthly (SPCM),645168a0-21b1-4e13-85d8-266ad9040af8,Not Rated,Not Rated,1.1.7,55.81,fcf5a844-f48d-428e-aa06-abe64e66185e,31.62
4.76,4.76,46.03,29.36,,"Trusted Research Environments for CVD-COVID-UK in England, Scotland, and Wales",646d65df-fc4c-4680-b949-79ec8f40b406,Not Rated,Not Rated,1.1.7,46.51,7e5f0247-f033-4f98-aed3-3d7422b9dc6d,29.12
33.33,19.05,65.08,34.12,,Civil Registration - Deaths,649261ce-833f-459e-908c-2ef93c5fed41,Not Rated,Not Rated,1.1.7,58.14,050163dc-1728-4ac5-a7d9-4dd3ca0ca12a,30.45
90.48,83.33,31.75,79.37,ALLIANCE > CPRD,HES Accident and Emergency data for CPRD Aurum,65481fcf-cc98-44f0-bcfe-c21bcb8db0f5,Silver,Silver,1.1.7,30.23,c43501ec-08b4-4d33-a7dd-d19fca821925,76.55
98.41,92.86,20.63,88.89,ALLIANCE > SAIL,Diagnostic and Therapy Services Waiting Times,65c8a30c-de2c-47bf-87e4-18c86e75e54a,Gold,Gold,1.1.7,16.28,97896866-ab5e-408a-ac5a-072802db9faf,88.29
33.33,19.05,55.56,38.88,,Falls and Fragility Fracture Audit  Programme - Inpatient Falls clinical dataset,65eaa19c-e4b6-4611-922a-4be585a6d348,Not Rated,Not Rated,1.1.7,53.49,3c19e2c9-96d5-45f3-9c55-fc3cec762cd7,32.78
33.33,19.05,55.56,38.88,,Fife Microbiology Lab,6615ba0a-9bcf-4a3b-8204-283c5e741b2b,Not Rated,Not Rated,1.1.7,53.49,0c43c0b6-de3a-478b-8190-4da37fbe5ff5,32.78
55.56,64.29,19.05,68.25,HUB > BREATHE,Theory of Planned Behaviour Intervention: respiratory disease in South India,661b27db-38d4-4a9c-ac40-e3146ef12350,Bronze,Bronze,1.1.7,18.6,7d23e729-72b0-4dd1-820d-07697b49acd0,72.84
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,interNational Anaplastic Thyroid Cancer Tissue Bank (iNATT),6620b221-6909-4106-a49e-f1b5820be2f3,Silver,Bronze,1.1.7,16.28,5ef75d71-73ce-4451-9d7a-a39dd82b712f,76.38
96.83,92.86,30.16,83.34,ALLIANCE > ROYAL COLLEGE OF GENERAL PRACTITIONERS,The Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) primary care sentinel network and database,664513d6-d766-461d-a69e-206a928cd14f,Silver,Silver,1.1.7,25.58,d5049af5-e351-4b22-8f75-6f3dfc96419b,83.64
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,National Asthma and COPD Audit Programme (NACAP): Adult Asthma secondary care clinical dataset,668eefeb-fb5c-46d8-a052-12fa8da4931b,Not Rated,Not Rated,1.1.7,34.88,becd2624-9a01-4f01-bcf8-56e94545a49a,46.84
33.33,19.05,55.56,38.88,,Scotland Accident and Emergency,670dbf72-0140-4228-b2de-4ad1ba1c920d,Not Rated,Not Rated,1.1.7,53.49,05e6752e-3a0b-4809-aa14-207b4761ef60,32.78
33.33,19.05,55.56,38.88,,NHS Tayside and Fife Biochemistry,672a54ba-0b41-4573-adf8-e97158fad9bc,Not Rated,Not Rated,1.1.7,53.49,10ffac16-d0c2-4d53-ab6a-69a38e283223,32.78
33.33,19.05,55.56,38.88,,NHS Tayside and Fife Haematology,674c290e-36c6-4d9b-a908-a23e89a6745c,Not Rated,Not Rated,1.1.7,53.49,c294bb01-062b-494e-942b-1efe8cbac3dc,32.78
4.76,4.76,46.03,29.36,,National Cardiac Audit Programme - Cardiac Rhythm Management (CRM),6762c371-8f4a-4511-910a-faf85760eab2,Not Rated,Not Rated,1.1.7,46.51,3cc81e6c-0c17-4ccd-8202-a9aceb82c989,29.12
33.33,19.05,55.56,38.88,,National Waiting List Clock Stops,67ab8a56-99d7-4951-aacb-5dca0b8ffa35,Not Rated,Not Rated,1.1.7,53.49,3f073707-50b4-48cf-93b6-76843519a5c0,32.78
71.43,80.95,12.7,79.37,HUB > BREATHE,Genetics of Asthma Severity & Phenotypes,67cd0c2b-3944-4bc4-a03a-4081ee67847f,Silver,Silver,1.1.7,11.63,6277abc6-c039-4886-8489-d4a2cdb8190c,84.66
82.54,76.19,33.33,74.61,NCS > OFFICE FOR NATIONAL STATISTICS,Covid-19 Infection Survey,67fa61c8-7973-4eb4-999c-fbed084d4445,Bronze,Bronze,1.1.7,27.91,628e9ad9-28c5-4d58-9ec5-04a63be9b4cf,74.14
33.33,19.05,55.56,38.88,,UK Renal Registry - AKI Lab Alerts Dataset,682b4d85-732a-4440-922d-07191a604143,Not Rated,Not Rated,1.1.7,53.49,c38541a7-cf43-4bfd-928d-75613abc8e3f,32.78
33.33,19.05,55.56,38.88,,Tayside & Fife Diabetes – Summary and a range of diabetes related datasets.,69220bf9-f223-4e88-91c8-8ae8eab9f438,Not Rated,Not Rated,1.1.7,53.49,49e63323-e564-48ac-9f11-cf77bf0fe20b,32.78
23.81,28.57,33.33,45.24,ALLIANCE > HQIP,National Joint Registry - Revision Ankle Replacement dataset,69547543-ca00-455c-872d-a176191d5ada,Not Rated,Not Rated,1.1.7,32.56,b4f076d2-c9a3-49ba-84f4-94148dc8511a,48.0
33.33,19.05,55.56,38.88,,"Deaths – CHI, Community Health Index",69833273-2b81-4657-8d80-5bafb2c0834d,Not Rated,Not Rated,1.1.7,53.49,faf2fc49-d09f-4ea2-a2cb-b1d30fffa406,32.78
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,National Asthma and COPD Audit Programme (NACAP): primary care workstream resources,6a11bc97-b57a-458f-8a3e-98c71221cb5c,Not Rated,Not Rated,1.1.7,34.88,8a3ec96a-0600-4c6d-8761-9d277f07b9da,46.84
96.83,92.86,20.63,88.1,HUB > DISCOVER NOW,North West London Patient Index (NWL PI),6a390359-1e26-470f-a4e5-bfb31a5ed643,Gold,Gold,1.1.7,16.28,1fe1e7bb-ef6e-4d89-9824-bb560afc81f0,88.29
80.95,73.81,36.51,72.22,ALLIANCE > NHS DIGITAL,Mental Health Services Data Set,6a63513f-92cb-43ce-b0dd-fdb1113150c9,Bronze,Bronze,1.1.7,32.56,fa2ec63d-f76d-4555-8fc1-f4bd66e3c60d,70.62
33.33,19.05,50.79,41.27,,UHB Linked Diabetic Eye Disease from National Screening to Hospital Eye Care,6a9a3c4c-95d4-45da-9520-c3b9aceb6d13,Not Rated,Not Rated,1.1.7,51.16,7c087b3c-cc04-4d3d-894b-7ea5419fa714,33.95
74.6,66.67,26.98,73.81,HUB > PIONEER,Synthetic Dataset: Patients at risk of sudden death: hypertrophic cardiomyopathy,6ae22437-38d7-4c47-b529-e100e15c81ab,Bronze,Bronze,1.1.7,25.58,7b1c1f1a-4fb2-452d-9a3c-7748992b1fa4,70.55
63.49,71.43,15.87,73.81,ALLIANCE > TISSUE DIRECTORY,York Tissue Bank,6aebcd6d-10c6-44cd-80d6-b5a90791db4f,Silver,Bronze,1.1.7,16.28,71e898d1-db8c-4887-a605-dd6336b92a34,77.58
33.33,19.05,50.79,41.27,,Moorfields AMD Dataset 002,6af010f2-5973-486f-a44b-ef296455bee6,Not Rated,Not Rated,1.1.7,51.16,bf392537-82b4-4d71-ace0-e7bea3b167fb,33.95
66.67,76.19,19.05,73.81,ALLIANCE > TISSUE DIRECTORY,Sheffield Brain Tissue Bank (SBTB),6bc36f07-d55a-4a97-afab-29d93dc65bde,Silver,Bronze,1.1.7,20.93,bdda7221-7c02-4ced-b7a8-3806a073d981,77.63
61.9,69.05,15.87,73.02,HUB > BREATHE,Leicester Respiratory Research Database,6bca5d27-5b98-45e7-b834-6980ba5db5c9,Silver,Bronze,1.1.7,16.28,01c3d08c-6948-4059-a027-3437e4f5d53b,76.38
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,Leeds Breast Research Tissue Bank,6bde3902-5d69-4c24-9d10-f84a63efdb22,Silver,Bronze,1.1.7,16.28,2dc1218d-df5f-4025-826c-cf5ca7d67882,76.38
33.33,19.05,55.56,38.88,,Moorfields Eye Image BioResource 001,6c12c555-c011-4f43-b98f-df0bfaad6b05,Not Rated,Not Rated,1.1.7,53.49,6bfe44ef-9532-4986-b8a2-9c2cda4a89cc,32.78
4.76,4.76,46.03,29.36,,Effects of second-hand smoke on pregnant women: a phenomenological study,6cae7a61-568d-40b1-984a-1dd9365f9c71,Not Rated,Not Rated,1.1.7,46.51,4a5c610f-019d-450a-90c5-0fe315027f56,29.12
23.81,28.57,33.33,45.24,ALLIANCE > HQIP,National Vascular Registry Audit Carotid Lower Limb Amputation clinical dataset,6cd16bca-395b-4dbc-a817-15fd55a1a8e8,Not Rated,Not Rated,1.1.7,32.56,03e77b9d-57b8-44d5-8d64-9b1325958b22,48.0
63.49,71.43,20.63,71.43,ALLIANCE > TISSUE DIRECTORY,DARWIN1 Trial,6ceec25d-2c8e-4dd7-8f99-2e56ec63c298,Bronze,Bronze,1.1.7,20.93,7f9672fa-dad5-479d-a929-52719e8cc2fa,75.25
31.75,35.71,33.33,49.21,ALLIANCE > BARTS HEALTH,Emergency Care Dataset (ECDS),6d41700e-6dac-47c1-ba31-eb2f23539efe,Not Rated,Not Rated,1.1.7,34.88,57fa56f2-78d1-49af-ab8d-e8146d711868,50.42
4.76,4.76,46.03,29.36,,Exploring Personal Preparedness and Self-Protective Measures during COVID-19,6dd170f2-c9fe-4496-9499-26783d84e3c2,Not Rated,Not Rated,1.1.7,46.51,680a7d41-0fd1-4b32-a2cd-190e338f8ac7,29.12
53.97,61.9,20.63,66.67,HUB > BREATHE,"Introducing pulse oximetry in IMNCI, primary health facilities in Pune India",6dd62b6b-d832-4c65-a101-20fe9edd75fc,Bronze,Bronze,1.1.7,20.93,dae5b81c-db28-414b-9328-5596632a8732,70.48
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,Wales Cancer Bank,6dd6c679-7c5f-4d8e-b1e4-8f1447425e96,Silver,Bronze,1.1.7,16.28,37886fb5-d0ae-400f-89eb-78664897bcf2,76.38
33.33,19.05,60.32,36.5,,Covid-19 Second Generation Surveillance System,6e47173e-651a-404e-a0b2-1fa1cbd887b1,Not Rated,Not Rated,1.1.7,55.81,fede31c6-a9c5-4cfb-9866-9b58b2199cff,31.62
36.51,40.48,23.81,56.35,UK Biobank,Biological samples,6e5916d4-017c-4542-bc71-edf6d4c5a055,Not Rated,Not Rated,1.1.7,25.58,41ac38b0-31cd-4865-a357-80ce557b2312,57.45
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,National Asthma and COPD Audit Programme (NACAP): Pulmonary rehabilitation - organisational audit,6e70b32a-dfbc-46d3-9784-479f3f09527e,Not Rated,Not Rated,1.1.7,34.88,4b33fc6d-3cac-4404-adac-d693328456fa,46.84
90.48,83.33,26.98,81.75,ALLIANCE > SAIL,Intensive Care National Audit and Research Centre,6f348bdc-21e4-459b-b658-dc839a1e2133,Silver,Silver,1.1.7,23.26,fa8bf269-4769-491b-b398-fa63137d14ab,80.03
33.33,19.05,55.56,38.88,,National Early Inflammatory Arthritis Audit - patient survey,6f9a4cb1-7c5a-4671-838a-9554a6491266,Not Rated,Not Rated,1.1.7,53.49,e87410ec-a819-43db-99d1-f887c977e525,32.78
33.33,19.05,55.56,38.88,,"NHS Tayside A&E, Diagnosis dataset during A&E visit",6fbdc930-be40-4492-ba79-82d06d49b539,Not Rated,Not Rated,1.1.7,53.49,14a39e96-8ac3-4df3-b42b-07718121c585,32.78
33.33,19.05,55.56,38.88,,Covid-19 UK Non-hospital Antibody Testing Results,6fd8abda-7e49-436c-9131-a1f607569c14,Not Rated,Not Rated,1.1.7,53.49,a77e52cc-d404-45d6-835f-32e2dc46778a,32.78
33.33,19.05,55.56,38.88,,"NHS Tayside A&E, Diagnosis During A&E visit",6ffc7fd8-732f-4360-b38b-fa94dd75a13d,Not Rated,Not Rated,1.1.7,53.49,14a39e96-8ac3-4df3-b42b-07718121c585,32.78
33.33,19.05,55.56,38.88,,School Workforce Annual Census (SWAC),7017aede-b38a-4b70-b7b2-aade001d0cc0,Not Rated,Not Rated,1.1.7,53.49,5692eade-5738-48ed-8527-39be9caaa7b5,32.78
33.33,19.05,60.32,36.5,,National Records of Scotland (NRS) - Stillbirth Data,70491568-676d-43e4-b3c3-b1db4f1ff530,Not Rated,Not Rated,1.1.7,55.81,dca0c95b-ae7d-4163-8c3b-a881f779df02,31.62
33.33,19.05,50.79,41.27,,GoDARTS,705f86b8-4c2f-4ed5-b792-3a0d49d14c75,Not Rated,Not Rated,1.1.7,51.16,8ca05f55-af73-42bd-b682-851c2c54a6cc,33.95
33.33,19.05,55.56,38.88,,National Waiting List Clock Starts,708839a0-d003-4917-bbd9-92741f54ab75,Not Rated,Not Rated,1.1.7,53.49,2b847fd2-0f65-43b7-84e1-10cec99d699e,32.78
33.33,19.05,60.32,36.5,,BathTAP Switching Cohort 3,70ad0b2c-a8dd-4f91-a5b8-adca272bf215,Not Rated,Not Rated,1.1.7,55.81,a20643c7-ef15-4f7d-9e48-5a9f23a645c1,31.62
60.32,69.05,17.46,71.43,ALLIANCE > TISSUE DIRECTORY,CASPS: A Phase II trial of Cediranib in ASPS patients,70b4d407-288a-4945-a4d5-506d60715110,Bronze,Bronze,1.1.7,18.6,7dcd5c0a-1922-4fe2-9b7e-090e4c39861b,75.22
4.76,4.76,46.03,29.36,,CuT-AsthMa: Culturally tailored school-based intervention for asthma in Malaysia,70c318c4-b388-4102-924e-5419d44c1679,Not Rated,Not Rated,1.1.7,46.51,009bcb87-05f3-46e6-8866-7e4df698cb19,29.12
33.33,19.05,50.79,41.27,,Moorfields DMO Dataset 003,719dd9c9-9aa5-426d-981a-57f0ad3f1480,Not Rated,Not Rated,1.1.7,51.16,120106fb-49b4-4bc0-b30c-50a59c5c6253,33.95
65.08,73.81,15.87,74.6,ALLIANCE > AVON LONGITUDINAL STUDY OF PARENTS AND CHILDREN,Avon Longitudinal Study of Parents and Children,71b8569c-b582-499c-85aa-909b825f6ea6,Silver,Bronze,1.1.7,16.28,255d70c6-9a50-4b62-adc0-44216606a216,78.77
4.76,4.76,46.03,29.36,,NIHR BioResource: SNP imputation data,7257d45c-6697-4c49-bbce-de0d456c0678,Not Rated,Not Rated,1.1.7,46.51,39d7ad29-be30-4e12-a7c8-d8757141de85,29.12
14.29,16.67,36.51,38.89,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,Infoflex Cancer Registry,72fe91de-b0c0-423a-ad68-bd7067b20ad8,Not Rated,Not Rated,1.1.7,37.21,5505e91d-9e0a-4969-87d5-00f256d91306,39.73
85.71,78.57,23.81,80.95,HUB > PIONEER,"Deeply-phenotyped hospital COVID patients: severity, acuity, therapies, outcomes",730b3e54-1f59-4c07-b5d6-e6b63e4dda35,Silver,Silver,1.1.7,23.26,16a09f1b-3654-4ec3-9913-fb70cb1e2364,77.66
69.84,78.57,11.11,79.37,HUB > BREATHE,UK BiLEVE Consortium Dataset,73462506-32c5-43a0-963e-06d67e967b97,Silver,Silver,1.1.7,9.3,b8bcda0b-3c90-4382-aeb7-b01fc27e58fa,84.63
33.33,19.05,55.56,38.88,,Postponed Admitted Procedures (CAPD),73edba9a-3799-47e4-9a6e-a52321c21367,Not Rated,Not Rated,1.1.7,53.49,bff94600-a254-4111-82f7-6167084d81ca,32.78
100.0,95.24,39.68,80.16,NIHR Health Informatics Collaborative Viral Hepatitis Theme,HIC Hepatitis v2,73f54071-62bf-48f5-8be1-569208b18ab8,Silver,Silver,1.1.7,34.88,66be725a-b950-4bf8-9a35-7e33ce765a25,80.18
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,Myeloma XII clinical trial samples,74241b17-23b7-4233-b7b9-1a484aa053b0,Silver,Bronze,1.1.7,16.28,576fbcf8-ff25-4230-ae69-e72ca02b95f1,76.38
33.33,19.05,55.56,38.88,,NIHR IBD BioResource: Contact detail,747d57aa-a02b-411c-9403-2e3ec9d3e5b5,Not Rated,Not Rated,1.1.7,53.49,02ddc5c9-03d4-40e4-9934-e60817ec8f3e,32.78
4.76,4.76,46.03,29.36,,NIHR BioResource: Metabolite data,74b54e34-0e01-4447-be1d-e9da3e03cd2e,Not Rated,Not Rated,1.1.7,46.51,dec09f2e-a93f-41e2-8217-72431ea4a19e,29.12
4.76,4.76,46.03,29.36,,National Audit of Dementia Round 4 - casenote audit,74be1c67-ab42-4716-a63b-be3f5de0d489,Not Rated,Not Rated,1.1.7,46.51,587a94e6-48a4-4e5e-8230-4018897bc7c7,29.12
38.1,42.86,25.4,56.35,UK Biobank,Cancer register,75614b69-bc18-416b-9d27-fd8ca9fc4521,Not Rated,Not Rated,1.1.7,27.91,a4751434-54ea-4d22-a66a-a5d32bd80c40,57.48
33.33,19.05,55.56,38.88,,Children Receiving Care and Support Census (CRCS),75b8e10e-cc35-41be-aad7-990afc13b08e,Not Rated,Not Rated,1.1.7,53.49,fb3fac03-a428-4b3f-8058-5622e1fd57d8,32.78
33.33,19.05,50.79,41.27,,National Exercise Referral Scheme,76535d6e-ce0c-407c-ba22-1b2420a1e654,Not Rated,Not Rated,1.1.7,51.16,131784c0-769d-4f7b-b7d0-b5f4b89886d4,33.95
33.33,19.05,50.79,41.27,,Moorfields DMO Dataset Release 001,77422eb1-7bdb-4205-b3d0-57d1add35317,Not Rated,Not Rated,1.1.7,51.16,120106fb-49b4-4bc0-b30c-50a59c5c6253,33.95
100.0,95.24,15.87,92.06,NHSX,The National COVID-19 Chest Imaging Database,77824298-ef3b-40f7-a0a4-b6dedb2e7a02,Gold,Gold,1.1.7,13.95,31f0148b-f965-4136-ab39-6c5bbbf8c2d9,90.64
63.49,71.43,15.87,73.81,ALLIANCE > TISSUE DIRECTORY,Leeds Multidisciplinary Research Tissue Bank,7793f54e-73be-4c97-a941-ba105b1b0480,Silver,Bronze,1.1.7,16.28,7e60a651-b3d6-40ef-93dc-1f87dabee7be,77.58
33.33,19.05,55.56,38.88,,Lifelong Learning Wales Record (LLWR),77b48222-3a00-4dcc-b0ef-3f99dfae697e,Not Rated,Not Rated,1.1.7,53.49,cba62a8d-5917-4912-ad4d-340472f7b904,32.78
33.33,19.05,60.32,36.5,,1958 National Child Development Study - Pain data,77dc7118-443c-4c85-a18c-e7bbe01e9e7a,Not Rated,Not Rated,1.1.7,55.81,33092502-12ef-4bc0-8400-5f63915cbf33,31.62
46.03,35.71,50.79,47.62,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,NHS Tayside and Fife Haematology Biochemistry (Lab Data Restructured),7858978f-30e8-42e7-abe4-d9af5447c278,Not Rated,Not Rated,1.1.7,46.51,10ffac16-d0c2-4d53-ab6a-69a38e283223,44.6
63.49,71.43,15.87,73.81,ALLIANCE > TISSUE DIRECTORY,UCL / UCLH Biobank for Studying Health and Disease,7862c1c2-d4d6-4b3c-aea1-1f15a5b3b5ea,Silver,Bronze,1.1.7,16.28,ce533c67-5565-4010-bedf-dca3863a9084,77.58
100.0,95.24,15.87,92.06,ALLIANCE > SAIL,COVID-19 Symptom Tracker Dataset,78ce070c-84db-4676-81c5-0c672f4e12e3,Gold,Gold,1.1.7,13.95,594cfe55-96e3-45ff-874c-2c0006eeb881,90.64
77.78,64.29,49.21,64.28,ALLIANCE > NHS DIGITAL,Mental Health Minimum Dataset v4.1 (Sensitive) Episodes,78fe2e13-7f40-406f-a584-04909d0ce060,Not Rated,Not Rated,1.1.7,44.19,efecbe58-4822-4f17-bf5c-92113d143db9,60.05
33.33,19.05,55.56,38.88,,CAPS,7964fc83-017a-4786-918e-bab61f7ddd99,Not Rated,Not Rated,1.1.7,53.49,a4c595a6-cb41-4743-bea3-feb4d4c72091,32.78
33.33,19.05,52.38,40.47,,Synthetic Dataset - Patients at risk of sudden death: hypertrophic cardiomyopathy,796d97b4-6f3d-4ee8-8966-9238efdcac2d,Not Rated,Not Rated,1.1.7,53.49,7b1c1f1a-4fb2-452d-9a3c-7748992b1fa4,32.78
63.49,71.43,17.46,73.02,ALLIANCE > TISSUE DIRECTORY,Central England Haemato-oncology and oncology Research Biobank (CEHRB),79b02690-798b-462d-9ced-f53c9e39d624,Silver,Bronze,1.1.7,18.6,314953f6-58e7-49c0-adfd-c60e623eba74,76.42
77.78,64.29,49.21,64.28,ALLIANCE > NHS DIGITAL,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Records,7aa02796-787a-42c2-b97e-d008fa77e4b8,Not Rated,Not Rated,1.1.7,44.19,1a8fc23c-b67b-4171-b5e1-1b650fce1ef4,60.05
33.33,19.05,60.32,36.5,,Education Wales (EDUW),7aa38c5c-771c-4157-a008-32051a5aed4b,Not Rated,Not Rated,1.1.7,55.81,204fa806-071d-4410-9c2c-143017d32d24,31.62
33.33,19.05,55.56,38.88,,NIHR BioResource: Contact detail,7ada943a-083d-44c5-a147-32e581e3ed20,Not Rated,Not Rated,1.1.7,53.49,fc2fcaec-bd5b-4d43-9e0c-2fed36eff0e4,32.78
4.76,4.76,46.03,29.36,,NIHR BioResource: Whole Genome Sequencing,7b922498-1757-418d-96ca-64980a50b647,Not Rated,Not Rated,1.1.7,46.51,ecb90b4a-6f4f-4398-a4f6-d64891c4a137,29.12
23.81,28.57,33.33,45.24,ALLIANCE > HQIP,National Joint Registry - Revision Shoulder Replacement dataset,7c1f02ee-a72e-4aca-9205-0013f0796db6,Not Rated,Not Rated,1.1.7,32.56,9623e62b-3c50-44aa-8923-0bbb94e7ad61,48.0
33.33,19.05,50.79,41.27,,GPES Data for Pandemic Planning and Research (COVID-19),7d313fa6-941f-48ca-93e1-05d912d183ac,Not Rated,Not Rated,1.1.7,51.16,696cfc9f-090d-4328-94ac-140760a77c73,33.95
33.33,19.05,55.56,38.88,,National Early Inflammatory Arthritis Audit - clinical dataset,7d98182a-18f8-4f2e-a59c-5048580557b5,Not Rated,Not Rated,1.1.7,53.49,b0797c05-352f-455f-8d27-150b6f6354cc,32.78
33.33,19.05,50.79,41.27,,COVID-19 Vaccination,7daacbe5-082d-4c12-b801-0fb08932dada,Not Rated,Not Rated,1.1.7,51.16,b0049073-3335-433d-bdb9-de22547698f8,33.95
41.27,47.62,25.4,57.94,HUB > BREATHE,Effect of personal air pollution exposure on asthma control in children,7df79ee6-e67d-4ad9-89f3-23bee6cb0ec5,Not Rated,Not Rated,1.1.7,25.58,57efab41-65fc-4069-8b9d-e5ced13cb4d3,61.02
39.68,45.24,26.98,56.35,HUB > BREATHE,At-Risk Registers Integrated into primary care to Stop Asthma crises in the UK,7e780260-e8d3-4541-b51e-213233dfc349,Not Rated,Not Rated,1.1.7,27.91,36a5da45-772c-4c67-8ec3-84c9e67332d3,58.67
4.76,4.76,46.03,29.36,,Next Steps,7ec7c8c4-770b-41f0-87d0-38ea232ae5bd,Not Rated,Not Rated,1.1.7,46.51,0ad7a3dd-e720-49ef-9d27-c394a32b0326,29.12
33.33,19.05,50.79,41.27,,Outpatient Appointments and Attendances - Scottish Morbidity Record (SMR00),7ed08209-f22e-4cdf-b8b5-e1d58b0bcaf9,Not Rated,Not Rated,1.1.7,51.16,04cb9964-54fb-4529-b09b-735c3daa1c7b,33.95
33.33,19.05,65.08,34.12,,Covid Lateral Flow Test (CVLF),7f49d025-11d9-4d04-9b77-19a2f5acf8e6,Not Rated,Not Rated,1.1.7,58.14,ce60d677-6263-4d41-9d45-d3c7ebb3ee36,30.45
95.24,88.1,25.4,84.92,HUB > INSIGHT,UHB Eye Image Dataset Release 001,7f4fb30c-2a09-4d75-bed2-114751e06723,Silver,Silver,1.1.7,23.26,21fb56d1-726f-40e3-a998-e4b34ba3e46f,82.42
4.76,4.76,46.03,29.36,,National Neonatal Audit Programme - 2 year outcomes audit,7f6c7bdc-c0ee-40a1-95bf-aa4a10ca46a7,Not Rated,Not Rated,1.1.7,46.51,3bb02d77-9678-4e6e-832d-c2ed3ede412c,29.12
100.0,95.24,30.16,84.92,GENOMICS ENGLAND,GENOMICS ENGLAND 100K CANCER & COMMON,7fdb684d-bb7a-4d0b-8666-9f10510f071f,Silver,Silver,1.1.7,25.58,702f0198-bdfe-401e-97f2-35f5d26357ad,84.83
82.54,76.19,26.98,77.78,ALLIANCE > SAIL,COVID-19 Test Trace and Protect [CTTP],80a7208f-c174-42bd-9127-e8f006de7c95,Silver,Silver,1.1.7,23.26,c0fc84af-aeab-4c7e-aa0b-8264baff55d9,76.47
100.0,95.24,15.87,92.06,ALLIANCE > SAIL,Cervical Screening Wales,80e9c439-4909-4534-8bfe-6f01fdec7de7,Gold,Gold,1.1.7,13.95,b32325d7-7f00-4d20-9935-dd02e1bc6932,90.64
33.33,19.05,55.56,38.88,,Critical Care Dataset (CCDS),8160dc2b-860a-47e1-a5d2-38473d1d31a0,Not Rated,Not Rated,1.1.7,53.49,1789286a-deaf-49df-88cd-660e92934af6,32.78
33.33,19.05,50.79,41.27,,Outpatient Dataset,8193e951-2ed8-4ccf-9fe5-5c2e6f933d60,Not Rated,Not Rated,1.1.7,51.16,d331159b-b286-4ab9-8b36-db39123ec229,33.95
90.48,83.33,33.33,78.58,ALLIANCE > CPRD,Systemic Anti-Cancer Treatment (SACT) data for CPRD GOLD,81a2abb5-e2b4-4224-8345-5aac1dc68a5d,Bronze,Silver,1.1.7,32.56,014e7973-b43e-4a4a-91b4-de3f353b71b9,75.38
84.13,76.19,25.4,79.36,HUB > PIONEER,Risk and outcomes of coagulopathies in acutely unwell adults,81c54c5a-ceb1-487c-820a-437b4dd002ca,Bronze,Silver,1.1.7,25.58,bf3fe16c-5377-4571-b5a5-7aa7e796594c,75.31
88.89,83.33,31.75,78.57,ALLIANCE > CPRD,HES Outpatient data for CPRD GOLD,81f3bdfe-de6b-4831-ba9a-4e28a34a6ab4,Silver,Silver,1.1.7,30.23,21dc2345-3983-4a46-960c-f17974bc7b71,76.55
77.78,64.29,49.21,64.28,ALLIANCE > NHS DIGITAL,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Episodes,8226b6fa-d815-4f15-9064-b56beb0fddb1,Not Rated,Not Rated,1.1.7,44.19,a27400b0-0efb-4af8-a7bc-e2c7e59796e3,60.05
66.67,76.19,19.05,73.81,ALLIANCE > TISSUE DIRECTORY,Research Donors Ltd,826114ca-2563-4c0c-b023-3417ead32956,Silver,Bronze,1.1.7,20.93,fcb62cb3-c876-47a3-961e-fb27c6f718fa,77.63
33.33,19.05,55.56,38.88,,NHS Tayside and Fife Immunology (Extractable),8286eef9-0533-488e-bf19-8fc0fa1dd00b,Not Rated,Not Rated,1.1.7,53.49,39055449-c074-4b58-adb2-b1c0d2441c4d,32.78
4.76,4.76,46.03,29.36,,Reasons for delay in seeking care for pneumonia in children under five,828bc515-6b42-4492-a77e-cf20226ba041,Not Rated,Not Rated,1.1.7,46.51,46f50b9b-b8e2-4ff1-a1b3-779174c3d032,29.12
79.37,71.43,28.57,75.4,NCS > OFFICE FOR NATIONAL STATISTICS,Labour Force Survey (Person),82b0be0d-3bd3-4a4e-a37d-be4c3b8a42f7,Bronze,Bronze,1.1.7,25.58,8c60a308-1e47-4a0c-8b69-9259f05338cb,72.93
63.49,71.43,15.87,73.81,ALLIANCE > TISSUE DIRECTORY,Northern Ireland Biobank (NIB),82f4cf19-9e6a-4c31-8cc3-085f3d44ba44,Silver,Bronze,1.1.7,16.28,c6e1ea88-f5bf-4a57-953f-688f313fcb04,77.58
23.81,28.57,33.33,45.24,ALLIANCE > HQIP,National Clinical Audit of Anxiety and Depression - Core audit of practice,83099c35-3152-4e7e-accf-ca4c7ed922b6,Not Rated,Not Rated,1.1.7,32.56,4a96b9bf-beb0-41b1-9211-e6ce39a21c1a,48.0
4.76,4.76,46.03,29.36,,Hypertonic saline nasal irrigation and gargling for suspected COVID-19,830c22bb-4321-4fa3-ba04-be9b30518877,Not Rated,Not Rated,1.1.7,46.51,574cf7bc-dd70-4508-a66d-ac59d8d06639,29.12
4.76,4.76,46.03,29.36,,Trusted Research Environments for CVD-COVID-UK / COVID-IMPACT,83e177bb-5a05-4ec1-be22-272a0f985957,Not Rated,Not Rated,1.1.7,46.51,7e5f0247-f033-4f98-aed3-3d7422b9dc6d,29.12
55.56,61.9,26.98,64.29,HUB > BREATHE,Deriving and validating a clinical prediction rule for the diagnosis of asthma in primary care,842e8c5c-a298-4942-9ac4-f95d1a5f87b3,Bronze,Not Rated,1.1.7,27.91,b0a68ee7-742d-45dc-aae9-4be4e1655fc0,67.0
100.0,95.24,34.92,82.54,NIHR Health Informatics Collaborative Cardiovascular Theme,HIC Acute Coronary Syndromes,844f3be0-f50d-4a88-9783-0928ad1c2aad,Silver,Silver,1.1.7,32.56,869a9b4e-3537-449f-9a59-a0eac523c4e4,81.34
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,"Oncology Clinical Trials Office, University of Oxford",8466ec6f-8a4c-4286-8138-04c35e12b1f8,Silver,Bronze,1.1.7,16.28,4a65f6d6-f2e4-4d98-a3a4-94a32206836d,76.38
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,National Audit of Psychosis - Audit on Early Intervention in Psychosis services -  patient experience survey,849d46e6-49a6-4456-a5ae-990c02012bf2,Not Rated,Not Rated,1.1.7,34.88,c3e63860-bd61-4154-ab5f-ca927fb029c4,46.84
39.68,45.24,22.22,58.73,OTHER > The University of Cambridge,COMPARE,84b6d047-2a05-4fc0-8537-809dbb3d18ed,Not Rated,Not Rated,1.1.7,23.26,8cbb73e2-a2c4-4caf-8dcd-6ac3795bb996,60.99
14.29,16.67,36.51,38.89,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,CRIS,84de0d13-f5bd-4c22-83d3-e1adb00d5a72,Not Rated,Not Rated,1.1.7,37.21,67cea834-33f5-4ed7-9dc2-072ad077de07,39.73
96.83,92.86,22.22,87.31,HUB > DISCOVER NOW,North West London Coordinate My Care (NWL CMC),850f99cb-f091-4f10-86ee-06a3eaa7df53,Gold,Gold,1.1.7,18.6,c853b41b-fbd1-4896-b0fb-85303109fec4,87.13
33.33,19.05,55.56,38.88,,Intensive Care National Audit and Research Centre - Covid19 (ICNC),859c37b7-3c37-4423-ad85-190b210f5627,Not Rated,Not Rated,1.1.7,53.49,add6226b-0f21-439a-84a6-51dc26cdc425,32.78
100.0,95.24,30.16,84.92,ALLIANCE > CYSTIC FIBROSIS TRUST,Cystic Fibrosis Patient Tendon Rupture,8638e095-a609-463f-b36e-c4cac4519660,Gold,Silver,1.1.7,20.93,4fcc8b11-2b9b-4f68-b51a-978749d89acc,87.16
60.32,69.05,17.46,71.43,ALLIANCE > TISSUE DIRECTORY,Oxford Musculoskeletal Biobank,865f0e79-f862-493b-b863-b39b777d60ca,Bronze,Bronze,1.1.7,18.6,ccd6e59d-3582-4f47-a4cd-f5845192d75c,75.22
68.25,78.57,12.7,77.78,HUB > BREATHE,Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS),8665b36e-f9a5-4062-ba56-d33fecfe3376,Silver,Silver,1.1.7,11.63,cc6f926a-90cf-4083-84e7-131d1e63813b,83.47
33.33,19.05,50.79,41.27,,SARS-CoV-2 viral sequencing data (COG-UK data) - Lineage/Variant Data - Wales,8670f9ea-d01f-4f41-9b01-be96f015b4db,Not Rated,Not Rated,1.1.7,51.16,602cbc9b-0113-4712-8c4a-0efe8d86b77c,33.95
76.19,64.29,41.27,67.46,ALLIANCE > NHS DIGITAL,HES:Civil Registration (Deaths) bridge,86d7088b-7a15-4e9a-b2b0-857a67e04650,Not Rated,Bronze,1.1.7,37.21,21aec912-444f-447d-b3c4-6791a6c82667,63.54
33.33,19.05,50.79,41.27,,Maternity Indicators Dataset (MIDS),87860b0b-fa39-4158-9a80-177703f4b0df,Not Rated,Not Rated,1.1.7,51.16,a0c27454-8cbe-418f-bdae-a85d5e92e9d4,33.95
90.48,83.33,33.33,78.58,ALLIANCE > CPRD,Cancer registration data for CPRD GOLD,88155e0d-a88f-4a72-ba3f-45d4e352439a,Bronze,Silver,1.1.7,32.56,e2f5d637-94b3-447b-b7eb-ea957ce449b6,75.38
41.27,47.62,23.81,58.73,HUB > BREATHE,EMEP4UK Pollution,8821748d-9d8b-4787-91cc-0a58c5ab890d,Not Rated,Not Rated,1.1.7,23.26,eb76598f-e228-413c-82f3-231809062611,62.18
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,University of Southampton Faculty of Medicine Tissue Bank,88576066-fb5f-43e2-8af4-0904630b2f1b,Silver,Bronze,1.1.7,16.28,786563e9-5377-4d18-8d32-65ff14d53987,76.38
90.48,83.33,31.75,79.37,ALLIANCE > CPRD,HES Accident and Emergency data for CPRD GOLD,8895d3d9-78bd-4216-986a-3bb7f864c382,Silver,Silver,1.1.7,30.23,733b1060-f958-4c3e-ab6a-2b87901d9a9a,76.55
77.78,64.29,49.21,64.28,ALLIANCE > NHS DIGITAL,Mental Health Minimum Dataset v2.6 (Non-Sensitive),895e5c2f-e484-4d08-91c6-35ac2f85c231,Not Rated,Not Rated,1.1.7,44.19,702201ff-e729-4e29-a428-32953c9a0332,60.05
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,Human Biomaterials Resource Centre,89aac17d-f8a1-4ddc-9495-4adc278234a9,Silver,Bronze,1.1.7,16.28,2f085ac6-d33d-4b9b-8a99-624cc51c3f17,76.38
85.71,78.57,28.57,78.57,ALLIANCE > NHS DIGITAL,Hospital Episode Statistics Admitted Patient Care,89f76cff-03dd-47a1-b6fc-29e42b78e7a5,Bronze,Silver,1.1.7,27.91,2b6409db-a669-4bef-9fd5-39c2b6f8d5e9,75.33
33.33,19.05,50.79,41.27,,"Studies Supported by NIHR CRN, ICD10 Coded, with Summary Site Recruitment Data",8a0d67e2-6daa-4ebe-913b-eb5ede8801ba,Not Rated,Not Rated,1.1.7,51.16,02397c83-62e6-4ec2-8366-89d211739564,33.95
15.87,19.05,39.68,38.09,ALLIANCE > BARTS HEALTH,CDE Documentation,8a91286f-3d29-40fc-ae5b-196c46a50426,Not Rated,Not Rated,1.1.7,41.86,f866b225-10b8-4df4-9c32-072411f816d8,38.59
100.0,95.24,20.63,89.69,ALLIANCE > SAIL,COVID-19 Consolidated Deaths,8bbcf9f4-a3c4-4f26-aa0e-c5c46457afa3,Gold,Gold,1.1.7,16.28,70e37f44-5c3e-4c83-a42a-89b3476d1d45,89.48
15.87,19.05,38.1,38.88,ALLIANCE > BARTS HEALTH,Sectra PACS,8c7abca7-4292-4d1f-b311-c132a7adf109,Not Rated,Not Rated,1.1.7,39.53,10bf4c08-6702-44fe-8faa-1280dea6b0c9,39.76
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,Falls and Fragility Fracture Audit Programme Fracture Liaison Service Database clinical dataset,8c8cf129-e87c-46b3-8812-19e07578ee89,Not Rated,Not Rated,1.1.7,34.88,d94a604c-5733-4f07-93bb-e77b6ea2313f,46.84
88.89,80.95,25.4,81.75,ALLIANCE > CPRD,Quality of Life of Cancer Survivors: Pilot Patient Reported Outcomes (Gold),8d06cb09-640c-40db-8387-adf7fab54c3b,Silver,Silver,1.1.7,25.58,83059be4-071b-4a36-8ab1-9fde1e32e75e,77.69
88.89,80.95,25.4,81.75,ALLIANCE > CPRD,Quality of Life of Cancer Survivors: Pilot Patient Reported Outcomes (Aurum),8d24889c-ac3c-4b9d-a8bd-cf9effd64370,Silver,Silver,1.1.7,25.58,3bc43876-507b-4dff-bd2b-7df147322e15,77.69
33.33,19.05,55.56,38.88,,Deaths – Date of Death,8d33b7a7-151a-4e2e-b87f-b14371e0cb37,Not Rated,Not Rated,1.1.7,53.49,faf2fc49-d09f-4ea2-a2cb-b1d30fffa406,32.78
77.78,64.29,42.86,67.46,ALLIANCE > NHS DIGITAL,Bridge file: Hospital Episode Statistics to Mental Health Minimum Data Set,8d3f80d4-aeae-46f0-809b-cd6c51e24f75,Not Rated,Bronze,1.1.7,39.53,31bb8022-f8b1-405a-a22f-140f7c4b4fa6,62.38
4.76,4.76,46.03,29.36,,Developing and evaluating interventions to improve asthma care: HEAL ASTHMA,8da6766c-df44-4414-a858-4415e473ea76,Not Rated,Not Rated,1.1.7,46.51,216924f0-585e-4842-a165-78cf9e0af0aa,29.12
4.76,4.76,46.03,29.36,,National Asthma and COPD Audit Programme (NACAP): Wales primary care dataset,8daf5886-4813-465d-9145-3585a8c584bb,Not Rated,Not Rated,1.1.7,46.51,8a3ec96a-0600-4c6d-8761-9d277f07b9da,29.12
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,National Clinical Audit of Anxiety and Depression - spotlight audit on psychological therapies (patient experience survey),8dc64dc2-91e0-4a43-9524-1658df371301,Not Rated,Not Rated,1.1.7,34.88,d94eb31c-04c4-41b6-ad38-45f6aef30132,46.84
69.84,61.9,38.1,65.87,ALLIANCE > IMPERIAL COLLEGE LONDON,REal-time Assessment of Community Transmission (REACT-2),8e5e3ebe-c0ae-458f-bc75-a5a3368d4c2d,Not Rated,Not Rated,1.1.7,32.56,25003f25-384c-4264-9c8f-dd8734ee5595,64.67
46.03,47.62,30.16,57.94,ALLIANCE > NHS DIGITAL,Mental Health Services Data Set - Inpatients,8eace3c2-1dc8-4708-9350-ad129b7d2bc9,Not Rated,Not Rated,1.1.7,32.56,275ac6a4-798b-4f49-a25e-008245050bbc,57.53
33.33,19.05,50.79,41.27,,Unscheduled Care Data Mart,8f54b1ad-b8cd-44a3-94d7-c98133ca913d,Not Rated,Not Rated,1.1.7,51.16,a265af2e-40fc-4759-af61-eab293cdad5a,33.95
84.13,76.19,25.4,79.36,HUB > PIONEER,The impact of hospitalised patients with COPD: from admission to outcome,8fac682b-96be-4e21-a2a9-5fe66c3b35ff,Bronze,Silver,1.1.7,25.58,780bf7d0-9ee1-4641-a74f-dc148e361970,75.31
33.33,19.05,50.79,41.27,,Eye images and retinopathy grades in diabetic eye screening,8fc6bf25-df25-429f-be41-b7d5ffd4ff15,Not Rated,Not Rated,1.1.7,51.16,3b1bb176-e22f-402a-b863-730d05b22021,33.95
33.33,19.05,55.56,38.88,,COVID-19 COG-UK Viral Genome (variant strain data),90ace555-da01-4940-a3ef-78bb83976ff0,Not Rated,Not Rated,1.1.7,53.49,9a36f3f8-3b7e-4e61-8993-b9cc2734fcb8,32.78
33.33,19.05,65.08,34.12,,RAPID (Hospital Stay Level Data),90db47a7-d082-4778-884c-78f9b6c7e57f,Not Rated,Not Rated,1.1.7,58.14,1fc57971-5af5-499e-a500-4ffbb087f0c4,30.45
33.33,19.05,50.79,41.27,,Prescribing Information System (PIS),90f44ae7-8394-4fe5-8c1e-c9aa5bf0edf1,Not Rated,Not Rated,1.1.7,51.16,22e3943e-edb5-44a1-9e4e-22b0f7a31767,33.95
63.49,71.43,15.87,73.81,ALLIANCE > TISSUE DIRECTORY,Bloodwise Childhood Leukaemia Cell Bank,914321d0-1d86-4974-a38d-97469f9ff2cd,Silver,Bronze,1.1.7,16.28,93baeb13-cc4b-47fd-9dae-5ae5277cba54,77.58
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,National Asthma and COPD Audit Programme (NACAP): Pulmonary rehabilitation - clinical audit,91b2fdab-1d0e-41a1-a9cc-1ebb536c7ee5,Not Rated,Not Rated,1.1.7,34.88,3afbb83d-d47b-43b3-a202-0d3081e5d294,46.84
52.38,59.52,23.81,64.28,HUB > BREATHE,Seasonal Influenza Vaccine Effectiveness II,91f1aef1-7dfe-4cb3-86ab-15e09f91e969,Bronze,Not Rated,1.1.7,23.26,50b47298-d935-4990-a002-e26b6bb26d30,68.13
4.76,4.76,46.03,29.36,,"Estimate the cost of care, quality of life and wider societal burden due to COPD",922f72c0-e3cb-4d89-a56f-50d938a87630,Not Rated,Not Rated,1.1.7,46.51,ee6013d6-5584-4275-b124-3113ee5ad37d,29.12
4.76,4.76,46.03,29.36,,Omega 3 Cohort,927beb63-f650-4972-a3ad-af8e29dc26a5,Not Rated,Not Rated,1.1.7,46.51,a1bcea4c-89dd-4cdb-978c-43db676ed73c,29.12
96.83,92.86,26.98,84.92,HUB > DATA-CAN,Yorkshire Specialist Register of Cancer in Children and Young People,931efe47-04eb-4ff3-aa62-97e2e4007aed,Silver,Silver,1.1.7,20.93,93582beb-e45a-47b6-aeab-d26f583e4c3b,85.97
100.0,95.24,22.22,88.89,ALLIANCE > SAIL,National Survey for Wales,9360bc6c-2a7d-4415-869d-3e853c558f4d,Gold,Gold,1.1.7,18.6,bcca421a-9077-4c47-9daa-b1bc030d3dee,88.32
46.03,35.71,50.79,47.62,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,Demography,93ad5a26-65f5-438f-b4e3-9f7078cc2f92,Not Rated,Not Rated,1.1.7,46.51,b88c2b24-b75d-4d28-9391-2dbac1605a17,44.6
87.3,80.95,28.57,79.37,HUB > DATA-CAN,South West Primary Care Dataset,93aeac00-2e6d-44d7-8643-092c587c241a,Silver,Silver,1.1.7,25.58,a47a8c77-3ced-43a0-acf0-3997c4eb5a29,77.69
34.92,38.1,23.81,55.55,UK Biobank,Imaging,93d26255-7199-4ea7-997d-f74890d12b87,Not Rated,Not Rated,1.1.7,25.58,32a2dcb1-1e18-44ba-ad49-b3da312ca447,56.26
4.76,4.76,46.03,29.36,,Exploring psychological issues of primary care teams in Malaysia amidst COVID-19,94188672-a44d-4ae3-8bb3-f249891a5af7,Not Rated,Not Rated,1.1.7,46.51,64f78a5f-268f-4951-9c91-f7e7130baffa,29.12
60.32,69.05,17.46,71.43,ALLIANCE > TISSUE DIRECTORY,National Unified Renal Translational Research Enterprise (NURTuRE),9445e723-655a-43d0-a4e5-50313d98eac0,Bronze,Bronze,1.1.7,18.6,15f07cef-f4cc-4a50-90bc-9fd40f8b6327,75.22
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,BioDock,94e28efd-a976-4748-81fd-956a598c26cb,Silver,Bronze,1.1.7,16.28,ecb82441-286f-408d-880c-9239a25fb5cd,76.38
87.3,80.95,20.63,83.34,ALLIANCE > PUBLIC HEALTH SCOTLAND,Unscheduled Care Datamart,94f983ec-af41-451a-af5d-657ac58207c6,Silver,Silver,1.1.7,20.93,a265af2e-40fc-4759-af61-eab293cdad5a,80.01
63.49,71.43,15.87,73.81,ALLIANCE > TISSUE DIRECTORY,RAPPER,94fab6d3-9753-4ffd-ade2-02d199d93f94,Silver,Bronze,1.1.7,16.28,76d26f0f-0136-4ae5-8be9-37782a70bac5,77.58
33.33,19.05,50.79,41.27,,GP dataset - Welsh Primary Care,953f6cc1-bd69-4fbc-a91b-d33f6c7aa6ca,Not Rated,Not Rated,1.1.7,51.16,33fc3ffd-aa4c-4a16-a32f-0c900aaea3d2,33.95
88.89,80.95,34.92,76.98,ALLIANCE > CPRD,Pregnancy Register for CPRD GOLD,9552365b-7b9a-4d04-a857-358d0e171424,Bronze,Silver,1.1.7,32.56,14aaf184-5922-4459-affb-6c9e55c12176,74.19
4.76,4.76,46.03,29.36,,"4 Country ChrOnic Respiratory Disease study: PILOT PHASE, Islamabad",95b26238-3379-4188-ad6c-a09657b77648,Not Rated,Not Rated,1.1.7,46.51,a6ea6185-2e2e-4738-b7f1-dc052eae902e,29.12
69.84,59.52,33.33,68.25,OTHER > UNIVERSITY COLLEGE LONDON,VIVALDI 2,96c73136-da1b-43de-9fd1-9d5e63631b14,Not Rated,Bronze,1.1.7,30.23,12f1ffbc-0ddd-4d6e-b126-2cccf6738658,64.64
90.48,83.33,23.81,83.34,ALLIANCE > SAIL,SAIL Dementia e-Cohort,9709ee81-c5f1-4c01-a1ac-51ae2a0a60f3,Silver,Silver,1.1.7,23.26,f48b7c05-6a44-480c-84c6-4f7a684f29f8,80.03
4.76,4.76,46.03,29.36,,FFFAP -  National Hip Fracture Database Facilities Survey 2019,97771ec7-2abb-4d6e-b630-77c61a5e314a,Not Rated,Not Rated,1.1.7,46.51,025c9e8a-938b-4886-9e03-fcad90fe7157,29.12
33.33,19.05,55.56,38.88,,CPRD COVID-19 Symptoms and Risk Factors Synthetic Dataset,977ca75e-32da-4e60-a2e5-2bdf534a5986,Not Rated,Not Rated,1.1.7,53.49,a48c65e2-a4e0-4d05-9e9c-fc84e050dea0,32.78
4.76,4.76,46.03,29.36,,"Resilience, Ethnicity & Adolescent Mental Health (REACH)",97a5f21e-c0a9-4a04-978b-9f054d7b6bcf,Not Rated,Not Rated,1.1.7,46.51,0f754b8b-353e-4e8d-9ff0-03d5e0817e02,29.12
92.06,85.71,31.75,80.16,ALLIANCE > CPRD,HES Admitted Patient Care data for CPRD GOLD,97ae3443-b60b-4b33-b861-83663caea1dc,Silver,Silver,1.1.7,30.23,4bcf64a6-f404-4ef4-ae6e-172512ab5f43,77.74
77.78,64.29,49.21,64.28,ALLIANCE > NHS DIGITAL,Mental Health Minimum Dataset v4 (Sensitive) Records,97fa09e6-5ea5-41cd-baf8-20366db13a3f,Not Rated,Not Rated,1.1.7,44.19,eab996ed-b268-439a-bff4-19925698336a,60.05
63.49,73.81,17.46,73.02,ALLIANCE > TISSUE DIRECTORY,RATHL Trial,99812cec-ea1c-4979-8e00-32df5bad000b,Silver,Bronze,1.1.7,18.6,e5ec63dd-4da5-4119-99c8-5cc79045618c,77.61
33.33,19.05,55.56,38.88,,Sars-CoV-2 Immunity & REinfection EvaluatioN (SIREN),99b505ee-44c6-497d-b30b-3ce80eba4047,Not Rated,Not Rated,1.1.7,53.49,8e0221d4-dcfa-4580-834b-f44421fca3b5,32.78
88.89,80.95,30.16,79.37,ALLIANCE > CPRD,Quality of Life of Colorectal Cancer Survivors: Patient Reported Outcomes (Gold),9a5fdb85-7bd6-4073-9058-e45667d497a8,Silver,Silver,1.1.7,27.91,61a607a9-b404-41e0-a52e-0c6d0ce8c2be,76.52
4.76,4.76,46.03,29.36,,Blended learning for primary care physicians on COPD in Bangladesh,9a836aa8-60c7-4911-943e-477b0ae8bbb8,Not Rated,Not Rated,1.1.7,46.51,3907a55f-104b-4533-ba21-69bd5f08ce8f,29.12
33.33,19.05,55.56,38.88,,Systemic Anti-Cancer Therapy Dataset [SACT],9abb8804-de89-4aba-8877-0e9a405870fe,Not Rated,Not Rated,1.1.7,53.49,6c4ed998-0f05-415c-a3e4-42430bb62d24,32.78
33.33,19.05,50.79,41.27,,Neovascular age related macular degeneration at University Hospitals Birmingham,9b356432-2650-4ded-aa75-657871b38fe3,Not Rated,Not Rated,1.1.7,51.16,89c2c798-2e0f-4235-9cd9-e2347f2dfc50,33.95
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,National Cardiac Audit Programme - National Congenital Heart Disease Audit (NCHDA),9b7d2306-35e2-44a3-a97d-0b0e03a15336,Not Rated,Not Rated,1.1.7,34.88,2b640175-725a-465f-9aec-6794e6d27791,46.84
46.03,47.62,30.16,57.94,ALLIANCE > NHS DIGITAL,Mental Health Services Data Set - Currencies,9b7f7994-0b9c-4809-b67d-45ae1f04ec5c,Not Rated,Not Rated,1.1.7,32.56,add485fa-4c54-4a3e-8676-abe2ff4725a5,57.53
85.71,78.57,30.16,77.78,HUB > DATA-CAN,PHM and Cancer Outcomes in the WYH Cancer Alliance,9bfba8a4-43c3-4356-93a5-3eb3b7bc247a,Bronze,Silver,1.1.7,27.91,bc839e9c-e303-4c3c-9c2c-9975602376e2,75.33
33.33,19.05,50.79,41.27,,Domiciliary Social Care Worker (DSCW),9c2356fe-409f-4a34-9fbf-663d2add3902,Not Rated,Not Rated,1.1.7,51.16,0e38bbf4-c788-4a1a-9af8-a24821250154,33.95
33.33,19.05,50.79,41.27,,Optimum Patient Care Research Database (OPCRD),9c31bd50-e999-4d4d-bb9d-545c00fcf23e,Not Rated,Not Rated,1.1.7,51.16,ac755244-4143-4629-9170-a9e8fc98bb1e,33.95
100.0,95.24,22.22,88.89,HUB > BREATHE,"Extended Cohort for E-health, Environment and DNA (EXCEED)",9ca6e8d2-98d2-4757-84e1-287585400e55,Gold,Gold,1.1.7,18.6,e22ddf52-7f9e-4072-ae61-cb722461b37d,88.32
33.33,19.05,55.56,38.88,,National Survey for Wales Dataset (NSWD),9cb83fb7-e8d7-436b-b847-e4759b9589c5,Not Rated,Not Rated,1.1.7,53.49,bcca421a-9077-4c47-9daa-b1bc030d3dee,32.78
33.33,19.05,55.56,38.88,,UK Renal Registry - Kidney PREM dataset,9cc82b97-d508-4cb9-98ca-0105aa897bb6,Not Rated,Not Rated,1.1.7,53.49,ea068fd4-1a96-4ed5-a010-8930afb968bb,32.78
95.24,90.48,23.81,85.72,HUB > GUT REACTION,IBD NIHR BioResource: Sample holding,9d4f445e-f81e-45d7-bd83-7e9f68199b4f,Silver,Silver,1.1.7,20.93,f2af20f9-af84-40ce-8a07-7d095948653e,84.78
33.33,19.05,55.56,38.88,,National Vascular Registry -  Abdominal Aortic Aneurysm Repair clinical dataset,9da5acec-1749-46a6-bf93-51457bbaa52c,Not Rated,Not Rated,1.1.7,53.49,fbe1ae63-0c12-48e5-be16-87d6bc7bd179,32.78
44.44,52.38,25.4,59.52,HUB > BREATHE,Respiratory social media database,9de20d42-8e9b-45c8-8574-52a49fba826c,Not Rated,Not Rated,1.1.7,25.58,43fc768a-9d2c-4c6d-952f-d8570c487b4a,63.4
100.0,95.24,20.63,89.69,ALLIANCE > SAIL,Annual District Death Daily,9e67001e-7c77-4bc0-9af2-5138b5d638e4,Gold,Gold,1.1.7,16.28,584bf8c8-d58f-44c6-9b65-e1611144fd54,89.48
33.33,19.05,50.79,41.27,,Radiotherapy Dataset (RTDS),9ea7a624-ce4c-460e-b68f-0655dac36765,Not Rated,Not Rated,1.1.7,51.16,f102ca50-d1e4-44ec-924e-be89446652af,33.95
4.76,4.76,46.03,29.36,,National Paediatric Diabetes Audit - survey of workforce in PDUs,9eaef4d3-0323-40bf-b799-03108b2c9f48,Not Rated,Not Rated,1.1.7,46.51,fe8f8e2c-2f77-464d-9d45-a601cb2f8bf9,29.12
87.3,78.57,26.98,80.16,ALLIANCE > CPRD,Patient postcode linked deprivation measures for CPRD GOLD,9f7608a0-2424-457d-ba50-f51a4444403b,Bronze,Silver,1.1.7,27.91,f5c9ba01-a9cb-4a85-9850-d9466b2ff4fb,75.33
33.33,19.05,55.56,38.88,,Outpatient Referral (OPRD),a0292641-9e1a-495d-a7f2-d9ce87ff0b88,Not Rated,Not Rated,1.1.7,53.49,7465c65e-c321-42e9-a2f4-6bc664caf1fc,32.78
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,UK CLL Trials Biobank,a06afa88-caba-4354-ac70-d05c67b34dfc,Silver,Bronze,1.1.7,16.28,636e216a-072b-4c8b-b867-23b7666d2cb2,76.38
63.49,71.43,19.05,72.22,ALLIANCE > HQIP,National Joint Registry - Primary Hip Replacement dataset,a0c4719e-871b-450a-b977-689df35131dd,Silver,Bronze,1.1.7,18.6,03280e87-6975-4a2a-967d-b332cb788e44,76.42
98.41,92.86,41.27,78.57,NIHR Health Informatics Collaborative Renal Transplantation Theme,HIC Transplantation,a0e0c0c2-072a-47ac-9252-e27b37ac024f,Silver,Silver,1.1.7,37.21,359a322e-3781-4796-b6b2-81962fa19b7a,77.83
87.3,80.95,30.16,78.57,ALLIANCE > CPRD,HES Patient Reported Outcomes Measures (PROMs) data for CPRD GOLD,a1164dbd-4057-45a2-9860-cbb69696bd7c,Silver,Silver,1.1.7,27.91,2439a88e-d961-4152-a7b5-042097946209,76.52
34.92,38.1,23.81,55.55,UK Biobank,Biological sample assays,a11a234b-8b59-41e8-920a-f8f1799d3c77,Not Rated,Not Rated,1.1.7,25.58,14c697a5-2d41-4d86-bf17-2e596d07418b,56.26
77.78,64.29,49.21,64.28,ALLIANCE > NHS DIGITAL,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Events,a1a67182-e81b-4144-ac51-92a86f277eb2,Not Rated,Not Rated,1.1.7,44.19,7b31b427-b447-432e-9a6c-ad2099343491,60.05
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,National Paediatric Diabetes Audit - Spotlight survey of diabetes-related technologies,a1d41f64-76e1-4576-a906-f64a7fe664c4,Not Rated,Not Rated,1.1.7,34.88,eecbdd8d-92a0-4dfd-a216-1cf7f1f8c98f,46.84
100.0,95.24,15.87,92.06,ALLIANCE > SAIL,Brecon dataset,a1e1ec62-d78c-40ac-9f90-66ef1dd865b2,Gold,Gold,1.1.7,13.95,9c6e891f-6449-48d2-a1c3-8dd236e34bbd,90.64
33.33,19.05,50.79,41.27,,Cafcass England (CAFE),a2226588-3fce-4103-8960-6bb0b22631fb,Not Rated,Not Rated,1.1.7,51.16,8ee61578-e298-423a-be22-cb0438023e5c,33.95
33.33,19.05,55.56,38.88,,Death Registration Data - Finalised Extracts,a239d453-7f49-4e80-a0ea-87a12d445df2,Not Rated,Not Rated,1.1.7,53.49,fdfa5116-4f44-457d-99ef-e8c1852aa858,32.78
33.33,19.05,50.79,41.27,,Enhanced Prescribing Database,a2a324f8-ccd3-405b-a146-34bbb85cc34a,Not Rated,Not Rated,1.1.7,51.16,2843087f-23a4-4cfe-8e72-53f2b9562cc3,33.95
100.0,95.24,26.98,86.51,HUB > DATA-CAN,Comprehensive Patient Records for Cancer Outcomes,a337845e-1dde-445b-90cf-91d8b825e3a5,Gold,Gold,1.1.7,20.93,ce4582a8-0985-46c6-b95f-29a5de862d4a,87.16
100.0,95.24,15.87,92.06,ALLIANCE > SAIL,Care Home Dataset,a45acd02-82d7-4bfe-9845-6b4df683bba8,Gold,Gold,1.1.7,13.95,aae02f9e-1bad-415d-9730-c46a07a990aa,90.64
33.33,19.05,55.56,38.88,,NIHR IBD BioResource: Demographic,a4936ec2-002e-4927-9a46-29ae9b5d695f,Not Rated,Not Rated,1.1.7,53.49,b4121feb-f91b-4e20-a19b-fa49c7a5c1c1,32.78
33.33,19.05,55.56,38.88,,SARS-CoV-2 viral sequencing data (COG-UK data) - Lineage/Variant Data - England,a4a26b35-7014-42f0-bda9-97ac3a01a399,Not Rated,Not Rated,1.1.7,53.49,9a36f3f8-3b7e-4e61-8993-b9cc2734fcb8,32.78
80.95,76.19,25.4,77.78,ALLIANCE > SAIL,Health & Attainment of Pupils in a Primary Education Network [HAPN],a4eb97a6-6a61-415b-9dfb-65503675ed00,Silver,Silver,1.1.7,23.26,464d8653-4e69-406b-93fd-d68c29d5dfdc,76.47
23.81,28.57,33.33,45.24,ALLIANCE > HQIP,Paediatric Intensive Care Audit Network - core dataset (referral),a513dd3b-7e58-4d7f-8164-0a4dbe0a96c0,Not Rated,Not Rated,1.1.7,32.56,79ae4881-6223-471a-a278-6b2d3b84f971,48.0
63.49,71.43,15.87,73.81,ALLIANCE > TISSUE DIRECTORY,UK ME/CFS Biobank,a5163bce-7c03-4e61-8ebc-024939c047a8,Silver,Bronze,1.1.7,16.28,d0694e15-b6ba-4a95-962a-dbf627ca207c,77.58
4.76,4.76,46.03,29.36,,National Neonatal Audit Programme - clinical audit,a5272a57-4fdc-4110-a1ae-1433f9fb036d,Not Rated,Not Rated,1.1.7,46.51,382e897a-77cf-46ca-8d44-d79449ab61df,29.12
85.71,76.19,28.57,78.57,ALLIANCE > CPRD,Rural-Urban classification for CPRD GOLD,a53b2f7a-c4a6-4914-9adb-17946c58afad,Bronze,Silver,1.1.7,30.23,a7d8c6a8-0825-4e73-8f29-3d76194d7114,72.98
4.76,4.76,46.03,29.36,,Air Quality Study: An ecological analysis of asthma health outcomes in Malaysia,a5b41636-a112-4631-aaee-215bc4cf200e,Not Rated,Not Rated,1.1.7,46.51,95f385b1-4f5c-4a88-8e79-9613acc66938,29.12
23.81,28.57,34.92,44.45,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,The Primary-Secondary Care Partnership to Improve Outcomes in Chronic Kidney Disease,a5c088cd-dae6-4c58-b381-a0d273585f4d,Not Rated,Not Rated,1.1.7,34.88,d472a895-8587-4503-956e-3bd66d990979,46.84
33.33,19.05,50.79,41.27,,Patient Medical Card Registration (NI),a5d1a44f-9e9d-4c6d-9ce0-53889d579781,Not Rated,Not Rated,1.1.7,51.16,4e5ba567-c452-4979-8e2e-865f7df20252,33.95
33.33,19.05,55.56,38.88,,Scottish Stillbirth and Infant Death Survey,a6252de5-4fc3-4dc7-950b-2f2528f58533,Not Rated,Not Rated,1.1.7,53.49,e54d35a6-2e7c-422d-a4a5-a7da930b08f2,32.78
60.32,69.05,17.46,71.43,ALLIANCE > TISSUE DIRECTORY,plasmaMATCH,a6472a29-17db-477c-bb6e-264686c8fc26,Bronze,Bronze,1.1.7,18.6,5618f65d-23fc-4bd5-9a4c-73e4b330c3a6,75.22
33.33,19.05,50.79,41.27,,Child Health Systems Programme - First Visit,a69493b6-991d-40b5-ba81-2f70c424c557,Not Rated,Not Rated,1.1.7,51.16,dec04153-f595-41ce-9d7e-5ef0c3fe8289,33.95
4.76,4.76,46.03,29.36,,National Records of Scotland (NRS) - Births Data,a7447f01-c3fd-43f1-8fc4-3e6f3b6e59ef,Not Rated,Not Rated,1.1.7,46.51,3b87eef0-bfb6-4bf4-84b9-29880197fec9,29.12
14.29,16.67,36.51,38.89,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,LIMS,a74f72ad-bf70-42e4-8933-069c7b53c7f9,Not Rated,Not Rated,1.1.7,37.21,df70b490-3c00-458e-a6dd-ea3242a3ebac,39.73
87.3,80.95,30.16,78.57,ALLIANCE > CPRD,HES Patient Reported Outcomes Measures (PROMs) data for CPRD Aurum,a79944dc-2696-4326-b378-dbd9224635f1,Silver,Silver,1.1.7,27.91,7958450d-bd25-42c4-b79e-0e3d0806ac21,76.52
4.76,4.76,46.03,29.36,,The 1970 British Cohort Study (BCS70),a8364fd6-2247-4ef0-af8c-51c7b3ec24cd,Not Rated,Not Rated,1.1.7,46.51,929186f3-e230-4b52-a9f5-0c20af7f5ce2,29.12
4.76,4.76,46.03,29.36,,NIHR BioResource: NHS Trust data,a889651d-a26e-4907-86a3-a06d100d13f5,Not Rated,Not Rated,1.1.7,46.51,3731006a-ee7c-4d15-bc07-4eeb29a3d031,29.12
98.41,92.86,17.46,90.47,ALLIANCE > SAIL,Healthcare Workers Risk Assessment,a8bb670a-b45b-48a6-8e4d-9e8f61de4f5b,Gold,Gold,1.1.7,16.28,ed131fee-0635-4613-a453-a383d5dd7cec,88.29
23.81,28.57,33.33,45.24,ALLIANCE > HQIP,Paediatric Intensive Care Audit Network - core dataset (transport),a8bfd0c4-1aec-47cc-9e45-00a713482fa2,Not Rated,Not Rated,1.1.7,32.56,45310176-6331-4bdd-bc53-d9194e212a35,48.0
4.76,4.76,46.03,29.36,,Scottish Immunisation Recall System (SIRS),a8c8978f-b5dc-448c-9a03-4d961d79a863,Not Rated,Not Rated,1.1.7,46.51,c027d0ca-7c7d-4864-b4dd-8040f4020fbb,29.12
55.56,61.9,19.05,68.25,HUB > BREATHE,Salford Lung Study,a8f5117e-7523-452f-abf3-ced72f03cb2e,Bronze,Bronze,1.1.7,18.6,86838cad-d5d3-4b65-9c37-29b0c8c36309,71.65
33.33,19.05,55.56,38.88,,COVID-19 Wastewater data,a95be055-c758-45e7-9010-80337239c5e8,Not Rated,Not Rated,1.1.7,53.49,fa9c25eb-1ce0-4f44-b6a6-46ec8caeef40,32.78
82.54,73.81,25.4,78.57,HUB > PIONEER,"Demography, interventions & outcomes of patients with Cerebrovascular Disease",a9b50e33-9974-4635-8e52-9c9b3cb87eb2,Bronze,Silver,1.1.7,25.58,ddf7f82f-b453-442d-b562-bb0157593831,74.12
96.83,92.86,22.22,87.31,HUB > DISCOVER NOW,North West London Primary Care Events Data (NWL PCE),a9f4a852-a1f2-4041-bb33-3a50e6c43f8d,Gold,Gold,1.1.7,18.6,0f930154-0a0e-4bef-9464-59e657b904d6,87.13
77.78,64.29,49.21,64.28,ALLIANCE > NHS DIGITAL,Mental Health Minimum Dataset v3_3.5 (Non-Sensitive),aa019da2-0f2f-493c-95e8-7263ee735f46,Not Rated,Not Rated,1.1.7,44.19,348b12fb-7718-477e-a572-4fc3c716152d,60.05
88.89,80.95,31.75,78.57,ALLIANCE > SAIL,ONS 2011 Census Wales (CENW),aa1fe6a9-79cc-4afc-bd38-ec0d5e4fc195,Silver,Silver,1.1.7,25.58,fc24482c-0f9b-445f-af7a-8598627c3b15,77.69
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,National Joint Registry - Revision Elbow Replacement dataset,aa3ba46a-9494-45f9-987d-fae9c5e9f759,Not Rated,Not Rated,1.1.7,34.88,12babf2b-42e8-4b1e-9143-3475a07bb343,46.84
4.76,4.76,46.03,29.36,,Assessing the eDPSEEA model in seasonal pollen induced asthma in Islamabad,aad2340a-ab87-40ee-bfbe-c56adb01fd47,Not Rated,Not Rated,1.1.7,46.51,bfa012ad-e609-4d15-a824-6d143758ca4d,29.12
4.76,4.76,46.03,29.36,,Developing Patient and Public Involvement in Research in Malaysia,ab2dafd8-b513-4b33-9365-5eb74f32f9d1,Not Rated,Not Rated,1.1.7,46.51,153c0ba6-f2ec-4fb4-b5a7-33e11cbdf7fc,29.12
4.76,4.76,46.03,29.36,,GOAL,ab7f482c-42ea-4ddb-8c92-5ecc1be868ce,Not Rated,Not Rated,1.1.7,46.51,563c0bfc-437e-4c10-b144-b392d983017c,29.12
33.33,19.05,50.79,41.27,,Walker Study Data,ac057e24-22d8-478e-8988-89fe4ee67b6c,Not Rated,Not Rated,1.1.7,51.16,245bffa9-07c3-40b6-916b-161062cdf674,33.95
33.33,19.05,55.56,38.88,,Tayside Bowel Screening Dataset,ac7927ca-ef8b-47d7-abce-33a03baaac5c,Not Rated,Not Rated,1.1.7,53.49,00201dde-1faf-41d3-b282-5c24c0ca3697,32.78
74.6,61.9,39.68,67.46,ALLIANCE > NHS DIGITAL,Mental Health Minimum Data Set,acafb160-b18a-436e-90f1-dc4530a90267,Not Rated,Bronze,1.1.7,39.53,285ae0ae-196b-4a75-b1f1-78b07162acfa,61.19
84.13,76.19,28.57,77.78,ALLIANCE > NHS DIGITAL,COVID-19 SARI-Watch (formerly CHESS),ad376d74-4f12-4fb4-8d34-a9e7d0b45b3b,Bronze,Silver,1.1.7,25.58,f61f116d-f732-450e-9d34-c6ae00e3fd1e,75.31
33.33,19.05,50.79,41.27,,2019 UK Parkinson's Audit - Elderly care and neurology,ad5dd22c-f6e1-4338-9d4e-80e4b9ec8f26,Not Rated,Not Rated,1.1.7,51.16,0cac3870-dd13-44fc-97c2-4bdb67550b39,33.95
92.06,88.1,23.81,84.12,HUB > GUT REACTION,IBD NIHR BioResource: Contact detail,ad638da8-366b-481f-995e-fc326301eb16,Silver,Silver,1.1.7,20.93,02ddc5c9-03d4-40e4-9934-e60817ec8f3e,83.58
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,Cardiff School of Dentistry Tooth Bank,adbee090-9634-455e-9be1-62843158fb08,Silver,Bronze,1.1.7,16.28,0d4f0103-82d8-43f4-8058-4aec80ea562f,76.38
96.83,92.86,22.22,87.31,HUB > DISCOVER NOW,North West London Admitted Patient Care Data (NWL APC),adce90ad-d576-4c98-9de9-dca19f7f4d41,Gold,Gold,1.1.7,18.6,788857b5-6a5b-4ec2-825e-d965e291cf45,87.13
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,Biobank for patients with retinal degenerations & dystrophies,ae2022bc-2083-4e57-b825-1fb610d910ee,Silver,Bronze,1.1.7,16.28,cee932f8-151c-4834-ac6d-61d842f9d170,76.38
33.33,19.05,55.56,38.88,,COVID antigen testing - Pillar 2,ae68c3c8-7930-40bd-86e8-7ca1aa6ce57d,Not Rated,Not Rated,1.1.7,53.49,c8f2ee14-2831-445d-a207-2f7f932f4735,32.78
100.0,95.24,30.16,84.92,ALLIANCE > CYSTIC FIBROSIS TRUST,Cystic Fibrosis Patient NTM culture,ae788191-69e5-4a03-b11b-bd25574b0e4f,Gold,Silver,1.1.7,20.93,69bdac5f-bb70-4ca5-a5ce-51a6106ad00b,87.16
15.87,19.05,38.1,38.88,ALLIANCE > BARTS HEALTH,Community Services Dataset,ae9e8a9f-533f-4823-8e00-84e39ad2c266,Not Rated,Not Rated,1.1.7,39.53,cae0a9a5-1bf2-49c3-b8d1-c315d3239074,39.76
50.79,57.14,20.63,65.08,ALLIANCE > UK BIOBANK,Accelerometer,aecc1328-3c30-4eff-9f56-ae1278846ef9,Bronze,Not Rated,1.1.7,20.93,ceab57e8-1e13-499b-a8f4-6ad60dad3721,68.1
63.49,71.43,15.87,73.81,ALLIANCE > TISSUE DIRECTORY,Manchester Cancer Research Centre (MCRC) Biobank,af2b3e6d-718e-464a-8c0d-5882fa1d869f,Silver,Bronze,1.1.7,16.28,095d805c-4b62-4726-b968-bb2f1c463701,77.58
63.49,71.43,15.87,73.81,ALLIANCE > TISSUE DIRECTORY,Cardiff University Biobank,af2ecff2-398c-437f-8c45-adef2406ce43,Silver,Bronze,1.1.7,16.28,097540aa-a0ed-492e-853b-9ebcfd061dea,77.58
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,NIHR Exeter Clinical Research Facility,af4af5cc-a9eb-4e0e-b50a-3cab4ac2daf9,Silver,Bronze,1.1.7,16.28,df9b7bb1-1b26-4e67-b885-df2dcb8e3450,76.38
33.33,19.05,55.56,38.88,,Education Daily Attendance Dataset (EDAD),af829238-feb6-4fc4-933a-b06812a6c1b8,Not Rated,Not Rated,1.1.7,53.49,17056e83-ee5a-4fe7-86e1-f09563256be1,32.78
33.33,19.05,55.56,38.88,,National Audit of Care at the End of Life - organisational level audit,afc74c32-efdf-4aab-a0bb-fe5586f4af78,Not Rated,Not Rated,1.1.7,53.49,a290592c-a6f5-4874-b283-1d33e923c487,32.78
4.76,4.76,46.03,29.36,,Childhood Pneumonia Governance in Bangladesh,b009b68f-730a-4d72-9a3c-c917b1ff715d,Not Rated,Not Rated,1.1.7,46.51,5df03d24-ad95-4d64-96df-0684a4f26e58,29.12
87.3,80.95,30.16,78.57,ALLIANCE > CPRD,HES Diagnostic Imaging Dataset for CPRD GOLD,b02e2091-f48a-4d50-91a0-de8c76f76c18,Silver,Silver,1.1.7,27.91,a1bef3a6-9700-43a5-8f3e-dad44ce1fe10,76.52
33.33,19.05,50.79,41.27,,COVID antigen testing - Pillar 1,b0319b9b-14ba-4e23-86ff-89363d4d69a7,Not Rated,Not Rated,1.1.7,51.16,3abc20ce-3dc6-4715-9de0-56aa97a6f5ec,33.95
33.33,19.05,60.32,36.5,,SICSAG Episodes (Scottish Intensive Care Audit Group),b07485ca-2d45-483d-9336-32cca4504712,Not Rated,Not Rated,1.1.7,55.81,6f8182d2-2993-400d-829d-b52cdb324bf3,31.62
33.33,19.05,50.79,41.27,,HIV-POGO,b132812c-7a5c-4d2d-aca2-fdcdb890283a,Not Rated,Not Rated,1.1.7,51.16,e171a080-a4cd-4e64-9c2b-e72beb7cac78,33.95
4.76,4.76,46.03,29.36,,Epilepsy 12 - National organisational audit and Trust profile,b1712bea-8198-4836-a153-b446ec4ab287,Not Rated,Not Rated,1.1.7,46.51,2c737d63-69f4-4a02-8df9-54c1e65e845f,29.12
34.92,38.1,23.81,55.55,UK Biobank,Primary-care data,b27afede-a51d-4aae-8bf7-ce94888fe898,Not Rated,Not Rated,1.1.7,25.58,439e71c7-33b5-4e85-98ce-4b068f2523ad,56.26
4.76,4.76,46.03,29.36,,Lothian Birth Cohort 1936 (LBC1936),b2f48da1-d3c6-4126-a74b-e87c2f629ef8,Not Rated,Not Rated,1.1.7,46.51,e63613a9-92e9-4147-8a76-40e4a87ec131,29.12
100.0,95.24,30.16,84.92,ALLIANCE > CYSTIC FIBROSIS TRUST,Cystic Fibrosis Patient Transplants,b2fb79c5-26db-484b-8e93-1c56d7654f57,Gold,Silver,1.1.7,20.93,bea354e8-c552-41ef-80c2-a76ca5767e4b,87.16
33.33,19.05,55.56,38.88,,Fife Microbiology: Tests,b3004f9b-11a0-482b-9cec-791b28fd492e,Not Rated,Not Rated,1.1.7,53.49,0c43c0b6-de3a-478b-8190-4da37fbe5ff5,32.78
100.0,95.24,39.68,80.16,NIHR Health Informatics Collaborative Critical Care Theme,HIC ICU 8.3.2,b40777a2-468b-4b45-8b7d-2f62f912e950,Silver,Silver,1.1.7,34.88,4f546f1e-433c-4884-a090-2a4520c878ac,80.18
33.33,19.05,55.56,38.88,,CPRD GOLD,b41215cd-afe1-4463-9786-ed86812143e2,Not Rated,Not Rated,1.1.7,53.49,a29feafa-7bdd-44e9-b977-c9d26425e67f,32.78
88.89,80.95,31.75,78.57,ALLIANCE > SAIL,UK Cystic Fibrosis Registry (CYFI),b43309eb-7860-49b7-9f11-1a7a0fd5532e,Silver,Silver,1.1.7,25.58,0628fb77-057d-4838-b80e-18245a8f535d,77.69
100.0,95.24,30.16,84.92,ALLIANCE > CYSTIC FIBROSIS TRUST,Cystic Fibrosis Patient Chronic Medication,b5033be2-0744-49c5-a398-a4d3ed4e1deb,Gold,Silver,1.1.7,20.93,0ad31772-0893-4cf7-bab0-683e80302201,87.16
74.6,61.9,49.21,62.69,ALLIANCE > NHS DIGITAL,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Episodes,b53f716d-a5c3-4ad8-a2aa-cae09c12ac18,Not Rated,Not Rated,1.1.7,44.19,ef22c16c-c294-46e1-abf9-5204212e9053,58.86
90.48,83.33,25.4,82.54,ALLIANCE > SAIL,Radiotherapy Dataset,b589b19b-b43f-4344-affb-5d7ea328c909,Silver,Silver,1.1.7,25.58,f102ca50-d1e4-44ec-924e-be89446652af,78.88
33.33,19.05,55.56,38.88,,National Vascular Registry - Lower Limb Angioplasty clinical dataset,b63aadf4-da85-478e-a171-05714ef9057e,Not Rated,Not Rated,1.1.7,53.49,c8b6c319-239b-4792-9898-644a63d07ab5,32.78
58.73,69.05,19.05,69.84,HUB > BREATHE,Development of spirometry predictive values for Indian population,b6a60be1-5d94-41f9-a426-5f9523a98d50,Bronze,Bronze,1.1.7,18.6,59521b01-6adb-4dd3-8b40-dbeb51171e4f,75.22
33.33,19.05,50.79,41.27,,Welsh Demographic Service (WDSD),b6f26b11-da8d-402a-91c7-3b7122be274c,Not Rated,Not Rated,1.1.7,51.16,8a8a5e90-b0c6-4839-bcd2-c69e6e8dca6d,33.95
33.33,19.05,50.79,41.27,,Welsh Longitudinal GP Dataset - Welsh Primary Care (WLGP),b6fe3b50-aff3-435d-9c57-8b46eaa34671,Not Rated,Not Rated,1.1.7,51.16,33fc3ffd-aa4c-4a16-a32f-0c900aaea3d2,33.95
100.0,95.24,15.87,92.06,ALLIANCE > SAIL,Cafcass England,b70900e9-85e9-4dd2-ae4b-02523be4219d,Gold,Gold,1.1.7,13.95,8ee61578-e298-423a-be22-cb0438023e5c,90.64
33.33,19.05,55.56,38.88,,UHB 100K Genomics patient clinical data including their acute care contacts,b789c975-7042-445c-bfa6-c24e5ca8a983,Not Rated,Not Rated,1.1.7,53.49,ceae4fe0-4e98-4e3c-85db-e86539aade81,32.78
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,Public Health England Seroepidemiology Unit,b7a352ee-6306-4bd8-b9bc-f2a69fe17d70,Silver,Bronze,1.1.7,16.28,89497432-17e0-49f4-96a4-65ef57d07701,76.38
4.76,4.76,46.03,29.36,,COVID-19 Detection from Chest X-Rays using Deep Learning,b95a3ebd-f1f2-4f5f-a598-1eaa60dd1790,Not Rated,Not Rated,1.1.7,46.51,57526718-0a9a-42ad-8b7a-582d9ef96d13,29.12
60.32,69.05,17.46,71.43,ALLIANCE > TISSUE DIRECTORY,ESPAC-TPlus,b9642fb3-3bee-491b-8d83-22f9de0fd77f,Bronze,Bronze,1.1.7,18.6,47f979bc-da9d-4e9e-9f2b-15e09366db04,75.22
33.33,19.05,55.56,38.88,,2019 UK Parkinson's Audit - Patient Reported Experience Measure (PREM),b97ff350-f84d-4739-a4d6-f3a607063799,Not Rated,Not Rated,1.1.7,53.49,6a6c4568-59e9-4760-89d6-07558a24944c,32.78
33.33,19.05,50.79,41.27,,Hospitalised patients with diabetic emergencies & acute diabetic health concerns,b988b8bc-fbc5-40a7-8123-76ea5286b8c7,Not Rated,Not Rated,1.1.7,51.16,0d556d7e-be27-4979-a09e-d419b2e838f3,33.95
23.81,28.57,33.33,45.24,ALLIANCE > HQIP,Paediatric Intensive Care Audit Network - customised data collection,b9b4ee9a-3ffa-483d-8e46-16f862c83740,Not Rated,Not Rated,1.1.7,32.56,6c78af2c-3898-435e-b1f4-e6a44682dc71,48.0
4.76,4.76,46.03,29.36,,Pneumonia case management practices in selected communities in Pakistan,b9ffcd6b-cabd-4875-ac5c-5cb878f7290f,Not Rated,Not Rated,1.1.7,46.51,cf190350-74c6-45f2-8ede-69ace62eb88d,29.12
77.78,64.29,49.21,64.28,ALLIANCE > NHS DIGITAL,Mental Health Minimum Dataset v4 (Non-Sensitive) Events,ba071b0b-5ef4-457b-b194-3a69c2c71a06,Not Rated,Not Rated,1.1.7,44.19,3adeb2f4-a924-49cb-9537-84a9a4242a62,60.05
33.33,19.05,55.56,38.88,,Emergency Department (Symphony),ba30a8b6-bfc7-4105-b094-11f187c7b293,Not Rated,Not Rated,1.1.7,53.49,8002b4d7-ff3b-4402-b805-a6a0022836fd,32.78
33.33,19.05,60.32,36.5,,BathTAP Updating Cohort 1,ba936454-e65e-491d-a16d-79115a4da09a,Not Rated,Not Rated,1.1.7,55.81,90131a34-3cc8-4a74-b72f-d9600cfa2808,31.62
33.33,19.05,50.79,41.27,,CPRD Aurum,bac86432-1ad7-4ff9-903d-26e28bf4ef97,Not Rated,Not Rated,1.1.7,51.16,1d574c14-1af0-490d-9c4e-be88cfd0e345,33.95
4.76,4.76,46.03,29.36,,TwinsUK,bb42dbfc-b4ef-443d-a4bb-8f5249ac6762,Not Rated,Not Rated,1.1.7,46.51,19b4cd38-3828-4bb1-a980-4f7420658965,29.12
33.33,19.05,55.56,38.88,,IBD NIHR BioResource: Case report form,bb61567b-431f-4e30-b906-654490ea14c7,Not Rated,Not Rated,1.1.7,53.49,877a7275-b99d-4ed4-9691-de577e0ab49e,32.78
4.76,4.76,46.03,29.36,,1958 National Child Development Study (NCDS),bbed7a4e-0c38-48b8-b4f8-b617ec307f59,Not Rated,Not Rated,1.1.7,46.51,0ceaaedc-4904-4820-8b74-d6a8e679fb11,29.12
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,National Cardiac Audit Programme - National Audit of Percutaneous Coronary Interventions (PCI),bc236fba-2935-4406-aaa9-0006cbbf693d,Not Rated,Not Rated,1.1.7,34.88,ac7016ce-f7a9-4c71-bebb-6af6efa27844,46.84
36.51,40.48,22.22,57.14,UK Biobank,UK Biobank Assessment Centre,bcb224fe-592f-4aaf-abd1-ad3e3caa61ff,Not Rated,Not Rated,1.1.7,23.26,2775b97f-1606-490e-81ef-35bad050434a,58.61
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,National Clinical Audit of Anxiety and Depression - spotlight audit on psychological therapies (therapist survey),bcb7804e-e852-423b-a3e7-343242098d70,Not Rated,Not Rated,1.1.7,34.88,bf2d780d-936b-4f4c-88f9-a280b849b652,46.84
90.48,83.33,26.98,81.75,ALLIANCE > SAIL,Education Daily Attendance Dataset,bd87cdf4-ec39-41f6-bb07-c19f10372840,Silver,Silver,1.1.7,23.26,17056e83-ee5a-4fe7-86e1-f09563256be1,80.03
88.89,80.95,25.4,81.75,ALLIANCE > CPRD,Cancer Patient Experience Survey (CPES) for CPRD GOLD,bd90290d-d60b-499f-b30d-88332274cc46,Silver,Silver,1.1.7,25.58,a4ecb8df-c72f-4018-8f23-e180c28dfdb6,77.69
77.78,64.29,49.21,64.28,ALLIANCE > NHS DIGITAL,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Events,bdc17b2c-8b0f-4959-ab9b-e2de32d8a5f9,Not Rated,Not Rated,1.1.7,44.19,3d348613-2d66-4814-a294-7e0c365f43f8,60.05
22.22,23.81,38.1,42.06,ALLIANCE > BARTS HEALTH,Outpatient Appointment Dataset,be0e737d-37a2-4af0-ac28-0bb7d3b49a52,Not Rated,Not Rated,1.1.7,39.53,1c27bfbf-c659-42ff-8afe-d58250b49c07,42.14
68.25,59.52,31.75,68.25,ALLIANCE > OXFORD UNIVERSITY HOSPITALS,Oxford Healthcare Workers,be1368c6-c97f-4ce0-8322-f97ccb28b9c3,Not Rated,Bronze,1.1.7,27.91,9de2f365-4c5d-4252-acee-6270b113aa93,65.81
60.32,69.05,19.05,70.64,ALLIANCE > TISSUE DIRECTORY,Barts CTU,be77a483-2eff-4c05-8091-035fe79b3c8a,Bronze,Bronze,1.1.7,18.6,22aa219f-f3c8-4a25-822e-aa2504f6f29a,75.22
33.33,19.05,60.32,36.5,,2011 Census - COVID19 Research Database Subset,be8ec01c-20ea-4863-ba7c-6d103df85a42,Not Rated,Not Rated,1.1.7,55.81,a05aef07-c3fa-4331-905a-6b6f58eac3d5,31.62
34.92,38.1,22.22,56.35,UK Biobank,Online questionnaires,bf625cfe-c4b2-4ea8-bbe8-1a8873ca4cb9,Not Rated,Not Rated,1.1.7,23.26,8ef26f38-d1b3-4b24-b80a-717f216c6aea,57.42
14.29,16.67,38.1,38.09,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,TheatreEvents,bf83ada4-b72e-4789-b177-12a53aa763ea,Not Rated,Not Rated,1.1.7,39.53,2c6adf80-f30b-46c9-b9d4-fe3e68622469,38.57
23.81,28.57,33.33,45.24,ALLIANCE > HQIP,National Diabetes Inpatient Audit Hospital Characteristics Survey dataset,c0025712-8bde-4cbb-93a6-c9a52b99d035,Not Rated,Not Rated,1.1.7,32.56,a9098b51-f8ec-432e-a52f-f4c1f2c1e4f6,48.0
33.33,19.05,55.56,38.88,,"Ventilatory strategies, medications and outcomes for patients with COVID",c01fbdae-33e3-4839-b842-3b61a722a925,Not Rated,Not Rated,1.1.7,53.49,55a744c4-a2d4-4ea0-b0eb-1af6e1465383,32.78
63.49,71.43,17.46,73.02,ALLIANCE > TISSUE DIRECTORY,Daisy Tumour Bank,c03468f4-ba51-4d9f-a785-f041adb84724,Silver,Bronze,1.1.7,18.6,b3ec5c18-e339-4bd8-8a59-5a3445a81f16,76.42
100.0,95.24,25.4,87.3,ALLIANCE > CYSTIC FIBROSIS TRUST,Cystic Fibrosis Patient Demographics,c1682cb7-8f43-49fa-b66a-0a4a205885d3,Gold,Gold,1.1.7,18.6,19bc55c2-13d7-4488-a52c-35287483ea4e,88.32
33.33,19.05,55.56,38.88,,COVID-19 Vaccination Status,c230a8d8-bf78-4713-8f2f-312162e92e55,Not Rated,Not Rated,1.1.7,53.49,98372a87-f3e6-475d-be12-46c0f9587413,32.78
60.32,69.05,17.46,71.43,ALLIANCE > TISSUE DIRECTORY,NICAM: Nilotinib treatment for c-KIT mutated advanced AMM,c2c77d1a-d4d8-40cd-95f3-31912d4bd561,Bronze,Bronze,1.1.7,18.6,ba0edcaf-854d-4907-851a-280b56128b3b,75.22
100.0,95.24,20.63,89.69,ALLIANCE > SAIL,Outpatient Referral,c2ddca9f-f144-437b-ac7a-0a628a50ba1a,Gold,Gold,1.1.7,16.28,7465c65e-c321-42e9-a2f4-6bc664caf1fc,89.48
87.3,80.95,26.98,80.16,ALLIANCE > NHS DIGITAL,National Diabetes Audit,c2e112a0-a198-46b0-9a0c-ec91edfb6839,Silver,Silver,1.1.7,25.58,9a434a5c-563b-4da1-9133-9994960ade54,77.69
63.49,71.43,17.46,73.02,ALLIANCE > TISSUE DIRECTORY,TRICON8,c3b4f4f2-953e-4470-bedd-9d09fd30a508,Silver,Bronze,1.1.7,18.6,85113a93-89ed-40e3-a479-33b461b91858,76.42
87.3,78.57,33.33,76.98,ALLIANCE > PUBLIC HEALTH SCOTLAND,2011 Census variables (and variable breakdowns),c4426ec2-fbf0-45b2-9f68-0477527257a0,Bronze,Silver,1.1.7,27.91,a05aef07-c3fa-4331-905a-6b6f58eac3d5,75.33
33.33,19.05,55.56,38.88,,National Waiting List Open Pathways,c47f463f-6e7e-4abb-b9bc-010ae68156b7,Not Rated,Not Rated,1.1.7,53.49,c7b1e328-f2d7-4d11-b38f-ce9930b95ca0,32.78
66.67,57.14,36.51,65.08,ALLIANCE > UNIVERSITY OF NOTTINGHAM,PANTHER study,c66f943f-4307-4486-817c-49f6d8b9fd6b,Not Rated,Not Rated,1.1.7,30.23,596077a9-298b-44cc-aa7a-81f04cf5dcb3,63.45
33.33,19.05,50.79,41.27,,Child Health Systems Programme - 4-5 year review,c6859b1b-4d5b-46bd-8532-089cff743be7,Not Rated,Not Rated,1.1.7,51.16,5844bde6-628d-4e76-bb56-3534e2728eb6,33.95
47.62,54.76,25.4,61.11,HUB > BREATHE,Exogenous sex steroid hormones and asthma in females of reproductive age,c6e2fffb-4817-462e-ba7e-ff546728f3d1,Not Rated,Not Rated,1.1.7,25.58,bc5d6d69-ec03-42fe-a63b-638c25c5258c,64.59
77.78,64.29,49.21,64.28,ALLIANCE > NHS DIGITAL,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Episodes,c713773c-e961-400e-b44a-947002deb073,Not Rated,Not Rated,1.1.7,44.19,334afc50-a05a-43b9-aa1e-a012a22733e0,60.05
66.67,76.19,19.05,73.81,ALLIANCE > TISSUE DIRECTORY,SCOT translational sample collection,c78122ae-8be1-40d7-8567-b83059941c16,Silver,Bronze,1.1.7,20.93,b3b790a7-a455-4efb-9c68-60e7131cb836,77.63
4.76,4.76,46.03,29.36,,National Asthma & COPD Audit:COPD and adult asthma organisational dataset,c8071ce3-699a-453b-9444-689a76e88424,Not Rated,Not Rated,1.1.7,46.51,1982d9ef-890a-41ff-a86a-de61d65aaa09,29.12
33.33,19.05,50.79,41.27,,UHB Linked Diabetic Eye Disease in Acute Diabetic Hospital Admissions,c8654ef8-585c-4ac4-ac0e-33a875d407a1,Not Rated,Not Rated,1.1.7,51.16,865c99c4-bbe9-45de-83b9-290fb54d5470,33.95
33.33,19.05,55.56,38.88,,CPRD Cardiovascular Disease Synthetic Dataset,c8db5528-7ba5-40fe-8c5f-2c86a9637c73,Not Rated,Not Rated,1.1.7,53.49,780c0a71-0264-4843-939d-1336eee60d40,32.78
33.33,19.05,50.79,41.27,,Admissions and Discharges,c8edcbd8-40e6-4c34-b138-307a94c19cc0,Not Rated,Not Rated,1.1.7,51.16,1d5b9205-dae4-4b0e-a3d3-04707875edf8,33.95
33.33,19.05,50.79,41.27,,Brecon Dataset (BREC),c94f3f11-1bc5-4b0e-9343-3fdd5763d8d6,Not Rated,Not Rated,1.1.7,51.16,9c6e891f-6449-48d2-a1c3-8dd236e34bbd,33.95
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,National Diet and Nutrition Survey (NDNS),c960ffab-a94c-45e3-96a0-598719acfbf5,Silver,Bronze,1.1.7,16.28,f86400cb-7cab-4e34-aab6-57138b6a96c2,76.38
77.78,64.29,49.21,64.28,ALLIANCE > NHS DIGITAL,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Records,c97b8058-a6a4-4c8d-92e1-6e9f4cddd301,Not Rated,Not Rated,1.1.7,44.19,01c88a30-b14d-401e-82bb-165cbde81942,60.05
33.33,19.05,50.79,41.27,,COVID-19 Test Results (PATD),c9809e56-5b29-4ab4-a5f3-f72a2d6419fc,Not Rated,Not Rated,1.1.7,51.16,f5f6d882-163d-4ef1-a53e-000fba409480,33.95
80.95,73.81,26.98,76.98,ALLIANCE > NHS DIGITAL,Secondary Uses Services Payment By Results,ca05a688-c305-4ebd-967f-facb010c29bf,Bronze,Silver,1.1.7,27.91,2004c512-f7c9-4995-b820-55f36aa3fad2,72.95
100.0,95.24,25.4,87.3,ALLIANCE > CYSTIC FIBROSIS TRUST,Cystic Fibrosis Patient Annual Review Encounters,ca2c6ec0-00ce-42fc-a077-88911259576c,Gold,Gold,1.1.7,18.6,11360490-8da3-4a25-bb87-4fcc249b9af5,88.32
33.33,19.05,55.56,38.88,,NHS Tayside and Fife Haematology (Lab Data Restructured),ca8c912d-82c4-481e-b17a-b567e3bf3c72,Not Rated,Not Rated,1.1.7,53.49,c294bb01-062b-494e-942b-1efe8cbac3dc,32.78
100.0,95.24,30.16,84.92,ALLIANCE > CYSTIC FIBROSIS TRUST,Cystic Fibrosis Patient Liver Enzyme,caa644b6-a50d-455b-bee1-96232443e2b9,Gold,Silver,1.1.7,20.93,f72e80fc-dcd3-4457-ae91-dd14449002dd,87.16
4.76,4.76,46.03,29.36,,The Million Women Study,caab69a0-b560-4320-ac61-557f81f37ae3,Not Rated,Not Rated,1.1.7,46.51,97ac8a7d-30b9-4fa6-84db-b4f9430fc1d6,29.12
33.33,19.05,50.79,41.27,,Northern Ireland Regional Maternity system (NIMATS),cace4854-a8de-4487-9c43-fe580b341d26,Not Rated,Not Rated,1.1.7,51.16,be7efa4f-e500-4a54-8157-6c4442a7e8a8,33.95
15.87,19.05,38.1,38.88,ALLIANCE > BARTS HEALTH,Critical Care Minimum Dataset,cb020c3c-f738-4741-bf6b-3df16611b02e,Not Rated,Not Rated,1.1.7,39.53,c71fbdc3-0311-4b3f-a9ff-7d2f2c0ba993,39.76
63.49,71.43,19.05,72.22,ALLIANCE > TISSUE DIRECTORY,UKCTOCS Longitudinal Women's Cohort (UKLWC),cb7370a6-a1b0-4473-a32f-ec85ec0155a5,Silver,Bronze,1.1.7,18.6,e0b951ba-0f7d-4743-9374-b965042accdd,76.42
33.33,19.05,50.79,41.27,,Congenital Anomaly Register and Information Service (CARIS),cbab40e4-9e61-4466-b706-db47771d2512,Not Rated,Not Rated,1.1.7,51.16,6fe7e004-eb51-4c7b-9905-1ec9a4827dca,33.95
33.33,19.05,55.56,38.88,,Falls & Fragility Fracture Audit  Fracture Liaison Service  clinical dataset,cbb0568c-510e-49de-af43-edb9345535a8,Not Rated,Not Rated,1.1.7,53.49,d94a604c-5733-4f07-93bb-e77b6ea2313f,32.78
33.33,19.05,60.32,36.5,,SARS-CoV-2 viral sequencing data (COG-UK data) - Lineage/Variant Data - Scotland,cc1a15ea-1bca-42c5-9915-8e6bfd733d6e,Not Rated,Not Rated,1.1.7,55.81,69a356d6-599e-4d02-8241-066ce3c297bd,31.62
77.78,64.29,49.21,64.28,ALLIANCE > NHS DIGITAL,Mental Health Minimum Dataset v4.1 (Sensitive) Records,cc383a3f-1c47-4b7d-99cf-be8ee0afe401,Not Rated,Not Rated,1.1.7,44.19,c00d5ad2-d5d2-4318-8849-4c2fe52aabd0,60.05
33.33,19.05,60.32,36.5,,Business Insights and Conditions Survey (BICS),cc9b9e79-e4b0-421e-a59e-f62ee56918a3,Not Rated,Not Rated,1.1.7,55.81,8e739a01-bcfa-4b75-b7f8-e694ee185f8d,31.62
63.49,73.81,19.05,72.22,ALLIANCE > TISSUE DIRECTORY,RIO,cde234d0-748b-4df6-a59d-3268cc7e8c1d,Silver,Bronze,1.1.7,20.93,18bc81e3-7d99-4152-bd7a-3c90ee7e489d,76.44
98.41,92.86,20.63,88.89,ALLIANCE > SAIL,Postponed Admitted Procedures,ce192e2e-4f31-4bb0-9c1f-5c4173c03011,Gold,Gold,1.1.7,16.28,bff94600-a254-4111-82f7-6167084d81ca,88.29
15.87,19.05,38.1,38.88,ALLIANCE > BARTS HEALTH,Maternity Services Dataset,ce1bcddb-a6af-4511-84c6-2a252d3eb202,Not Rated,Not Rated,1.1.7,39.53,173d07ab-5930-4d19-b3de-dcca193e62fd,39.76
96.83,92.86,26.98,84.92,HUB > DISCOVER NOW,North West London Community Data (NWL COM),ce896b89-5f4a-407c-bb10-7eec51089458,Silver,Silver,1.1.7,20.93,65dad445-ed81-4005-9f5a-4f8a7164043e,85.97
100.0,95.24,15.87,92.06,ALLIANCE > SAIL,Welsh Demographic Service (WDS),cea328df-abe5-48fb-8bcb-c0a5b6377446,Gold,Gold,1.1.7,13.95,8a8a5e90-b0c6-4839-bcd2-c69e6e8dca6d,90.64
92.06,85.71,30.16,80.95,ALLIANCE > CPRD,Death Registration data for CPRD GOLD,cf1feb84-837e-4f51-8320-6171f4970a5f,Silver,Silver,1.1.7,27.91,1d35e229-13eb-4be1-9dae-4752b6c27c4a,78.9
60.32,71.43,17.46,71.43,HUB > BREATHE,4 LMIC Asian Country ChrOnic: estimating respiratory disease burden in adults,cf64602c-7703-4f29-bd90-e0d511e2b24e,Silver,Bronze,1.1.7,16.28,490747bf-b268-41f3-8f35-f6bc4a4bdbfa,77.58
33.33,19.05,60.32,36.5,,The Airwave Health Monitoring Study,cf867e7f-51b9-4627-828d-dd4fd420b37e,Not Rated,Not Rated,1.1.7,55.81,98bfe17f-be12-47b1-943a-2d3a621b7618,31.62
98.41,92.86,20.63,88.89,ALLIANCE > SAIL,Referral to Treatment Times,cfdb9fbd-9f67-435c-b257-6b51430451bb,Gold,Gold,1.1.7,16.28,0bf54842-c1db-4bdb-9f55-c5be490bf758,88.29
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,Cancer Group CTR Cardiff trials,d006821e-a507-4699-b560-b5d023e09d4b,Silver,Bronze,1.1.7,16.28,cd833805-f0a8-4ddb-a50d-b12695c92120,76.38
33.33,19.05,50.79,41.27,,Child Health Systems Programme - 6-8week review,d07f2709-ccc7-410b-9b73-a45918e21fed,Not Rated,Not Rated,1.1.7,51.16,f9cf4be7-fbc9-4601-8beb-5d3c3596bf04,33.95
33.33,19.05,55.56,38.88,,National Vascular Registry Audit - Carotid Endarterectomy Clinical Dataset,d094b10a-b1b4-4805-9424-33547e9c46ba,Not Rated,Not Rated,1.1.7,53.49,f857055b-c29e-4c7f-99ce-65f4ed59648e,32.78
90.48,83.33,30.16,80.16,ALLIANCE > CPRD,Death Registration data for CPRD Aurum,d0f5761c-66af-4a1c-81c3-eae0f87724b1,Silver,Silver,1.1.7,27.91,ad8f07ef-a984-449b-8a60-d1dd564cc36d,77.71
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,National Audit of Psychosis - Early Intervention Psychosis Audit patient experience survey,d15b6d4a-a5de-4df4-8f29-4a8926af8024,Not Rated,Not Rated,1.1.7,34.88,a464c126-8591-4af6-a10f-99c020f59527,46.84
98.41,92.86,17.46,90.47,ALLIANCE > SAIL,Welsh Dispensing Dataset,d27f265d-8931-4f76-83a2-cb47189a53f0,Gold,Gold,1.1.7,16.28,50ef6443-ed4b-40f9-97fb-1cfd53be6579,88.29
33.33,19.05,55.56,38.88,,NIHR IBD BioResource: Case report form,d2981964-3ff7-47e2-91e1-ac5812227a80,Not Rated,Not Rated,1.1.7,53.49,877a7275-b99d-4ed4-9691-de577e0ab49e,32.78
46.03,33.33,53.97,46.03,ALLIANCE > NHS DIGITAL,Patient Reported Outcome Measures,d2af6a29-291b-4444-a17c-40f4208f1e1b,Not Rated,Not Rated,1.1.7,51.16,55614ed3-2484-4408-a4e9-e5fffed9e8e4,41.09
100.0,95.24,25.4,87.3,ALLIANCE > SAIL,Education - Wales,d2da2750-7482-4ce9-ae5c-2ab393408a67,Gold,Gold,1.1.7,18.6,204fa806-071d-4410-9c2c-143017d32d24,88.32
33.33,19.05,55.56,38.88,,Cancer Network Information System - CNIS / CANISC,d3010e1b-09ea-49e5-a5fb-3cf5a030fda6,Not Rated,Not Rated,1.1.7,53.49,da91f0eb-1761-485b-8b7f-9121b6a1d004,32.78
23.81,28.57,33.33,45.24,ALLIANCE > HQIP,National Diabetes Audit - National Diabetes in Pregnancy clinical Audit dataset,d3523bb1-c129-4574-ba26-839ba1d3a320,Not Rated,Not Rated,1.1.7,32.56,7c789df2-46f0-4e0e-b6ff-b04dce801445,48.0
14.29,16.67,36.51,38.89,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,JANUS,d3fd4dac-2d15-401c-8185-905ee108d9ce,Not Rated,Not Rated,1.1.7,37.21,6590f79d-cfea-4695-9fe0-dc5f85e6d273,39.73
33.33,19.05,55.56,38.88,,Follow-COVID,d524cd6b-14be-44a5-868c-f3e187d4e5d8,Not Rated,Not Rated,1.1.7,53.49,e50d2b20-ef95-43fe-bbf0-83224d88e480,32.78
14.29,16.67,36.51,38.89,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,OUH Patient Master Index,d57a096a-4fa3-4529-b508-0b9df0f1893c,Not Rated,Not Rated,1.1.7,37.21,5d7465f6-ced8-434b-9907-d357ad125024,39.73
42.86,47.62,22.22,60.32,OTHER > The University of Cambridge,INTERVAL,d58d02f1-47c2-44fc-b16e-4f6cbbb46e62,Not Rated,Not Rated,1.1.7,23.26,c1fa9b47-a954-4587-a0c2-bae0f3ec2b9b,62.18
4.76,4.76,46.03,29.36,,Use of digital auscultation to improve diagnosis of paediatric pneumonia,d5af13e0-cbcc-47f9-8d85-21867f198051,Not Rated,Not Rated,1.1.7,46.51,198bd2cc-ca40-4dff-992c-a9480703fc37,29.12
61.9,52.38,34.92,63.49,OTHER > UNIVERSITY OF CAMBRIDGE,TRACK-COVID,d614f4fc-fae9-4775-86d9-4d4710017cf4,Not Rated,Not Rated,1.1.7,30.23,9e89af6b-bfa8-43dc-a2d4-5540c899a670,61.08
33.33,19.05,55.56,38.88,,Annual District Birth Extract (ADBE),d62892f9-539e-48be-b77e-d3f903d3d118,Not Rated,Not Rated,1.1.7,53.49,12a77014-4a77-4eb1-8b26-f49689352d1b,32.78
60.32,69.05,17.46,71.43,ALLIANCE > TISSUE DIRECTORY,UNIRAD UK Sample collection,d6296f3e-ccd9-46a5-acc9-50eb5aa41c56,Bronze,Bronze,1.1.7,18.6,a1d16f3f-c7e7-41c5-a071-07889bf49ab1,75.22
33.33,19.05,55.56,38.88,,NACAP Pulmonary rehabilitation - clinical audit,d6d1588d-b65c-479d-8f15-7fddf5ed4cc0,Not Rated,Not Rated,1.1.7,53.49,3afbb83d-d47b-43b3-a202-0d3081e5d294,32.78
4.76,4.76,46.03,29.36,,Research on use of an online learning platform on under-five pneumonia,d7f1b4ab-ae3c-4318-afc9-1b561d46d442,Not Rated,Not Rated,1.1.7,46.51,a3d85fd2-9df3-4f6e-9035-0830a3488ddb,29.12
33.33,19.05,60.32,36.5,,BathTAP Headache Cohort 1,d864c698-b98c-4a1e-9c6a-7b941d61a35c,Not Rated,Not Rated,1.1.7,55.81,9cff3fc9-25d6-49fe-8218-dbbc3b3bc1ab,31.62
33.33,19.05,55.56,38.88,,HIV PiNS,d89732fc-1bc3-4bd6-a634-9e9d03f3fea4,Not Rated,Not Rated,1.1.7,53.49,1abc859e-4ac6-431a-b550-af1afb36df1b,32.78
4.76,4.76,46.03,29.36,,Generation Scotland: Scottish Family Health Study,d95be3ed-f767-4ea5-9e4d-295446f68eb5,Not Rated,Not Rated,1.1.7,46.51,f4f0ef1a-46cf-4734-8516-3adb0b62ae6d,29.12
33.33,19.05,55.56,38.88,,National Vascular Regsitry - Oragnisational Audit dataset,d977abd8-a966-4b4c-99f0-7a4c368f9934,Not Rated,Not Rated,1.1.7,53.49,3c661240-e4d2-456c-a809-133c23f9c469,32.78
4.76,4.76,46.03,29.36,,Child Health Systems Programme - School,da191840-9037-4e1f-8e6c-ec66eb80b798,Not Rated,Not Rated,1.1.7,46.51,2c31cb1c-2b3d-40c5-b8d4-bf0b81f089b4,29.12
100.0,95.24,15.87,92.06,ALLIANCE > SAIL,Looked After Children Wales,da5098df-414f-48e0-aaa7-7e2277f80eb7,Gold,Gold,1.1.7,13.95,cfdafacb-48f0-4ad8-9f20-193a5eec2da4,90.64
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,King's Health Partners Cancer Biobank,da9cdc4c-2790-47f4-b4b5-76e87ce450ae,Silver,Bronze,1.1.7,16.28,a218d0b4-0273-4a04-ba17-c01dae6dcf33,76.38
77.78,64.29,49.21,64.28,ALLIANCE > NHS DIGITAL,Mental Health Minimum Dataset v4.1 (Sensitive) Events,db113fcd-69a0-4357-9c6d-250085deb3f5,Not Rated,Not Rated,1.1.7,44.19,a1154967-a80e-41da-a9ae-6183584ecf6b,60.05
33.33,19.05,55.56,38.88,,National Vascular Registry Audit  - Lower Limb Amputation clinical dataset,db53c086-db48-4f7e-9264-ed44a9154753,Not Rated,Not Rated,1.1.7,53.49,03e77b9d-57b8-44d5-8d64-9b1325958b22,32.78
71.43,80.95,11.11,80.16,HUB > BREATHE,UK Lung Volume Reduction Surgery,db89a123-0402-4962-8a8f-78557ba4d84f,Silver,Silver,1.1.7,9.3,9f98a674-12f6-42f4-b1a5-322b3b75eef1,85.83
17.46,21.43,36.51,40.48,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,"NHS Tayside, A&E Drugs given during an A&E visit",dba474a3-90c4-423d-beb0-5ef79c490d24,Not Rated,Not Rated,1.1.7,37.21,acfbef89-344c-49a5-8079-7344f4316e0f,42.11
4.76,4.76,46.03,29.36,,The Consequence of Respiratory Syncytial Virus (RSV) Infection in Young Infants,dbcf49c1-f23c-4bb8-8c4f-6fc4e996ff97,Not Rated,Not Rated,1.1.7,46.51,51d41006-727e-43d4-bdb6-f8b427c295c6,29.12
33.33,19.05,50.79,41.27,,Outpatient Dataset (OPDW),dc5507d0-807e-4981-906b-731690a5e085,Not Rated,Not Rated,1.1.7,51.16,d331159b-b286-4ab9-8b36-db39123ec229,33.95
63.49,71.43,15.87,73.81,ALLIANCE > TISSUE DIRECTORY,NHS Greater Glasgow & Clyde Bio-Repository,dcb4c87b-5884-41c0-b9af-d7d094dd0922,Silver,Bronze,1.1.7,16.28,762976cc-83d0-4b31-a879-37f87f947406,77.58
33.33,19.05,55.56,38.88,,Prescribing,dcd6f957-1fcc-481a-bbd2-89abfe933449,Not Rated,Not Rated,1.1.7,53.49,6d044471-62d2-4190-b315-503f77d33ef2,32.78
63.49,71.43,19.05,72.22,ALLIANCE > HQIP,National Joint Registry - Primary Knee Replacement dataset,dd2b5b8c-a2b5-48f2-a2b2-0432d54a0486,Silver,Bronze,1.1.7,18.6,d517e6fc-9a88-4647-b787-dcbed3635885,76.42
4.76,4.76,46.03,29.36,,Decode-ME,dd6e4344-9cee-41f3-8062-6bb9cdfda012,Not Rated,Not Rated,1.1.7,46.51,a71d0b2a-620c-4c04-b7bb-45843461db9f,29.12
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,MesobanK,ddbc149a-db56-41de-bd2c-3624149f6e7e,Silver,Bronze,1.1.7,16.28,b03835b7-7408-49a0-a9aa-ea405f9855c9,76.38
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,NIMRAD-TRANS,ddd49721-ff49-4f68-b3f5-e95a417fb0ac,Silver,Bronze,1.1.7,16.28,039b55f7-d416-49ab-9bdb-4ff7dbc733df,76.38
4.76,4.76,46.03,29.36,,VIKING GENES,ddf35f0d-ca89-4f74-bbdd-65d1a84b38ca,Not Rated,Not Rated,1.1.7,46.51,43636f80-27fd-43d0-8556-d0a2de0cd819,29.12
65.08,73.81,14.29,75.4,HUB > BREATHE,Children's Health in London and Luton (CHILL),de4b46f5-1591-442d-a896-6e0d91657c01,Silver,Bronze,1.1.7,13.95,722be723-04bd-48b4-923b-e7d393f0c22b,79.93
33.33,19.05,55.56,38.88,,UK Renal Registry - COVID-19 dataset,de8d0b95-b968-45f2-8cd4-2c87d72ff729,Not Rated,Not Rated,1.1.7,53.49,2a3dba77-34ff-4781-b273-1b3d54d11f32,32.78
100.0,95.24,26.98,86.51,HUB > DATA-CAN,Children’s Kidney Cancers - Great Ormond Street Hospital,df23aabd-3e5f-4fc2-aad6-af990cff6f19,Silver,Gold,1.1.7,23.26,3f71bef5-c5a2-400c-a482-2ad30b29a240,85.99
95.24,90.48,28.57,83.34,HUB > GUT REACTION,IBD NIHR BioResource: SNP chip data,df3cc57d-08ae-4e81-ae79-283d71cf8d95,Silver,Silver,1.1.7,23.26,3c749cfc-4008-4916-b64f-969d6a754c0f,83.61
33.33,19.05,55.56,38.88,,Welsh Health Survey Dataset (WHSD),df55c56f-b081-45f4-b265-ed1b2c6d94cd,Not Rated,Not Rated,1.1.7,53.49,e4d8edb3-6e8e-435d-9732-60c83027d8f9,32.78
57.14,61.9,23.81,66.66,ALLIANCE > HQIP,National Paediatric Diabetes Audit - core clinical dataset (care processes and outcomes),dfba178f-ce67-4c2d-8693-b23110aeecae,Bronze,Bronze,1.1.7,25.58,e355c9b9-44f0-4ba3-a872-645aa88f4f2b,68.16
33.33,19.05,55.56,38.88,,MATCH,dfc16033-7620-4002-aa3b-e5bbc400bbfd,Not Rated,Not Rated,1.1.7,53.49,5429fc2a-3d72-414d-9393-4079c4c6c0fa,32.78
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,Generation Scotland,dfc3205c-3079-4e95-93e2-8a3a3beeea5a,Silver,Bronze,1.1.7,16.28,019fad36-65ea-4d47-8d6d-a47240eeb801,76.38
33.33,19.05,55.56,38.88,,NIHR BioResource: Demographic,dfd65358-d5a4-40f1-873a-c8c304799cbf,Not Rated,Not Rated,1.1.7,53.49,d2c486bb-b95b-4093-bb58-b196cfc08c7b,32.78
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,National Asthma and COPD Audit Programme (NACAP): secondary care workstream – children and young people asthma (organisational),dfedefac-c389-4d07-a8a3-eb2e4ff34587,Not Rated,Not Rated,1.1.7,34.88,3efd9b30-1f84-48c0-a3e0-402ecb5c7724,46.84
4.76,4.76,46.03,29.36,,COVID Tests,e00284e3-439b-4a6d-9781-679c539404f8,Not Rated,Not Rated,1.1.7,46.51,607b17d6-74de-466a-a377-238444707abb,29.12
33.33,19.05,55.56,38.88,,UK Renal Registry - Your Health Survey dataset,e096053e-b028-4487-a6d0-6958cbb5f388,Not Rated,Not Rated,1.1.7,53.49,14ed4ab3-470b-45c8-b48f-27fd382a912e,32.78
85.71,76.19,28.57,78.57,ALLIANCE > CPRD,Rural-Urban classification for CPRD Aurum,e149e0c4-7edd-4e9c-af9d-2b3b2baef9bd,Bronze,Silver,1.1.7,30.23,b7d24b82-f8a4-4838-844c-ecd86ddf5db2,72.98
69.84,78.57,11.11,79.37,HUB > BREATHE,SpiroMeta Consortium Dataset,e172870f-37c4-4103-afae-8a60cae43ccb,Silver,Silver,1.1.7,9.3,fb6d98c5-e41d-4804-bb28-839556e0f657,84.63
85.71,78.57,25.4,80.16,HUB > PIONEER,Coagulopathies & arterial/venous thrombosis in COVID patients: an OMOP dataset,e22f93fb-bc08-44eb-b292-dc2baf0ad343,Silver,Silver,1.1.7,25.58,dd4629c0-14b6-4cba-8dcf-31ec5fea68bb,76.5
60.32,69.05,17.46,71.43,ALLIANCE > TISSUE DIRECTORY,"Leeds Dental Institute/School of Dentistry Leeds, Skeletal Tissues Bank",e3373d01-48c6-49bc-8c9b-827831e525b3,Bronze,Bronze,1.1.7,18.6,f94168a1-cab8-4211-90e0-38a241609697,75.22
63.49,71.43,15.87,73.81,ALLIANCE > TISSUE DIRECTORY,eLIXIR - Early Life Data Cross-Linkage in Research,e443bc67-bc8a-430b-88a9-d3380cd2ae38,Silver,Bronze,1.1.7,16.28,c8cd0645-b728-4c62-84b8-036c1d8763be,77.58
4.76,4.76,46.03,29.36,,IBD Registry,e4a1be81-8f3c-4731-ae8a-7cbd594c78f5,Not Rated,Not Rated,1.1.7,46.51,a406d06b-350e-4392-ab4e-b1012e422a34,29.12
33.33,19.05,50.79,41.27,,Care Home Dataset (CARE),e4a745d6-f44c-481a-b337-aae4cfe72594,Not Rated,Not Rated,1.1.7,51.16,aae02f9e-1bad-415d-9730-c46a07a990aa,33.95
33.33,19.05,65.08,34.12,,NHS Scotland General Practice (GP) Contact Data - Subset,e5a0c70c-7429-487d-8dc7-04cf073191cc,Not Rated,Not Rated,1.1.7,58.14,8f486c3d-9504-4a0e-8e24-ab96f057fc9e,30.45
4.76,4.76,46.03,29.36,,National Asthma and COPD Audit (NACAP): Adult Asthma secondary care clinical,e5ad8cc0-906e-4ecf-ada9-832e803e83ec,Not Rated,Not Rated,1.1.7,46.51,becd2624-9a01-4f01-bcf8-56e94545a49a,29.12
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,National Asthma and COPD Audit Programme (NACAP): COPD secondary care clinical dataset,e6433c92-8439-4e2e-a3e7-016e7812dcfb,Not Rated,Not Rated,1.1.7,34.88,85b4dc84-88f4-4740-80fa-fa1eb04a0ae6,46.84
33.33,19.05,60.32,36.5,,HDR UK Papers & Preprints,e6d31775-961b-457f-886c-1c0672308a55,Not Rated,Not Rated,1.1.7,55.81,fd8d0743-344a-4758-bb97-f8ad84a37357,31.62
4.76,4.76,46.03,29.36,,Epilepsy 12 - clinical audit,e6d3be74-3679-4089-8bad-fe07addda6a1,Not Rated,Not Rated,1.1.7,46.51,1fcaf429-8762-454c-b999-c5fdd757b880,29.12
4.76,4.76,46.03,29.36,,National Emergency Laparotomy Audit - Patient Audit Dataset,e70f4e13-440b-4dec-a13c-c17d9d9da553,Not Rated,Not Rated,1.1.7,46.51,25b93812-191f-49bb-bbd0-782fb85b2bd2,29.12
63.49,71.43,15.87,73.81,ALLIANCE > TISSUE DIRECTORY,IDRIS Trial,e7979d81-708d-4657-857c-4ca95d05cda2,Silver,Bronze,1.1.7,16.28,8437b207-c925-4dd1-9478-5af329cd736e,77.58
69.84,61.9,30.16,69.84,ALLIANCE > GREAT ORMOND STREET HOSPITAL,COVID-19 Staff Testing of Antibody Responses Study (Co-STARS),e79c5f26-deb0-4531-834d-58912c9fe663,Bronze,Bronze,1.1.7,25.58,435bfcda-f378-44f6-9387-042d959eb945,68.16
33.33,19.05,60.32,36.5,,BathTAP Headache Cohort 2,e7b615a0-2867-47ff-bb40-0d459b41226c,Not Rated,Not Rated,1.1.7,55.81,2d79feab-3046-4735-a4ec-a4c11c9c1aa8,31.62
33.33,19.05,55.56,38.88,,Air Pollution Exposure Estimates,e8932b23-ed21-40f4-8fb1-00ef186e6ee1,Not Rated,Not Rated,1.1.7,53.49,584cbecc-43ef-4015-adf7-ff70178d7abe,32.78
53.97,61.9,20.63,66.67,HUB > BREATHE,Strategy introducing Pulmonary Rehabilitation for COPD management in rural India,e8c3b66d-f06b-4e3f-944d-f65235133f00,Bronze,Bronze,1.1.7,20.93,e8afaf39-86fa-4085-a075-6118cc25fae0,70.48
33.33,19.05,55.56,38.88,,IBD NIHR BioResource: Health and Lifestyle Questionnaire,e9820518-54e3-46d1-a63f-c5da867dcd82,Not Rated,Not Rated,1.1.7,53.49,18bfe765-5733-41f3-8114-0a1ec2524b5b,32.78
33.33,19.05,55.56,38.88,,National Asthma and COPD Audit Programme - Pulmonary rehab organisational audit,e9902b10-84ca-495f-a4d9-a9948d0d64ca,Not Rated,Not Rated,1.1.7,53.49,4b33fc6d-3cac-4404-adac-d693328456fa,32.78
100.0,95.24,20.63,89.69,ALLIANCE > SAIL,Children Receiving Care and Support Census,ea9fa5fb-928d-4736-8fbf-e3b58a49c6d6,Gold,Gold,1.1.7,16.28,fb3fac03-a428-4b3f-8058-5622e1fd57d8,89.48
14.29,16.67,36.51,38.89,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,Sunquest,eaca9ed1-30b6-4157-8894-8e53efc84849,Not Rated,Not Rated,1.1.7,37.21,a80b2567-4755-46f1-bd2a-f3817ce4f10c,39.73
33.33,19.05,55.56,38.88,,Scottish Birth Record (SBR),eaec06fa-a27e-46d1-9be9-6e1f9a16fb5d,Not Rated,Not Rated,1.1.7,53.49,81c53293-ef64-4507-8fcf-2a254dc19936,32.78
4.76,4.76,46.03,29.36,,English Longitudinal Study of Ageing (ELSA),eb030592-7f5d-4969-abde-c4a962251406,Not Rated,Not Rated,1.1.7,46.51,f12cb023-1402-49d1-aa27-e0fe4ed19fd7,29.12
4.76,4.76,46.03,29.36,,ICT-based intervention for adult asthma with limited health literacy,eb376dc5-1abb-4d06-a39a-e479078bcf9d,Not Rated,Not Rated,1.1.7,46.51,1d6b02f1-47b8-42ad-919d-f738b545cff7,29.12
23.81,28.57,33.33,45.24,ALLIANCE > HQIP,National Joint Registry - Primary Shoulder Replacement dataset,eb50327d-03d1-4672-94b1-67116d95b2d0,Not Rated,Not Rated,1.1.7,32.56,0e903b9e-a329-478a-937c-480eecee4996,48.0
100.0,95.24,20.63,89.69,ALLIANCE > SAIL,Annual District Death Extract,eba50bb1-e971-4062-8ece-81be39ceca5b,Gold,Gold,1.1.7,16.28,15cf4241-abad-4dcc-95b0-8cd7c02be999,89.48
33.33,19.05,55.56,38.88,,Community Services Data Set,ec121652-b3ab-4f90-8b93-ab5f6b1bc64c,Not Rated,Not Rated,1.1.7,53.49,5616e0a6-22f1-43a5-a2bd-dcecfa2f3b70,32.78
63.49,71.43,15.87,73.81,ALLIANCE > TISSUE DIRECTORY,NHS Grampian Biorepository,ece82228-9af1-4699-a763-b4608908b645,Silver,Bronze,1.1.7,16.28,10d0def8-dc03-473f-b60b-4c0dc3642a25,77.58
33.33,19.05,50.79,41.27,,National Exercise Referral Scheme (NERS),edac1d8a-af24-43a6-82a7-e15028d5a5db,Not Rated,Not Rated,1.1.7,51.16,131784c0-769d-4f7b-b7d0-b5f4b89886d4,33.95
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,Falls and Fragility Fracture Audit Programme National Hip Database Facilities Survey 2019,ee099373-8a72-4ec7-818f-3cbb9c8a793d,Not Rated,Not Rated,1.1.7,34.88,025c9e8a-938b-4886-9e03-fcad90fe7157,46.84
33.33,19.05,55.56,38.88,,Hospital Episode Statistics Accident and Emergency,ee2350f2-c619-446e-9785-fce8e0ac9f44,Not Rated,Not Rated,1.1.7,53.49,3ddfccc3-ba32-4653-a999-966b8d6c412f,32.78
60.32,69.05,19.05,70.64,ALLIANCE > TISSUE DIRECTORY,The PEACE Study,ee4a73ef-fb4e-4926-9fcc-db6b44b1447e,Bronze,Bronze,1.1.7,18.6,33b1a989-5f61-412e-bdae-b551c92d1ed6,75.22
33.33,19.05,55.56,38.88,,Scottish Covid-19 Vaccination Data,eee15509-f23a-441e-b5be-ee76bd2ba649,Not Rated,Not Rated,1.1.7,53.49,bcfd3b49-f7f0-489e-bc1b-bcce0bd261f2,32.78
4.76,4.76,46.03,29.36,,Understanding Society,ef478925-7612-4cd6-a10e-5e64ee8a0f4d,Not Rated,Not Rated,1.1.7,46.51,932cecdf-65fb-4e3d-9454-7a2d0585e970,29.12
15.87,19.05,38.1,38.88,ALLIANCE > BARTS HEALTH,Freetext Dataset,ef727724-6c38-483b-b28d-8e94b5a9d7ac,Not Rated,Not Rated,1.1.7,39.53,0f07f939-1265-4e8b-aaa6-d897d254c2f3,39.76
33.33,19.05,50.79,41.27,,GP Out of Hours,f08bfb75-f2b8-4afb-9c3d-59cdd2b6b3ce,Not Rated,Not Rated,1.1.7,51.16,731dc868-3e79-4722-9b79-6bb8dec9435b,33.95
23.81,28.57,33.33,45.24,ALLIANCE > HQIP,National Audit of Care at the End of Life - case note review,f0e2688e-d36e-403e-9faa-bd9912a8f7bc,Not Rated,Not Rated,1.1.7,32.56,d8c67899-2d81-48c2-8482-31cd33973a36,48.0
90.48,83.33,28.57,80.96,ALLIANCE > SAIL,Welsh Health Survey Dataset,f0fc13b4-f801-4647-82f3-07ed07f26ea0,Silver,Silver,1.1.7,25.58,e4d8edb3-6e8e-435d-9732-60c83027d8f9,78.88
33.33,19.05,50.79,41.27,,Child Health Systems Programme - 13-15 Month Review,f16f0b1b-650d-486b-bc89-946b1623103e,Not Rated,Not Rated,1.1.7,51.16,e77af7a3-32fa-4a08-8455-4fb489e5b64a,33.95
87.3,80.95,31.75,77.78,HUB > DISCOVER NOW,North West London Acute Patient level Data (NWL Acute PLD),f2268d4e-0149-4913-9832-0399960eecd4,Silver,Silver,1.1.7,25.58,0d5a40e6-52c0-43c4-bd9f-f2a803cc8ff6,77.69
79.37,71.43,23.81,77.78,NCS > OFFICE FOR NATIONAL STATISTICS,Labour Force Survey (Household),f25c8ba2-aa2f-4644-b017-b0a2aa76af65,Bronze,Silver,1.1.7,23.26,0b630200-1e7c-4b19-ad53-bcc8863f7ade,74.09
33.33,19.05,50.79,41.27,,Welsh Results Reports Service (WRRS),f298cb2a-20bb-4607-933e-6951942ae6d7,Not Rated,Not Rated,1.1.7,51.16,71d37610-ac55-432d-82a3-bdb04407acd8,33.95
19.05,21.43,38.1,40.48,ALLIANCE > BARTS HEALTH,Admitted Patient Care Dataset,f29c2012-132d-4994-b5f4-7992d79a0a08,Not Rated,Not Rated,1.1.7,39.53,b67f0edd-fed2-4d68-a25f-d225759aa3b0,40.95
15.87,19.05,38.1,38.88,ALLIANCE > BARTS HEALTH,"Problems, Diagnosis and Procedures",f2b4211b-1af7-46ff-82a3-35b29d1d478e,Not Rated,Not Rated,1.1.7,39.53,51b41359-1558-48df-9950-88f75ca6ac4c,39.76
23.81,28.57,33.33,45.24,ALLIANCE > HQIP,National Audit of Care at the End of Life - Quality Survey,f499041f-197e-4cd5-9295-952d60110e48,Not Rated,Not Rated,1.1.7,32.56,51a8dfba-5c94-48bd-9c68-3707f0ebc2a2,48.0
23.81,28.57,33.33,45.24,ALLIANCE > HQIP,National Diabetes Inpatient Audit - Harms clinical dataset,f4f5647e-e1bc-4813-8cdc-5c1d6b16d1f9,Not Rated,Not Rated,1.1.7,32.56,f1471a45-a6f4-4ed7-96b0-56a1af21086e,48.0
33.33,19.05,55.56,38.88,,UHB Linked Diabetic Eye Disease and Cardiac Outcomes,f58a3c47-44aa-4815-aeab-e19a4a330926,Not Rated,Not Rated,1.1.7,53.49,4385ed4c-1c42-4ba5-b57f-9ab18e5ffbe1,32.78
33.33,19.05,50.79,41.27,,CAFCASS Wales (CAFW),f5d0e254-1005-43a9-88d3-5180c015b7f0,Not Rated,Not Rated,1.1.7,51.16,29a714e1-5289-4362-be24-2848c954344e,33.95
4.76,4.76,46.03,29.36,,National Cardiac Audit Programme - Myocardial Ischaemia National Audit (MINAP),f636abcd-91b1-4408-b44b-5f6274bc98d6,Not Rated,Not Rated,1.1.7,46.51,3558f8a1-6d52-4b59-b513-51c068095bc2,29.12
4.76,4.76,46.03,29.36,,National Paediatric Diabetes Audit - Parent and Patient Experience measures,f6827397-47e9-4487-ad5a-cad7b4c4d3d2,Not Rated,Not Rated,1.1.7,46.51,b0979e07-3331-408f-853b-5eeba80ce8f9,29.12
100.0,95.24,20.63,89.69,ALLIANCE > SAIL,Substance Misuse Dataset,f6aa8836-b437-40b6-bd1e-ae20010048dd,Gold,Gold,1.1.7,16.28,291c0dd4-0988-42d2-8e0b-878a892add57,89.48
96.83,92.86,23.81,86.51,HUB > DISCOVER NOW,North West London Integrated Care Record (NWL ICR),f6e25ba4-4f7a-436e-a5f9-f0257d45a612,Silver,Gold,1.1.7,20.93,602d8093-6a1e-42cf-a89c-8bf0d47ecc8c,85.97
63.49,71.43,15.87,73.81,ALLIANCE > TISSUE DIRECTORY,PHOTO Translational bladder cancer biorepository,f71e0f89-edf6-4070-9045-6024b00f79ca,Silver,Bronze,1.1.7,16.28,07d1b768-78f6-41e8-995a-66afd2549b34,77.58
33.33,19.05,60.32,36.5,,Suspected Cancer Pathway Monthly (SCPM),f76d0428-f93c-41ba-9ebb-08e4211bf17a,Not Rated,Not Rated,1.1.7,55.81,fcf5a844-f48d-428e-aa06-abe64e66185e,31.62
23.81,28.57,33.33,45.24,ALLIANCE > HQIP,National Maternity and Perinatal Audit clinical audit,f786ff92-f6bb-489e-bf27-c27d1a1a0ab1,Not Rated,Not Rated,1.1.7,32.56,1419533e-3d46-4d8a-992b-b5311e6bd27b,48.0
82.54,76.19,25.4,78.57,ALLIANCE > NHS DIGITAL,Medicines dispensed in Primary Care (NHSBSA data),f80940e8-0ee1-46be-876b-46fb4bbbc4d2,Bronze,Silver,1.1.7,25.58,f201b68f-d995-4a70-a9ee-aa3510232777,75.31
84.13,76.19,25.4,79.36,HUB > PIONEER,Ventilation strategies for patients on intensive care,f8a268c1-831c-4c80-b62c-e254a572b9a0,Bronze,Silver,1.1.7,25.58,1a66dbc1-4f06-455c-85fc-68b372575cad,75.31
17.46,19.05,34.92,41.27,OTHER > UK Longitudinal Linkage Collaboration (UK LLC),UK Longitudinal Linkage Collaboration (UK LLC),f93aea28-7592-42c0-a5e7-5802f0d6051f,Not Rated,Not Rated,1.1.7,34.88,d858cd90-9a2f-4330-9bbe-46e047a5d0a2,42.09
33.33,19.05,50.79,41.27,,2019 UK Parkinson's Audit - Speech and language therapy,f98d83ec-ad27-46d7-9786-7a0f2749aa11,Not Rated,Not Rated,1.1.7,51.16,c7f7541b-5030-40b9-962a-4aba44af7e1a,33.95
33.33,19.05,50.79,41.27,,Bowel Screening Wales (SBSW),f98f9578-a4a3-4d93-b32e-f30ff75888b7,Not Rated,Not Rated,1.1.7,51.16,9f29d47e-4e9a-41b8-b7bc-5ef3570294ef,33.95
36.51,40.48,22.22,57.14,ALLIANCE > IMPERIAL COLLEGE LONDON,Real-time Assessment of Community Transmission (REACT) Study 2: COVID antibody,f9959c00-c063-4fbf-933d-755e3b6ecedc,Not Rated,Not Rated,1.1.7,23.26,70656016-c1c9-4bc2-93d1-c66341fcdf36,58.61
63.49,71.43,15.87,73.81,ALLIANCE > TISSUE DIRECTORY,Tommy's National Reproductive Health Biobank,f99d82da-13eb-42db-ad0d-348be2173535,Silver,Bronze,1.1.7,16.28,20639743-9a28-43dd-a8af-7571ece2a7f8,77.58
63.49,71.43,17.46,73.02,ALLIANCE > TISSUE DIRECTORY,PHOENIX DDR-Anti-PD-L1 Trial,f9c40294-92d8-45cd-b11a-70eb0fc09004,Silver,Bronze,1.1.7,18.6,df94730b-374b-4d91-8116-1c10a7c77c4e,76.42
33.33,19.05,55.56,38.88,,National Vascular Registry Audit - Lower Limb Bypass clinical dataset,fa07a8df-4584-4dc1-87f9-f03ff8d31861,Not Rated,Not Rated,1.1.7,53.49,d357be1e-27fe-4b2f-9174-3a2a03ecc12b,32.78
25.4,30.95,34.92,45.24,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,Genvasc Primary Care Data,fa179e24-2068-4c34-b73c-230003010e9f,Not Rated,Not Rated,1.1.7,34.88,f397acff-a7af-4062-8e8b-c85889cc41df,48.04
33.33,19.05,50.79,41.27,,Scottish Cancer Registry (SMR06),fa45c071-1852-4c02-bddc-fda4517bffa8,Not Rated,Not Rated,1.1.7,51.16,ad36dc03-1856-44de-99b0-1af6f312d86b,33.95
38.1,42.86,25.4,56.35,UK Biobank,Hospital Inpatient data,fb2a851b-3f1c-4665-bbdb-5461f1f36bca,Not Rated,Not Rated,1.1.7,27.91,97c68424-dc80-4faa-b777-67c42f92a9b6,57.48
100.0,95.24,15.87,92.06,ALLIANCE > SAIL,Breast Test Wales,fb4a069b-fd74-47b2-bbb1-9cde6b590d66,Gold,Gold,1.1.7,13.95,8b9efd45-f56d-4aa3-b2b8-c66ff3813a2b,90.64
71.43,80.95,11.11,80.16,HUB > BREATHE,Idiopathic Pulmonary Fibrosis (IPF) Genome-wide Association Study,fb50af29-4aa6-4071-9300-bd2d57c850b0,Silver,Silver,1.1.7,9.3,b850e56c-5c5b-413e-b829-743772053978,85.83
33.33,19.05,55.56,38.88,,NHS Tayside and Fife Immunology,fb65ff7c-fc02-402e-ab55-59765d7b0d43,Not Rated,Not Rated,1.1.7,53.49,39055449-c074-4b58-adb2-b1c0d2441c4d,32.78
4.76,4.76,46.03,29.36,,Asymptomatic COVID-19 in Education (ACE) Cohort,fba3b66d-8d3a-473f-bb3d-537a6ab1fa7a,Not Rated,Not Rated,1.1.7,46.51,48adf432-9b66-4d03-a25e-008fbbb24f56,29.12
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,National Asthma and COPD Audit Programme (NACAP): secondary care workstream – children and young people asthma (clinical),fbb5d74c-802a-4888-9452-3e0faf257f82,Not Rated,Not Rated,1.1.7,34.88,33b36393-3760-40d8-bb98-61806fea5398,46.84
23.81,28.57,33.33,45.24,ALLIANCE > HQIP,National Vascular Registry Audit Carotid Endarterectomy Clinical Dataset,fc08ad6a-3e94-44db-a122-945c4c875616,Not Rated,Not Rated,1.1.7,32.56,f857055b-c29e-4c7f-99ce-65f4ed59648e,48.0
96.83,92.86,25.4,85.72,HUB > DISCOVER NOW,North West London High Cost Drugs Data (NWL HCD),fc704af0-368b-4dd0-866f-753b6d1dccf8,Gold,Silver,1.1.7,18.6,75638d2c-556a-46b6-afcc-7ab425b34679,87.13
14.29,16.67,36.51,38.89,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,CellPath,fc7b44f0-eb69-4257-8c07-7516c1210c46,Not Rated,Not Rated,1.1.7,37.21,c4538af4-505f-45df-aeae-788ddfd7cb54,39.73
4.76,4.76,46.03,29.36,,National Bowel Cancer Audit - clinical dataset,fc7ea07b-d60f-4be9-a840-89b17d4c2414,Not Rated,Not Rated,1.1.7,46.51,c8a28f0b-a5f8-4dbb-8d71-5b89c7cb3111,29.12
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,Infectious Diseases BioBank at King's College London,fd2317ea-c729-433b-b578-309118118b78,Silver,Bronze,1.1.7,16.28,47b544f4-301c-43e0-b347-fc623ea1a8b3,76.38
87.3,80.95,28.57,79.37,ALLIANCE > NHS DIGITAL,MSDS (Maternity Services Data Set),fd296ed6-6e12-49ab-9e5f-f40428a47b02,Silver,Silver,1.1.7,27.91,11d3cf0f-ae5d-42f4-a756-b98c3eff46bc,76.52
36.51,45.24,26.98,54.77,HUB > BREATHE,"Projections of global, regional and national prevalence of asthma from 2018-2040",fdb053d7-375a-4422-aa16-c899661d72b1,Not Rated,Not Rated,1.1.7,25.58,0911f991-6c0f-4412-b805-1ee0ded93a12,59.83
33.33,19.05,55.56,38.88,,COVID-19 Test Trace and Protect (CTTP),fdd5864f-c777-4e6c-a5a7-6c85968edc60,Not Rated,Not Rated,1.1.7,53.49,c0fc84af-aeab-4c7e-aa0b-8264baff55d9,32.78
33.33,19.05,60.32,36.5,,Covid Vaccination Dataset (CVVD),fddd0686-1742-45ce-85d8-684a66aa7b30,Not Rated,Not Rated,1.1.7,55.81,471f101c-a45e-4620-8710-be3036a46fba,31.62
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,Bristol Biobank,fe3f2246-aec4-4be4-8f51-3e5bde80931d,Silver,Bronze,1.1.7,16.28,9d56ae46-5955-4f03-a93c-a4a6d9f641ab,76.38
23.81,28.57,34.92,44.45,ALLIANCE > HQIP,Falls and Fragility Fracture Audit Programme National Hip Database clinical dataset,fed22efe-8a84-4b1e-a642-2412a1420ce8,Not Rated,Not Rated,1.1.7,34.88,e06b951b-e9d8-4a2c-a51f-1d819f669205,46.84
60.32,69.05,15.87,72.22,ALLIANCE > TISSUE DIRECTORY,REQUITE,fede80e2-aea9-4229-8024-39b09110be7b,Silver,Bronze,1.1.7,16.28,b5217dcb-582f-4914-ae45-9eb3899add30,76.38
33.33,19.05,60.32,36.5,,UK SARS-CoV-2 viral sequencing data (COG-UK data)-Lineage/Variant Data-Scotland,fee7f039-99d6-4eab-951d-b35e0ae71a75,Not Rated,Not Rated,1.1.7,55.81,69a356d6-599e-4d02-8241-066ce3c297bd,31.62
4.76,4.76,46.03,29.36,,Enhancing access to pulmonary rehabilitation through implementation research,ff0ee5d5-aeb4-4dc0-bddf-79336e0ab004,Not Rated,Not Rated,1.1.7,46.51,6265a41f-9444-457b-b401-1d0978f5c58a,29.12
33.33,19.05,50.79,41.27,,Mortality (Death registration),ff10d5c4-42a2-4a06-b6af-a2f7393c62e0,Not Rated,Not Rated,1.1.7,51.16,59fb436a-f8c3-4d4a-bc76-d4a02904b078,33.95
77.78,64.29,49.21,64.28,ALLIANCE > NHS DIGITAL,Mental Health Minimum Dataset v4 (Non-Sensitive) Records,ff2c6982-00f3-4483-9fc2-19b3a7211d8d,Not Rated,Not Rated,1.1.7,44.19,b9f24f81-bcf2-4e47-8909-0d5414e2d7a4,60.05
4.76,4.76,46.03,29.36,,Oxford Carpal Tunnel Syndrome (CTS) Cohort,ff727b8e-4805-424a-ba34-acc9b90225fe,Not Rated,Not Rated,1.1.7,46.51,cd3555b0-514a-4693-8f68-c8267a8e9939,29.12
63.49,71.43,15.87,73.81,ALLIANCE > TISSUE DIRECTORY,IMPORT HIGH trial blood samples,ff8231e5-3ede-4844-a21b-b1d05120e07e,Silver,Bronze,1.1.7,16.28,edafebac-9479-4d2c-b44e-349091d5b35b,77.58
